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PREFACE 
More than seven ago years ago I was introduced to the fascinating world of fungi and my-
cotoxins by Ole Filtenborg and Thomas O. Larsen. The opportunity to work on my own with 
an array of sophisticated equipment, made me stay in the Mycology Group, and led to my 
M.Sc. project where Suzanne Gravesen and Thomas convinced me to work with satratoxins 
in buildings. Successfully ending this work, it resulted in my Ph.D. project financed by the 
Danish Building Research Institute where Erik Christophersen organised the funds for the 
project as well as the many travels. 
However, it has also been frustrating to work in a field where you are unable to help people, 
often socially disadvantaged, who are forced to move from their mouldy homes due to mas-
sive symptoms, often victims of the ignorance of the authorities. 
Working in such a multidisciplinary area requires help from a lot of people, and at the Danish 
Building Research Institute I would like to thank the librarians, especially Lillian Nielsen who 
have been a tremendous help in ordering scientific papers. Gunnar Holm has been a great 
help in constructing experimental set-ups, Lotte P. Uttrup and Per Hansen have prepared 
material samples, Jan Carl Westphall helped with various photographic problems, Yelva 
Jensen has been a good secretary, and Solveig Nissen with the language revision of some 
of the papers as well as this thesis. Peter A. Nielsen is acknowledged for the fruitful discus-
sions on health and building related issues. 
Jørgen Ø. Madsen, Department of Organic Chemistry, in preparing the 4-D2-ergosterol was a 
great help in making the ergosterol analytical method work. 
The private consultants Mikael Ø. Hansen and Peter Thompson have kindly supplied me with 
"real" mouldy materials, interesting field observations, and taken their time to show me the 
real mouldy world outside the laboratories. 
I would like to thank Dr. Aino Nevalainen, Dr. Maija-Riitta Hirvonen, and their helpful Ph.D. 
students for letting me work in their laboratories at the National Public Health Institute, Ku-
opio, Finland.  
Working at TNO Bouw, The Netherlands, with Dr. Olaf Adan and Gerben van der Wel helped 
me understand the importance of instationary environmental conditions for mould growth. 
Having Professor Bruce B. Jarvis in our group for a year raised the level of my work on 
Stachybotrys and natural products significantly and introduced me to a number of other re-
search groups.  
The help of colleagues in the Mycology group, in particular Elisabeth Krøger, Kir Lyhne, 
Flemming Lund, Thomas O. Larsen, Jørn Smedsgaard, Jens C. Frisvad and Birgitte Ander-
sen has been encouraging. Ulf Thrane has been the perfect Ph.D. supervisor who always 
had time - if needed, and on the other hand never intervened much in my work. 
Thanks to Suzanne Gravesen who believed so much in my work and have taught me so 
much about so many different things and introduced me to so many people as well as help-
ing with the language revision of this report. 
The support and understanding of my beloved wife Hanne - especially during my stays in 
Finland, Holland and various conference as well as the acceptance of the large piles of pa-
pers, CD, books etc. during my project cannot be overestimated.  
 
 
Lyngby, June 2001 
 
Kristian Fog Nielsen 
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ABSTRACT 
The aim of this study was to document if the moulds produce mycotoxins and other biologi-
cally active metabolites when growing in buildings, as well as investigate the influence of 
environmental conditions on the production of these metabolites. The growth of moulds un-
der various humidities should also be investigated along with the use of chemical biomarkers 
for quantitation of mould growth.  
It was shown that Stachybotrys chartarum produced a number of mycotoxins when growing 
in buildings. These components were produced in significantly higher quantities than by other 
moulds investigated in this study. Only 35% of the isolates from buildings produced the ex-
tremely cytotoxic satratoxins. Actually these metabolites are probably not responsible for 
idiopathic pulmonary hemosiderosis in infants, which is probably caused by other S. charta-
rum metabolites.  
For the first time ever Stachybotrys metabolites were found in air-samples, where several 
classes of spiriocyclic drimanes and satratoxins were detected. 
Aspergillus versicolor produced high quantities of the carcinogenic mycotoxin, sterigmato-
cystin at water activities (aw) > 0.95. At lower aw more than 10 unknown metabolites were 
produced, including at least 5 metabolites also produced by A. ochraceus. A. versicolor was 
often growing in mixed cultures with others moulds where it sporulated poorly, meaning that 
it may evade detection based on cultivating methods. The A. ustus isolates from buildings 
were macro-morphologically and chemically very different from the cereal isolates, and 
should be described as a new species. 
Penicillium chrysogenum produced few detectable metabolites and often none when growing 
on materials. Combined with the no observed effects on persons experimentally exposed to 
high quantities of the spores, these observations implies that this species may not be impor-
tant and is actually obscuring the detection of more toxic genera and species. P. brevicom-
pactum produced mycophenolic acid and P. polonicum the tremorgenic verrucosidin when 
they were inoculated on water-damaged materials. 
Chaetomium globosum produced high quantities of chaetoglobosins whereas Trichoderma 
species did not produce detectable quantities of trichothecenes when growing on materials. 
Even on laboratory media <1% of the isolates produced trichodermol or esters of it. 
Ergosterol content of building materials was quickly and precisely quantified by isotope dilu-
tion GC-MS/MS. Determination of ergosterol is only needed as a supplement for assessing 
mould growth on test materials, as visual assessment, especially supported by dissection 
microscopy generally was just as sensitive. The minimal RH for growth on wood based mate-
rials and material containing starch was just below 80% at room temperature, and increased 
to about 90% at 5°C. On paper-mineral composites such as gypsumboard the minimal RH 
was approx. 90% RH from room temperature to 5°C. Pure mineral based materials with few 
organic additives seem to be able to support growth at RH ≥ 0.90, although ≥95% RH was 
needed to generate chemical detectable quantities of biomass.  
The phylloplane Cladosporium was able to outgrow P. chrysogenum on materials under 
transient humidities. This is presumably why phylloplanes like Cladosporium, Ulocladium, 
Phoma and Aureobasidium are very common in bathrooms and other places with instation-
ary humidity conditions. 
Mould growth in buildings is causing various health effects among the occupants, however 
the causal components is still partly unknown making scientifically based guidelines for "how 
much is too much" and cost efficient remediation of mouldy buildings almost impossible. 
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RESUME 
Målet med dette studium var at dokumentere om skimmelsvampe producerer mykotoksiner  
og andre biologisk aktive stoffer, når de vokser på byggematerialer. Anvendelse af kemiske 
markører til kvantificering af den producerede biomasse skulle også undersøges sammen 
med svampenes vækst og metabolisme under forskellige temperatur- og fugtforhold. 
Stachybotrys chartarum producerede en række mykotoksiner, når den voksede på byggema-
terialer. Mængderne af disse stoffer i svampepartiklerne, der blev frigjort ved en let vakuum 
opsamling, var klart større end de mængder, der blev produceret af andre skimmelsvampe. 
Kun 35% af isolater fra vandskadede bygninger producerede de celledræbende satratoxiner, 
og inhalationen af netop disse synes næppe at være årsagen til lungeblødninger hos spæd-
børn; men kunne derimod skyldes andre stoffer fra Stachybotrys, eks. de spiriocykliske dri-
maner.  For første gang blev Stachybotrys metabolitter fundet i luftprøver. Her blev flere ty-
per af spiriocykliske drimaner samt satratoxiner påvist. 
Aspergillus versicolor producerede meget store mængder af de kræftfremkaldende sterigma-
tocystiner når vandaktiviteten (aw) > 0.95, hvorimod den ved lavere aw i stedet producerer 
mindst 10 ukendte metabolitter. Heraf er 5 tidligere set i kulturekstrakter fra A. ochraceus.  
A. versicolor gror oftest i blandede kulturer med mange andre svampe, og da den sporulerer 
dårligt vil den oftest ikke blive påvist ved dyrkning på vækstmedier. A. ustus isolater fra byg-
ninger var både kemisk og makro-morfologisk forskellige fra stammer isoleret fra korn og bør 
derfor beskrives som en ny art. 
Penicillium chrysogenum producerer stort set ingen påviselige metabolitter, når den gror på 
byggematerialer. Sammenholdt med de ikke observerede effekter efter patienters ekspone-
ring for meget store mængder luftbårne sporer i et enkelt forsøg indikerer det, at den langtfra 
har det samme toksiske potentiale som A. versicolor og S. chartarum. I stedet forhindrer den 
påvisning af mere vigtige arter. P. brevicompactum producerede mycophenolsyre og P. po-
lonicum det tremorgene verrucosidin, når de voksede på vandskadede materialer.  Under 
samme forhold producerede Chaetomium globosum store mængder af de toksiske chae-
toglobosiner, hvorimod Trichoderma spp. ikke producerede påviselige mængder trichothece-
ner på materialer, og selv på laboratoriesubstrater producerede <1% af isolaterne trichoder-
mol eller estre af denne. 
Ergosterol-indholdet i materialer kunne hurtigt og præcist blive kvantificeret med isotop for-
tynding GC-MS/MS. Dette er kun nødvendigt som et supplement til bestemmelse af biomas-
se på testmaterialer, idet visuel bestemmelse kombineret med stereomikroskopi generelt er 
lige så følsomt. Den minimale relative fugtighed (RH) for at der kan opstå vækst af skimmel-
svampe ligger lige under 80% ved stuetemperatur og stiger til ca. 90% RH ved 5°C. På gips-
plader kræver skimmelsvampene ca. 90% RH for at kunne vokse. Beton med nogle organi-
ske additiver kan tilsyneladende give anledning til meget minimal vækst ved RH > 90%, og 
ved RH > 95% kan der blive produceret ikke ubetydelige mængder biomasse på dette mate-
riale. Den phylloplane Cladosporium kan udkonkurrere P. chrysogenum på materialer under 
transiente fugtforhold, og det er sandsynligvis årsagen til at phylloplaner som Cladosporium, 
Ulocladium, Phoma og Aureobasidium dominerer i badeværelser og andre steder, hvor der 
er skiftende fugtforhold. 
Skimmelsvampevækst i bygninger er sundhedsskadeligt, med en del af de aktive stoffer og 
mekanismer en endnu ukendte. Derfor er det ikke muligt at fastsætte hygiejniske grænse-
værdier for skimmelsvampe i bygninger, ligesom det ikke endnu er muligt at renovere an-
grebne bygninger økonomisk effektivt, idet man ikke ved hvor langt man skal gå. 
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ABBREVIATIONS AND TERMS 
AFB1 Aflatoxin B1  
ALK Alkaloid forming agar 
Antibiotic Activity against microorganisms, usually against bacteria 
aw Water activity 
CE Capillary electrophoresis 
CFU Colony forming unit 
Conidia Asexual production structure from fungi /moulds. 
CYA Czapek yeast extract agar 
DAD Diode array detection 
DAS Diacetoxyscirpentriol, a type A trichothecene 
DG18   Dichloran 18% glycerol agar 
DON Deoxynivalenol, a type B trichothecene 
EI+ Positive ion, electron impact ionisation 
ESI Electrospray ionisation, method used extensively in LC-MS 
FLD Fluorescence detection  
GC Gas chromatography 
HFB Heptafluorobuturyl, derivative-group -CO-CF2-CF2-CF3. 
HPLC High performance liquid chromatography, also referred to as LC 
IL-1 Interleukin 1, a cytokine 
IL-6 Interleukin 6, a cytokine 
IPH Idiopathic pulmonary hemosiderosis 
LC Liquid chromatography 
LC50 Concentration lethal to 50% of the test organisms 
LD50 Dose lethal to 50% of the test organisms 
MEA Malt extract agar 
MS Mass spectrometry 
MS/MS Tandem mass spectrometry 
MTR Macrocyclic trichothecene 
MVOC Microbial volatile organic compound 
MW Molecular mass (Da) 
NICI  Negative ion chemical ionisation 
NIV Nivalenol, a type B trichothecene 
NO Nitrogen oxide, as inflammatory mediator 
OAT Oatmeal agar 
PCR Polymerase chain reaction  
PFP Pentafluoropropionyl, derivative group, -CO-CF2-CF3. 
PSA Potato sucrose agar 
RE Roridin E, a macrocyclic trichothecene 
RH Relative humidity (%) 
RI Retention index 
RT Retention time 
ROS  Reactive oxygen species 
SG Satratoxin G, a macrocyclic trichothecene 
SH Satratoxin H, a macrocyclic trichothecene 
SPE Solid phase extraction, chemical clean-up method 
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Spore Reproductive structure of fungi/moulds and certain bacteria 
ST  Sterigmatocystin 
5ST 5-methoxysterigmatocystin 
T-2 T-2 toxin, a type a trichothecene 
TA Type A trichothecene 
TB Type B trichothecene 
TFA Trifluoroacetic acid 
TLC Thin layer chromatography 
TMS Trimethylsilyl, derivative group, -Si(CH3)3 
TNFα Tumor necrosis factor α, a cytokine 
TR Trichothecene 
V8 V8 juice agar 
VB Verrucarin B, a macrocyclic trichothecene 
VJ Verrucarin J, a macrocyclic trichothecene 
Water-damaged Floating water present, aw ≈ 1 
WP Wallpaper 
YES Yeast extract sucrose agar 
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1 INTRODUCTION 
During the last 10 years several studies have shown that people living and working in damp 
or mouldy buildings have an increased risk of airways infections, adverse health effects, res-
piratory problems such as asthma, and CNS symptoms1-9. However concern of mould growth 
in buildings is not a new problem, already in the Bible (Leviticus Chapter 14, 33-48) it is writ-
ten that contaminated spots on walls should be removed, and if consistently reappearing the 
house should be torn down.  
The estimated proportion of dwellings with microfungal problems in Northern Europe and 
North America is perhaps as high as 20-40% based on data from the United Kingdom with 
30-45%1,10, the Netherlands with 20-25%6,11,12, Finland with 20-30%9,13, USA with up to 40%2 
and Canada with up to 30%3 buildings affected. No data exist for dwellings in Denmark, but 
the majority of schools and day-care centres build in the late 1960s and 1970s seem to have 
problems.  
Mould growth only occurs in water-damaged and humid constructions. Consequently the 
major part of the problems in Scandinavia and North America are due to poorly manufac-
tured constructions and inadequate maintenance14-16. 
The health problems observed in mouldy or damp buildings can be grouped into three major 
categories as seen in Table 1.  
 
Table 1 
Health problems associated with mouldy and damp buildings 
General symptoms incl. CNS-symptoms Mucosal symptoms Lung symptoms 
• Extreme fatigue7,8,17-20. 
• Lack of concentration and memory7,8,17-20, in 
extreme cases as cognitive impairment21. 
• Nausea1,7,8,17,18 
• Lowered immune function due to a misbal-
ance in the lymphocytes sub-populations or 
chronic stimulation of some of the these22,23. 
• Blocked nose.1,5,12,19 
• Itching eyes19,24,25 
• Burning sensation of the 
skin7,8,17,18,24,25 
• Hoarseness.1,7,8,17,18 
• Recurrent airway infections, 
especially sinusi-
tis7,8,17,18,24,25. 
• Wheeze1,2,4 
• Cough2,3,5,6,8,12 
• Bronchitis2,3 
• Asthma2,4,6,8 
• Pulmonary he-
mosiderosis in in-
fants26-28. 
 
To cope effectively with the health problems it is essential to identify the causative agents 
and the cellular mechanisms as it would lead to: 
• Clinically valid analyses documenting the patients' complaints. 
• Targeted analysis of causative compounds in buildings suspected of having mould prob-
lems  
• Consent guidelines for "how much is too much". 
• Economically sound cleaning procedures. 
 
However, very little knowledge have been established on peoples' specific exposures and 
the non-immunologic mechanisms, especially toxic reactions, after exposure to moulds8,29,30. 
Non-immune mediated chronic activation of immune competent cells22,30,31 have been sug-
gested as the major mechanisms. 
From the agricultural occupational environment exposure-effect data exist. Here inhalation of 
fungal spores have been shown to cause cancer32,33, premature birth34 and farmers lung25. 
However the levels of spores and metabolites are magnitudes higher than in indoor air35. 
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A number of potentially causative agents produced by moulds in the water-damaged build-
ings have been suggested: 
• Proteins causing the well-known immediate allergic reactions within minutes of exposure 
(Type I allergy) 24,25,36 and in rare incidences type III allergy25. 
• β-(1,3)-d-glucans triggering inflammatory reactions very similar to symptoms observed on 
exposure to endotoxin37-39.  
• Microbial volatile organic compounds (MVOC) released from the fungi during growth40-43. 
• Mycotoxins released from fungal spores and fragments after inhalation19,40,44-49. 
 
Compounds from other organisms associated with moulds such as mites6 and bacteria50-53 
should also be considered as they may play an important role in the ecosystem of the 
infested materials. Additional bacteria growing on building materials also produces a number 
of very potent bacterial toxins54. 
 
The work carried out during the study and this report, focused on the secondary metabolites 
and mycotoxins produced by moulds during growth on building materials, as these 
metabolites are potential risk factors for the adverse health effects observed in mouldy 
buildings.  
Consequently, a major part of the following literature review will focus on fungal growth on 
materials and the different metabolites produced by moulds during their growth in buildings. 
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2 MOULDS IN BUILDINGS 
Viable mould spores and bacteria are ubiquitous in buildings10,55 and are well adapted to in-
habit this ecological niche if just sufficient water is available10,55-57. 
The moulds growing on a particular material are referred to as the associated funga58, and 
have been divided into three groups by Grand et al55 following their water requirements on 
laboratory substrates: 
• Primary colonisers capable of growth below a water activity (aw) of 0.8 including species 
of Wallemia, Penicillium, Aspergillus and Eurotium59. 
• Secondary colonisers, with a minimal aw between 0.8 and 0.9 including species of the 
phylloplanes: Cladosporium, Phoma, Ulocladium and Alternaria. 
• Tertiary colonisers, demanding aw of at least 0.9, including genera such as: Stachybot-
rys, Chaetomium, Trichoderma, Auraeobasidium40,60 as well as actinomycetes and other 
bacteria57,61. These conditions are generally only met by incoming water and not just high 
humidity or condensation on indoor surfaces25,55. 
2.1.1 The building associated funga 
The associated funga reported from different countries varies considerable for a number of 
reasons, such as different climates, materials, different isolation procedures and difficulties in 
identifying the isolates to species level especially in Penicillium, Aspergillus and Cladospo-
rium59,62-64. In Table 2, the most common fungal species isolated in buildings have been com-
piled. 
In Europe, P. chrysogenum is the most abundant59,63,65, whereas it seems to be Penicillium 
aurantiogriseum and P. viridicatum in North America. However, this is probably due to mis-
identification with other species from the P. aurantiogriseum complex. 
For the genus Aspergillus consensus seems to exists with A. versicolor being the absolutely 
most frequently isolated species, followed by A. sydowii and A. ustus63,64.  
 
Table 2 
The most common part of the building associated funga* 
Genus Species Natural habitat Common on 
Water damage moulds 
Chaetomium globosum Soil, straw, wood Mostly on wood and cellulose 
containing materials 
Stachybotrys chartarum Hay and straw66, paper, soil Gypsum boards, pipe insulation 
Ulocladium chartarum and atrum Soil, dung, grasses Wood, wallpaper, gypsum boards 
Trichoderma harzianum, citrinoviride, atro-
viride and longibrachiatum 
Wet wood, soil Mostly on wood 
Alternaria tenuissima Saprophyte on plants, foods Cereals, 
leaves 
Wallpaper, gypsum 
Aureobasidium pullulans Soil, leaves, cereals Paint especially in bathrooms, 
window frames, paint 
Rhodulotorula  rubra  Paints, wood 
Phoma sp. Plant material, soil,  Paints, wood, wall papers, caulk-
ings, especially in bathrooms 
High relative humidity moulds 
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Table 2 
The most common part of the building associated funga* 
Genus Species Natural habitat Common on 
Aspergillus versicolor Cheese, cereals, spices, dried meat 
products 
Most materials, primary coloniser, 
grows in dust 
Penicillium chrysogenum Various foods, spices, dry cereals All materials 
Penicillium brevicompactum Soil, nuts, fruits and juices Especially wooden materials 
Penicillium corylophilum Various foods Most materials, primary coloniser 
Aspergillus Sydowii Soil, cotton, beans, nuts and straw Most materials, primary coloniser 
Aspergillus ustus Soil, cereals, groundnuts  
Cladosporium sphaerospermum Dead plants Paints, wood, wall papers, caulk-
ings, especially in bathrooms 
Cladosporium herbarum Dead plans, stored fruits Paints, wood, wall papers, caulk-
ings, especially in bathrooms 
Penicillium palitans Cheese, wood Most materials, but especially 
wooden 
Eurotium repens Cakes, dried food, cereals  
Wallemia sebi Dried foods, jam, cakes, dates, salted 
fish, sugar, chocolate 
 
Paecilomyces variotii Compost  
Penicillium polonicum Cereals, meat products  
Aspergillus niger Dried food, spices  
Penicillium expansum Nuts, fruits (apples) Wood 
*References14,16,40,49,59,63,65,67,67-72 
 
When measuring viable fungi, as colony-forming units (CFU), the laboratory media will al-
ways favour certain genera and species65, thus several media are needed for covering the 
majority of the building associated funga. Dichloran 18% glycerol agar (DG18) is generally 
considered the best media for xerophilic fungi (moulds who can grow aw <0.8573), and low 
nutrient high aw media as V8 juice agar (V8), malt extract agar (MEA) or rose Bengal agar74-76 
for the secondary and tertiary colonisers77. However MEA can be supplemented with cellu-
lose agar to enhance detection of Stachybotrys who have difficulties competing with species 
of Aspergillus and Penicillium as well as having many sterile spores49,78. 
2.1.1.1 Air measurements 
For investigating moulds associated health problems, air measurements would provide the 
best exposure data. However, as the causal agents have not been identified, it has not been 
established what should actually be measured. Four main techniques are used for air meas-
urements: i) cultivation of viable spores; ii) collecting spores and counting them microscopi-
cally79; iii) detecting chemical markers80,81; iv) using different molecular-biological (DNA) 
techniques82. In sections 2.5 and 2.6.3 measurements of biomarkers, including mycotoxins, 
will be dealt with in detail. 
A major problem with cultivating techniques is that a major part of the spores may not be 
viable83. In addition, hyphal and spore fragments are also released from the mouldy materi-
als84. Aggressive air sampling methods are generally preferred over sedimentation plates 
which are unreliable 40,59,77. 
Even in rooms with visible mould growth aggressive sampling may give low counts85-87 al-
though other authors have found clear relationships10. Especially if the ratio between out-
doors and indoors is used and speciation of the collected moulds is performed, a clear rela-
tionship between infested areas and air measurements can be found14. Determining the ratio 
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of Penicillium and Aspergillus versus outdoors phylloplane moulds as Cladosporium and Al-
ternaria has been successful for indicating a humid environment40,87,88. 
A totally different and very elegant approach, is to measures the personal exposure and re-
sponse by determining inflammatory mediators, such as IL-1, IL-6, TNFα, NO, eosinophil 
cationic protein and myeloperoxidase in nasal lavage fluid89-91. 
Nevertheless interpretation and knowledge of the limitations of the different techniques is 
crucial78 and generally no single method will provide the full picture of mould exposure and 
presence in a building69.  
2.2 Growth of moulds on building materials 
Moulds can grow on laboratory media at temperatures as low as -7°C92 and some wood as-
sociated cladosporia and penicillia are able to grow at temperatures as low as -5°C on wood, 
but seem to require at least 0°C to germinate93. In comparison Aspergillus restrictus94 re-
quires 9°C, and A. versicolor  4°C25 for growth on a high nutrient substrate such as MEA, 
indicating that temperature cannot be used to avoid fungal growth in buildings. 
The associated funga is also selected by aw, light92 and especially the composition of the 
material, including organic carbon, pH, nutrients like trace metals, nitrogen, phosphor and 
sulphur10,56,57,92,95,96, consequently the most important of these factors will be reviewed in the 
next subchapters. 
2.2.1 "Water - the key factor"11 
This is undoubtedly the most important factor for determining if mould growth will start in a 
building11. Most of the moulds have their optimal aw at 0.96-0.98 even though some are able 
to grow at much lower aw11,95,97. Some xerophilic fungi like Eurotium spp. and Wallemia will 
not grow at such high aw65,73. 
The germination process requires a slightly (approx. 0.02) higher aw than the critical aw for 
growth57,94,98-101, older spores also require longer time to germinate99.  
In Table 3, data on the minimal aw for growth on food products and agar media have been 
compiled. On agar media the aw was usually regulated by adding glycerol or occasionally 
sugars to the media. 
 
Table 3 
Minimal aw for fungal growth of selected species  
Medium Aspergillus 
versicolor 
Eurotium 
 spp. 
Penicillium 
spp. 
Cladosporium 
spp. 
Rhodotorula 
spp. 
Alternaria 
spp. 
Stachybotrys 
chartarum 
Food products73 0.78 0.70-0.72 0.78-0.84     
MEA94  0.71 0.74     
MEA99   0.81     
MEA100  0.71 0.79-0.82    0.94 
MEA102    0.81  0.85  
Different agars56 0.80 0.70 0.80     
MEA94 0.74 0.71      
MEA103 0.81 0.76 0.82 0.85 0.92 0.89 0.95 
DRBC*103 0.81 0.77 0.83 0.86 0.93 0.89 0.95 
* Dichloran Rose Bengal chloramphenicol agar. 
 
Table 4 compiles data on selected mould growth on different building related materials, as 
the minimal aw on these are higher than on the more nutrient rich agar substrates. 
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Table 4 
Minimal water activity for fungal growth on materials of selected species and genera 
Medium Aspergillus 
versicolor 
Eurotium 
spp. 
Penicillium
spp. 
Trichoderma 
spp.  
Cladosporium 
spp. 
Rhodotorula 
spp. 
Alternaria 
spp. 
Stachybotrys
chartarum 
Ceiling tile104  0.85-0-90  
Fibre glass104  0.85-0-90  
Wood chip paper, 
25°C55 
0.84  0.84-0.89 0.96  no growth
Viscose 105 0.80 0.80 0.80-0.85 0.85-0.90 0.90  0.90
Woodchip paper, at 
12°C55 
0.91  0.91-0.87 0.97  no growth
Painted woodchip 
paper, 25°C55 
0.79  0.84 0.93  0.97
Painted woodchip 
paper at 12°C55 
0.87  0.87 0.87-0.91  0.96
Fibre glass earth 
cont.106 
0.69-0.72  0.53-0.60 0.85-0.87  
Fibre glass106 0.85-0.87  0.96-0.98  
Wallpaper and 
paper107 
  0.78-0.81
Gypsum107    0.84-0.89
Cellulose filter108   0.84-0.89
Woodchip 
wallpaper103 
0.85 0.77 0.86 0.89 0.93 0.90 0.97
 
Table 5 shows data on building materials, where the moulds were applied as a mixture, the 
natural contamination was used or where moulds growing were not identified, often referred 
to as mildew. 
 
Table 5 
Minimal water activity for fungal growth of mixtures or unidentified fungi (mildew) 
Medium Mixture 
Pinewood , planned109 0.80 
Painted wood109 0.80 
Hardened paint109 No growth 
Distempered wood109 0.80 
Brick109 0.88 
Cement rendered brick109 0.80 (but almost no growth) 
OSB, MDF, Particle board, Fibre board, wood110 Growth at 0.70 (after 8 weeks) 
Glass wool and cotton111 0.92-0.96 
Cotton fabrics112 0.70 
Wood and wool111 0.85 
Leather111 0.76 
Different wood113 0.80, 0.90 when temp < 5°C 
White brick109,109 0.80  
 
It is clear from Tables 4 and 5 that no consensus exists on the minimal aw for fungal growth 
on materials. It is however generally known that the humidity calibrations in many studies are 
not correct11. Hence studies are needed with more precisely controlled humidity and other 
environmental conditions. 
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2.2.1.1 Humidity - some definitions 
The water activity is called equilibrated relative humidity in some papers103 and is the same 
as the RH/100 (at steady state). Aw is considered a better descriptor of available water57,114 
than the absolute water contents in the material56,57,105. This is perhaps seen more clearly 
when the aw relation to the osmotic 
pressure is shown56,57,114, as it is the 
difference between this pressure and 
the osmotic pressure in their own cy-
toplasma the moulds have to maintain: 
V
aTRpressureOsmotic w)ln(××−=  
Where T is the absolute temperature, R 
the gas constant, and V the partial molal 
volume of water. 
 
Large local differences in ventilation 
and surface temperatures, especially on thermal bridges, can generate micro climates with 
very high aw, even in rooms with low RH. This is due to the large temperature dependency of 
RH and the water contents of air as illustrated in Figure 1. For example, if the indoor air tem-
perature is 22°C and the RH is 50%. The RH at a cold wall of 15°C can be estimated to 
about 80% RH, which is at the RH point where moulds starts to grow.  
Precise measurements of the humidity in materials and the air is difficult especially at RH > 
90%. Especially if the measurements are calibrated against sulfuric acid it gives inaccurate 
determinations11,57. 
2.2.1.2 Transient conditions 
Physical parameters including humidity and temperature are not constant in buildings, and 
greatly influence the mould growth11,115-117. A bathroom is one of the extreme examples of 
this, and in this environment the funga is different than in environments with more constant 
environmental conditions65,118 as it is being dominated by phylloplane fungi such as Phoma, 
Aureobasidium, and Cladosporium. This field observation is explained by data of Park119 who 
showed that after drying for one week, phylloplane fungi were able to re-attain growth from 
the hyphal tip within 60 min, whereas storage moulds (Penicillium spp.) and soil fungi (Fusa-
rium spp., Verticillium, and Trichoderma) needed 1-2 days, meaning that the phylloplanes 
can cope with a few hours of humid environment in the bathroom. 
Adan11, who worked with mould growth on plaster and painted materials, introduced the term 
Time-of-wetness (TOW) defined as the ratio between the wet period (RH ≥ 80%) and the 
total period, and the term f, for the number of cycles per day. It was shown that using air 
dryer than 65% during the dry period did not affect the growth, and that growth increased 
slowly with TOW from TOW=0.17 to 0.5, with a dramatic increase of higher TOWs. The 
parameter f had only very limited effect on growth, unless very high values were used (f>4). 
Viitanen116,120 also showed that when short time fluctuations were applied (0.25 days) the 
growth occurred more slowly compared with longer periods (1, 2, 7 and 14 days).  
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Figure 5. Relations between air temperature, relative humidity 
and absolute humidity. 
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2.2.2 The impact of the material on the mould growth 
Moulds are able to degrade almost all natural and many man made materials25,65, especially 
if they are hygroscopic11,111. Even totally inorganic materials will still get mouldy as they over 
time absorb dust which is a good medium for especially A. fumigatus25 and A. 
versicolor121,122.  
Wood is still one of the most commonly used materials, and is highly susceptible to mould 
growth116,123,124. It may become infested with Cladosporium, P. brevicompactum and P. 
expansum, already at the sawmill93. Kiln drying makes the surface of the wood more 
susceptible to mould growth116,120, as the surface will get a higher content of nitrogen and low 
molecular carbohydrates125. A number of modified wood materials are commonly used, and 
materials such as OSB, plywood and MDF are more susceptible to growth of Aspergillus, 
Trichoderma and Penicillium than solid wood, particleboard110, acylated wood126 and wood-
polyethylene composites127. 
Prefabricated gypsum board is the most commonly used inner-wall material in new Danish 
buildings. However due to the paper, used to reinforce the material, the boards are highly 
susceptible to growth of moulds especially the cellulytic S. chartarum14,25,72,107,128. The 
gypsum itself (used to plaster walls) can also support fungal growth and the susceptibility is 
then correlated to the relative nutrient content of gypsum11 and additives who make it more 
hygroscopic at lower humidities129. 
Many indoor surfaces are wallpapered and this increases the susceptibility of the walls, as 
paper and the glue are very good media for most indoor moulds55,64,72. 
Plastic materials are being increasingly used, and polyethylene and PVC are vulnerable to 
mould growth, as the moulds utilise most plasticizers130. Already in 1957, Berk, et al131 
showed that 90 of 127 different plasticizers could be degraded by moulds commonly found 
on indoor surfaces. Even fibre glass insulation106,132 and fibre glass ceiling tiles (10% urea 
phenol-formaldehyde resin)104 support fungal growth of especially A. versicolor and 
Penicillium sp. Polyurethanes has been used in many composites as well as insulation 
materials, and some of them are highly susceptible to mould attack133 and they should be 
routinely tested for microbial degradation. Especially Paecilomyces variotii, T. harzianum, 
and Penicillium spp. are frequently growing on urea-formaldehyde foam insulation 
materials72. 
Paints can both increase and decrease the susceptibility of a given base material. 
Waterborne paints, which are the most commonly used in Europe due to occupational health 
problems with organic solvents, are highly susceptible to mould growth and should be 
routinely tested11,134. However the base material for paint is also important for the mould 
growth11,55. Aureobasidium pullulans is the absolutely most common mould on paints which it 
deteriorates in contrast to Penicillium and Aspergillus species which grow superficially on the 
paints135. Actually A. pullulans is often succeeding Aspergillus, Alternaria and Cladosporium 
on acrylic paints136.  
Mould growth in air filters137 and in ventilation ducts138 is of special concern, as the ventilation 
system will act as an effective carrier of the spores. In the ventilation ducts growth generally 
occurs on painted surfaces and especially in dust139, although certain fibre glass insulation 
materials may support growth16,140. 
2.2.3 Modelling mould growth on materials  
Validated models which can predict fungal growth under different environmental conditions 
on building materials are extremely important as they can be interfaced with many of the 
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current PC programs which can model humidity conditions on materials, and simulate real 
buildings. However only a very few models for growth on materials have been published: 
• Rowan103 predicted RH limit for growth of S. chartarum, A. versicolor and Eurotium 
herbariorum, as a function of temperature (3rd order polynomial), and interfaced this 
simple model for transient temperature and humidity conditions in buildings.  
• Hukka & Viitanen141 have an almost identical model, and have improved it120,141 to include 
also growth under transient temperature and humidity conditions. 
However, none of these models have been validated on a large number of real buildings with 
and without mould problems, which is the only way to validate these models. 
Adan11 have developed several models for comparing the susceptibility with building 
materials to both constant and transient humidity conditions. These are however more 
sophisticated and they are based on a non-linear logistic model, which is able to cope with 
the non-linear, 6-point scale, used to compare the susceptibility of different materials. 
2.3 Health problems associated with airborne moulds 
A number of different approaches exist for studying the health effects associated with mouldy 
buildings. The two major approaches are: i) comparing the toxicity or biological activity, 
based on in vitro and in vivo data, with the actual exposures in the buildings; ii) epidemiologi-
cal studies where symptoms in a large population are correlated to exposure in normal and 
mouldy buildings. 
 
In the first studies of health problems related to mouldy buildings it was believed that people 
were type I allergic25,142, meaning that IgE antibodies are formed against specific proteins, 
called allergens, from the fungal spores25. Type I allergy can be precisely diagnosed by the 
classic skin prick testing (SPT) or in serum if extracts of the appropriate allergens exist25.  
SPT panels and antibody-allergen-kits for the outdoor air moulds, Alternaria and Cladospo-
rium, as well as some penicillia and aspergilli have been commercially available for a number 
of years, but are not available for many of the building associated moulds. Allergic persons 
are often genetically predisposed25 and may develop asthma due to inflammation of the lung 
as a results of large quantities of inflammatory mediators released from the different lung 
granolocytes. However, as type I allergy is not the main cause of the health problems ob-
served in mouldy buildings22,30, the use of SPT or specific IgE in serum has a very limited 
diagnostic value when working with mouldy buildings.  
A number of other types of antibodies, including the IgG antibodies, are naturally produced 
against most "non-self" proteins and help clearing these from the body. Detection of specific 
IgG antibodies against these "non-self" proteins can hence be used do determine if a person 
have actually been exposed to a specific mould. However only positive results can be used, 
as not all people will develop detectable quantities of IgG antibodies23.  
High exposures to protein dust may result in such high levels of antigen-antibody complexes, 
in the blood vessels, that these are deposited in such quantities that they may trigger an im-
mune response (allergic alvolistis / hypersensitivity pneumonitis) seen as malaise, elevated 
temperature, pains in joints and even astma25,143.  
2.3.1 In vivo and in vitro effect of fungal spores 
As earlier mentioned, the vehicle for exposure to mycotoxins in the indoor environment 
seems to be the fungal spores46 and fragments of these and the mycelia84. Hence, studies of 
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the effects of whole spores are important as they contain the whole "mixture" of metabolites 
and structural components as well as the particle effect of the spores144. 
An interesting study showed that rats exposed to naturally released spores of A. versicolor 
(up to 10×106 CFU/m3) originating from growth on the walls, during one month developed 
severe lung damages including granulomatous lesions, partly due to high production of IL-1 
from the macrophages145.  
Instillation of P. chrysogenum spores in mice146 revealed similar results, and in addition 
showed that 104 spores instilled twice a week increased total IgE in serum and IL-4 in the 
lung bronchoalveolar lavage, interestingly this was not seen when the spores were treated 
with methanol to kill them or extract metabolites. 
Shahan et al147 showed that spores from different fungal species induced very different re-
sponses in rat macrophages, measured as mRNA induction of TNFα and other inflammatory 
mediators. Spores from A. terreus and P. spinulosum did not stimulate any inflammatory re-
sponse, in contrast to A. fumigatus, A. candidus, A. niger, Eurotium amstelodami, and C. 
cladosporioides which stimulated production of several inflammatory mediators. 
Ruotsalainen148 showed that Stachybotrys isolates (21 different) induced either strong in-
flammation, by releasing NO, TNFα, IL-6 and reactive oxygen species (ROS), or cytotoxicity 
(induced by satratoxins producing isolates) in macrophages. In vitro studies with instilled 
Stachybotrys spores in mice have showed similar results45,45 and will be dealt with in details 
in section 2.4.1. 
The cytotoxicity of Penicillium and Aspergillus isolates from damp buildings in Scotland cul-
tured on MEA was studied at it was found that about 50% of the investigated isolates were 
cytotoxic to the fibroblasts149,150. Such cytotoxicity may cause severe lung damage, especially 
if the fibroblasts and perhaps also macrophages die by necrosis, as the latter subsequently 
will liberate high quantities of inflammatory mediators. 
However there seems to be many different mechanisms associated with the effects in cell 
cultures, especially when both cytotoxicity and inflammatory potential are tested simultane-
ously 151. Generally many mould spores will kill macrophages before they are able to respond 
with an inflammatory response. 
These studies indicate that the lung damage induced by fungal spores may be partly or fully 
due to the inflammation induced by the macrophages as it has been shown that excess in-
duction of some cytokines, NO and ROS may play an important role in the pathogenesis of 
inflammatory diseases such as asthma152-154. It is also notable, that isolates/species specific 
metabolites are involved. However, except for the first, they have all used spores from agar 
culture, which is seriously biased as moulds usually produces much higher quantities of me-
tabolites on these media64. 
Literature on in vitro and in vivo studies of specific metabolites will be found in respective 
mould species in section 2.4. 
2.3.2 Epidemiological studies 
Epidemiological studies have been widely used to study health effects in mouldy build-
ings6,9,155, especially combined with questionnaires to determine symptoms and/or if the 
home or workplace has been damp or mouldy. However several studies have concluded that 
objective measures are needed to obtain statistically significant results6,30,86,88. 
A large number of studies on general health problems and the association dampness and 
mould growth have been published (see Table 1, p. 1), however reviewing these is outside 
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the scope of this work, and only case studies of specific moulds will be further dealt with, as 
they may be correlated to specific fungal metabolites.   
Johanning et al23,156 studied an office building heavily infested with S. chartarum. Only two 
persons were IgE positive to S. chartarum, these persons worked in the same area and 
some had abnormal complement function and composition of T and B lymphocytes, CD3+ T 
cell (CD3 is a protein found on both Tcytotoxic and Thelper cells143) concentrations were lower 
among the employees than among controls. IgG measurements showed only small differ-
ences between exposed and non-exposed employees and were not significantly correlated 
with symptoms. In later papers20,157, they reported several more cases from the clinic with 
corresponding surveys of their homes for mould occurrence. Specific IgG antibodies could 
only be used as exposure markers but was only positive in 25% of the cases of actual expo-
sure. 
In a 10 years old building with severe water damages Hodgson et al19 found that the occu-
pants had significantly more pulmonary problems, as eye irritations, stuffy nose, and espe-
cially flue like symptoms, than normal. Air samples in one of the rooms revealed up to 8000 
CFU/m3 of especially A. versicolor, and in an other room up to 129 CFU/m3 but with up to 
50% of the colonies being S. chartarum.  
2.3.2.1 Idiopathic pulmonary hemosiderosis cases 
A dramatic escalation in the symptoms observed in mouldy buildings has been reported from 
the Cleveland, Ohio, area158,159. Here idiopathic pulmonary hemosiderosis (IPH) in infants (< 
6 months old) was associated with growth of S. chartarum in the homes. It should be noted 
that IPH is extremely rare in infants, with a general prevalence of 0.2-1.2 per 106 children per 
year in the Western world160. Reports of such life threatening conditions including fatal cases 
have great legal implications, especially in the USA, as well as economic importance for the 
rest of the world as it could lead to guidelines not accepting growth of S. chartarum in build-
ings. 
The first 10 IPH cases from Cleveland were reported in December 1994 by the US CDC161 
however with no plausible reason. Later CDC reported additional 27 cases from Cleve-
land158,159, and at this time it was concluded that IPH was associated with growth of S. char-
tarum. Additional 7-9 cases were identified in Chicago162 and 6 from Detroit163, however no 
mould investigation of the houses has been published.  
An overview of the IPH cases in USA has been made by Dearborn et al26, who found 138 
IPH cases in USA the period 1993-1995, and that the IPH incident rate in Cleveland was 1.5 
IPH per 103 infants per year in the period. The association between IPH and Stachybotrys 
exposure has been questioned by the CDC164, after a anonymous review to which the inves-
tigators have not been able to respond. 
An additional case has been reported from Kansas city165,166 in a home with a mould infested 
ventilation system, yielding 420 Stachybotrys spores/m3 (counted by microscopy) from the 
bedroom of the infant, however also extremely high counts of Penicillium and Aspergillus 
(11250 spores/m3 counted by microscopy) in the air was detected. 
From Houston a case has also been described28, and here Stachybotrys (= Houston 
strain167) was isolated from the lung of a 7 years old white boy with IPH, chronic cough, and 
chronic fatigue.  
From Cleveland an additional case has been reported168 with no abnormal clinical tests ex-
cept from the hemosiderin laden macrophages (showing that the bleedings had been occur-
 Page   12 
ring over some time) recovered from the lung. The bedroom of the child was heavily infested 
with S. chartarum and air samples revealed 6×104 CFU/m3 of the fungus. 
From St. Louis there is also a report27 on a case of IPH in an infant, who was exposed to 
fungi during a 2 weeks holiday. On the return trip the infant developed the hemorrhage upon 
exposure to tobacco smoke. Low quantities of hemosiderin in macrophages in the lung indi-
cated no preceding bleedings. During the vacation (14 days) the infant had resided in a room 
with visible mould growth of Trichoderma, Penicillium, Cladosporium and Ulocladium.  
Recently a fatal IPH case has been discovered in Belgium (N. Nolard, personal communica-
tion), in this case airborne spores were detected, they were released in high numbers due to 
constructional work in the bathroom. 
2.4 Biologically active metabolites from moulds  
Microfungi have the ability to produce a high number of secondary metabolites, which they 
for various reasons need in their natural habitat169,170. Most of these are produced as a re-
sponse to other organisms especially other fungi171. Some of these metabolites can cause a 
toxic response "when introduced by a natural route in low concentrations to higher verte-
brates and animals" and are referred to as mycotoxins172. 
Sorenson173 and Miller69 were some of the first to realise the implications of mycotoxins in the 
indoor environment. The latter emphasises that moulds generally produce several mycotox-
ins and synergizers, which are not toxic themselves, but enhance the toxicity of some my-
cotoxins174. It is also stressed that repeated low concentration exposure of airborne mycotox-
ins would be very difficult to diagnose.  
When trying to predict which biologically active compounds of microfungal origin may be pre-
sent in water-damaged buildings - at least five problems have to be addressed: 
• Most secondary metabolites and mycotoxins are species specific making identification of 
isolates to the species level extremely important. Changes in taxonomy including introduc-
tion of new species and synonomisation of others have further complicated this work62,175.  
• False positive findings of mycotoxins are often common from laboratories which use insuf-
ficiently specific methods, or which are not experienced in mycotoxin analysis and the 
large number of interfering compounds produced by moulds62.  
• Even in fungal extracts of species, which have been extensively studied for their metabo-
lites as e.g. Aspergillus flavus, A. fumigatus, and Fusarium graminearum, unknown bio-
logically active metabolites are still present69. 
• A large number of the secondary metabolites described in the literature have been tested 
in a very few assays, and extremely few compounds have been tested in full animal stud-
ies.  The latter method is unfortunately often the only way of finding defects in the off-
spring or reveal metabolites which are activated in special organs such as liver or kid-
ney144,176. For exposure assessment even fewer metabolites have been tested in inhala-
tion studies where some metabolites have been magnitudes more potent177. 
• The produced metabolites vary considerably between media, so the moulds may produce 
very different metabolites when growing on building materials63,178. 
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It should be considered that on naturally infested materials the moulds do not grow in pure 
cultures, but in mixed cultures with other moulds and often also bacteria. These conditions 
may induce production of other metabolites than in pure cultures50. 
The following review will target the potential fungal metabolites produced in buildings by the 
building associated funga, and may have a varying detailing level. This reflects where most 
of the experimental work has been concentrated and where less known species and genera 
have been reviewed.  
The tables of the metabolites reported from the reviewed species have been moved to Ap-
pendix B, as many of them run over several pages, and hence will diminish the readability of 
this thesis. 
2.4.1 Stachybotrys 
Stachybotrys chartarum (Ehrenberg ex Link) Hughes (= S. atra Corda, and S. alternans 
Bonord.) is the only species from this genus which has been found in buildings.  
Jong & Davis179 made a revision of the genus in 1976 based on available cultures and found 
that the genus comprised ten species: S. albipes, S. bisbyi, S. cylindrospora, S. dichroa, S. 
kampalensis, S. microspora, S. nephrospora, S. parvispora, S. oenanthes and S. theobro-
mae. Later McKenzie180 described three new species from decaying leaves, and Dorai & 
Vittal 181 and Hua-zhong182, Miyazaki  et al183 additional species. 
Most interest of S. chartarum has been due to its capacity to deteriorate organic fabric fi-
bres179 and its ability to produce the highly cytotoxic macrocyclic trichothecenes184,185 which 
have given significant problems in mouldy straw in Eastern and Northern Europe184,186-188. 
Stachybotryotoxicosis was first described in the 1930s by Russian researchers189, and later 
by Forgacs in the English written literature187,190. He assisted Russian veterinarians during 
World War II, where stachybotryotoxicosis in horses was a severe problem for the Russian 
army191. Russian researchers showed that horses were very susceptible to Stachybotrys 
infested straws192. Forgacs describes two types of toxicosis: i) A typical form with inflamma-
tion of the stomach, and the mouth as well as necrosis of some areas, followed by a de-
creasing number of thrombocytes and a decreases in the blood clotting, followed by a de-
creasing number of leukocytes and an almost total absence of blood clotting192; ii) An atypical 
form, characterised by nervous disorders, as loss of reflexes, elevated body temperatures, 
and altered cardiac action192. 
The link to indoor air appeared in 1986, when Croft et al47 described a household in Chicago, 
where the occupants suffered from symptoms similar to stachybotryotoxicosis. Filters from 
air sampling in this home was black after sampling due to the many Stachybotrys spores (B. 
B. Jarvis, personal communication).   
2.4.1.1 Trichothecenes 
In 1973, Eppley & Bailey184 were the first to isolate trichothecenes from S. chartarum, they 
found the known components, trichodermol and roridin E (RE) and three novel components, 
named satratoxins H, G and F193. These three components were first structure elucidated 4-7 
years later185,194. All trichothecenes produced by Stachybotrys species have been compiled in 
Table 1 in Appendix B. 
The trichothecenes (TR) are divided into the following four groups195. 
• Type A trichothecenes (TA), easily described as the trichothecenes (TR) not included in 
the following three groups. These trichothecenes have been isolated from species within 
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the fungal genera Memnoniella, Trichoderma, Trichothecium, Myrothecium, Stachybot-
rys, and Fusarium, are highly cytotoxic. 
• Type B trichothecenes (TB) are characterised by the C8-keto group. This group is ap-
proximately only 10% as toxic as the TA176,196 and is only produced by Fusarium species. 
• Type C trichothecenes are characterised by the ring from R2 to the R3 alcohol group and 
are generally referred to as macrocyclic trichothecenes (MTR). These are at least 10 
times more cytotoxic than the type A, and are produced by species of Stachybotrys and 
Myrothecium. 
• The very rare type D trichothecenes are characterised by a C-7,8 or C-9,10 epoxy group. 
 
The sesquiterpenoid pathway of the trichothecenes produced by Fusarium has been exam-
ined in detail (see Figure ) due to the economical importance of this genus197. An important 
step in the biosynthesis is the then cyclization to trichodiene by trichodiene synthase, en-
coded by the TRI5 gene197-199, which has been characterised in Fusarium, Myrothecium and 
Stachybotrys197,200,201. Trichodiene 
is volatile and can be used as an 
indicator for the synthesis of 
trichothecenes202,203. The MTR is 
the synthesised over trichodermin 
and the trichoverroids as seen in 
Figure  197,204. 
Several studies have shown that 
S. chartarum strains isolated from 
cereals can produce MTR107,108,205 
when grown on building materials 
and air filters. In naturally infested 
materials MTR have been de-
tected by Croft et al47 who found, 
satratoxin H (SH), verrucarin B 
(VB), verrucarin J (VJ), and the 
trichoverrins. Several later studies 
have verified these find-
ings50,165,206. From an exposure 
point of view, Sorenson46 has 
shown that the spores from MTR 
producing isolates contained 
approx. 10-40 ppm of the MTR ≈ 
40 fg MTR per spore, whereas 
Nikulin et al45 found 140 fg/spore. 
Not all S. chartarum strains pro-
duces satratoxins, Korpinen & Uoti188, showed that 67% of the S. chartarum strains isolated 
from toxic feed in Finland were cytotoxic to fibroblasts (presumably producing satratoxins). 
Andrienko & Zaichenko207, showed that Russian S. chartarum isolates grown on seeds, could 
be grouped in four: i) 19% with highly dermatoxic properties (presumable being satratoxin 
produces); ii) 4% with only antifungal activities; iii) 47% strains with antifungal and antibacte-
rial activity also being dermatoxic; iv) 26% with no biological activity. Jarvis et al208 found that 
80% of the strains isolated from stachybotrytoxicosis cases in farm animals from Eastern 
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Figure 2. Purposed biosynthesis of the macrocyclic trichothecenes. 
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Europe produced MTR. This is significantly different from the strains isolated in water-
damaged buildings in the USA where only 30-40%, of the isolates from the IPH case homes 
produced MTR44,209 and from Finland148 where about 50% of the strains were highly cytotoxic 
to murine macrophages, resembling the biological activity of MTR producing strains. 
 
Toxicology of the trichothecenes 
It has long been known that the TR generally inhibited the protein synthesis196, where some 
inhibited the ribosomal termination or the elongation of the translation process. Later both TR 
and MTR have been shown also to induce apoptosis in cells, by activating SAPK/JNK and 
p38 MARK kinases by ribosome binding inhibiting the protein synthesis196,210. Interestingly 
trichodermol and trichodermin are the only TR that are non-cytotoxic196.   
Parent-Massin & Parchment211 grouped haematoxicity, abnormal blood cell grouping or mal-
function, of mycotoxins in three groups: 
• Haematoxicity not described in literature: patuline, verrucosidin, and fumonisins. 
• Compounds able to cause adverse haematoxic effects, but with the principal mechanism 
not being haematoxic: ochratoxin, aflatoxin and zearalenone. 
• Compounds giving severe haematoxic effects, with minor symptoms, like the trichothe-
cenes. 
At high concentrations (10-20 mM) T-2 (the most toxic TA) induces haemolysis of red blood 
cells of rodents, pigs, dogs, horses and humans. Single doses of DAS (a TA) given to hu-
mans as anti-cancer drug (Phase I test), resulted in vomiting and central nervous toxification. 
TR have a significantly lower LD50 value in new borne animals (mice, lowered by approx. 100 
×) in which the pathologists found severe lesions of bone marrow, thymus and spleen. 
As only few MTR are commercially available, only few studies on these components exist. 
However Hughes et al212 studied the effect of 11 different MTR on the immune system of 
mice. They were administered, once, with half the LD50 dose and sacrificed after 4 days. 
White blood cell concentration decrease upon exposure to VJ and RE, but some of the oth-
ers MTR had the opposite effects. This might be due to more circulating white blood cells at 
the start. ELISA showed a decreased production of antibodies against sheep red blood cells 
for some components. 
Pestka & Bondy213 who showed that mice exposed to TR had up to a 10 000 lower LD50 to 
Salmonella typhimurium exposure. This is presumably due to the fact that leukocytes (white 
blood cells) are affected at far lower concentrations than the acute ones211. Especially TA, 
are cytotoxic to granulocyte, monocyte and erythroblast progenitors211 at concentrations 
higher than 5×10-8 M.  Effects at this level includes inhibition of antibody production, delayed 
skin graft rejection, and inhibiting phagocytosis of murine macrophages144.  
These symptoms resemble the ones observed in humans from Stachybotrys infested build-
ings reported by Johanning et al23,156 (see section 2.3.2), especially when combined with the 
data of Creasia et al177,214 who showed that the acute effects of the TR T-2 toxin in rodents 
was 10-20 time stronger when it was inhaled than when it was administrated through the 
feed. However Pang et al215 was not able to verify this effect in pigs. 
 
Animal studies on the inhalation of Stachybotrys spores   
The association of IPH cases with S. chartarum26 has of course triggered a number of pro-
jects on the influence of S. chartarum spores on cell cultures and whole animals. 
Lung mycotoxicosis in mice was demonstrated by Nikulin et. al.45 who used two S. chartarum 
strains, isolates #72(=CBS 414.95 = IBT 9460) and #29 (=CBS 413.95 = IBT9472). It was 
shown that #72 induced much more severe haemorrhage in the mice than #29. The first iso-
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late produced satratoxins and high quantities of stachybotrylacetones and the later strain 
produced only minor quantities of the latter type. The same group216 also instilled mice with 
103 and 105 spores of the same two S. chartarum isolates 6 times during 3 weeks. In the 
mice instilled with the highest dose, severe inflammatory changes were observed in the 
lungs. The mice administered with spores from #72 developed much more severe inflamma-
tions than the mice instilled with spores from #29. At the lowest level only the mice instilled 
with the spores from the satratoxin producing isolate, #72, developed inflammatory changes 
in the lungs. However due to the few isolates used and the variation in both MTR and 
stachybotrylacetone production the study remains partly inconclusive on the responsible 
components. 
This is the same for the study of Mason et al217,218 who instilled S. chartarum spores and iso-
satratoxin F in the lungs of mice, and observed that both obstructed the lung homeostasis 
whereas Cladosporium spores did not. However the S. chartarum spores and the pure toxin 
induced very different surfactant production (P60 and P100 phosphor lipids), but no chemical 
analyses were performed on the strain so it is unknown if it produced MTR. 
Rao et al219 instilled spores in rat lungs, and showed that when spores from a highly cytotoxic 
(presumably a MTR producer) of S. chartarum was methanol extracted, the toxicity of the 
spores almost disappeared compared with unextracted spores. This clearly shows that the 
pulmonary toxicity is due to extractable metabolites as MTR or most of the metabolites de-
scribed in the following subchapter. 
The conclusion drawn from these studies is that S. chartarum spores indeed contains a 
number of metabolites which can induce severe inflammation, haemorrhage and death in 
animals. However there is no evidence that these effects are only caused by the MTR. 
2.4.1.2 Non trichothecene metabolites 
Most species in Stachybotrys and especially S. chartarum produces high quantities of a 
number of spiriocyclic drimanes183,220 as 
shown in Figure 3. These components 
have a number of biological properties, 
inter alia inhibition of TNFα liberation 
from human macrophages221, comple-
ment inhibition183,222 and  antiviral activ-
ity223. When considering that one of the 
most common symptoms in mouldy 
buildings is recurrent airway infections, 
metabolites which inhibits the complement system are interesting, as the complemet system 
is an important part of our defence against bacteria143. A number of triprenyl phenol metabo-
lites (see Figure 3) have been described from several Stachybotrys species. They are pre-
cursors of the spiriocyclic drimanes, as the triprenyl can be cyclizied into the drimane part. 
These metabolites can activate and enhance the plasminogen-mediated fibrinolysis (at levels 
down to 100 µM)224-226  and could in that way be plausible components responsible for IPH, 
as this could account for the brittle blood vessels in the lungs. 
Both the triprenyl phenols and the spiriocyclic drimanes are produced by two mixed biosyn-
thetic pathways, partly by the sesquiterpenoid pathway (shown in blue on Figure 3) and 
partly by the polyketide pathway. Reviewing the literature on these components has been 
troublesome as Russian groups have published known structures under new names, data on 
the stereochemistry is often not available, and a significant number of the publications have 
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Figure 3.  Left, the spiriocyclic drimanes, stachybotrylactone 
(X=O) and stachybotrylactam (X=NH). Right, SMTP-1, one of 
their precursors. 
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been Japanese patents and patent applications. Chemical and biological data on the spirio-
cyclic drimanes and other non-trichotehcene metabolites are given in Table 2, Appendix B. 
A new type of metabolites has been isolated from non-satratoxin producing isolates of S. 
chartarum, and has been named atranones209. They are 227 biosynthetically related to the 
dolabellanes228 and altogether 8 atranones and two dolabellanes have been isolated from the 
S. chartarum cultures209,227. Three of these metabolites (6β-hydroxydolabella-3E,8E,12-trien-
14-one, atranones B and C) have also been detected in material samples from a IPH case 
home in Cleveland229. However the biological activity revealed until now on these compo-
nents has been rather limited, but with the number of enzymatic steps used to synthesise 
such complicated components228 they must have a biological activity. 
A component belonging to the immunosuppressing cyclosporin family has also been isolated 
from a Stachybotrys sp.230, and is of course interesting due to many infections experienced 
by people living in mouldy buildings. Also components, shown not to be TR, damaging the 
cell membrane of boar sperm cells has also been described231 from S. chartarum, however it 
has not been cleaned up and characterised. 
Vesper et al232 tested the haemolytic activity229 of S. chartarum isolates from the Cleveland 
IPH cases, grown on gypsum boards. Haemolysis was correlated to growth at 35°C and not 
at 23°C, and a higher percentage of the spores from IPH case homes were haemolytic. The 
responsible component has just been partly charecterised233 as a novel haemolytic protein, 
stachylysin. Additionally the group has showed that the S. chartarum strains from the IPH 
case homes produces higher quantities of siderophores than strains from non-IPH case 
homes167.  Iron is a key component for pathogens and iron binding proteins and peptides 
excreted from pathogenic bacteria234 and fungi235 are well known. The authors seem to indi-
cate that a mechanism might be partly due to actual growth of Stachybotrys in the lung tissue 
of the infants. 
All these findings clearly show that the biologically active components from S. chartarum are 
far from known, and even when they are all known there will still be much left to do in deter-
mining the actual exposure to these in mouldy buildings.  
2.4.2 Aspergillus  
As the genus of Aspergillus Mich. ex Fr. is one of the anamorph genera placed in the family 
Trichocomaceae, where it is associated with 8 holomorph genera. This is new in comparison 
with the last monograph by Raper & Fennell236, which is still extensively used, although it 
should only be used in combination with "Integration of modern taxonomic methods from 
Penicillium and Aspergillus classification" and “Modern concepts in Penicillium and Aspergil-
lus classification” from 2000237 and 1990238 respectively. 
The following sub chapter has been divided into subsections on the most important species. 
2.4.2.1 A. versicolor 
A. versicolor  (Vuillemin) Tiraboschi belong to the subgenus »Nidulantes« section »Versicol-
ores«, with no known teleomorphs. This species is common in many dry environments and is 
one of the few aspergilli, which are also common in temperate and cold environments25. It is 
the absolutely most common Aspergillus in damp and water-damaged buildings. 
Together with several streptomycetes239 and Chaetomium globosum240 it may be one of the 
major producers of the mouldy smelling component, geosmin, in buildings241. 
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Fragments which are significantly smaller than the spores are liberated from A. versicolor 
infested building materials84 and may account for the health problems in buildings where it is 
the predominant species on the materials without being so in cultivation based air-samples. 
Prolonged exposure may lead to significant lung damage, maybe as a secondary effect of IL-
1 liberation145, as discussed earlier in the report. 
 
Sterigmatocystin 
Sterigmatocystin (ST) is considered the most important toxic metabolite of A. versicolor and 
as seen in Table 3 in Appendix B, a number of analogues have been isolated including a 
number of precursors that are also biologically active. 
The biosynthesis of ST has been studied in detail, as ST is only two enzymatic steps from 
aflatoxin B1 (AFB1) which is of great economical importance for the agriculture industry. ST is 
deca polyketide synthesised over a C20 precursor, which is then transformed to norsoloric 
acid, averatin, 1'hydroxyversicolorone, versiconal hemiacetate acetate, versicolorin A and 
finally ST242, meaning that findings of ST would also imply the presence of a significant num-
ber biologically active precursors. 
ST is cytotoxic by itself, but the major problem is the carcinogenic properties after activation 
in the liver by the cytochrome P450 mono-oxidase system, to the 8,9-epoxide analogue 
which then preferable reacts with guanine as seen in Figure 4, just as for AFB1 176,243. 
ST has been shown to be a very strong inhibitor of the of chicken tracheal cilia244, and as this 
is one of the important ways we clean our upper airways, inhibition of this system may in-
crease the risk of upper airways infections. 
No studies of airborne ST have been found. However several exist for AFB1, which in rats 
and mice (one dose 17 mg/kg) suppressed the macrophage phagocytosis for 2 weeks as 
well as their release of TNFα upon exposure to endotoxin. Airborne dust containing AFB1 has 
been shown to increase the risk of liver cancer in workers handling ABF1 infected animal 
feed by two- to threefold with 
a 10 years latency32,33. Later 
studies have shown that the 
AFB1-guanine-adduct is an 
important exposure bio-
marker243. 
ST production is influenced by 
the humidity on cereals, as 
was only detected at RH over 88.5% and the maximum production of the toxin as well as 
biomass occurred at 93% RH245, and hence the same phenomena may be found in buildings. 
 
Other metabolites 
A. versicolor produces a number of other metabolites shown in Appendix B, table 4, but their 
toxicity is generally not very well described. The production of cyclopiazonic acid by A. versi-
color reported by Ohmomo et al246 was due to misidentification with A. oryzae62 and isolation 
of griseofulvin, dechlorogriseofulvin, and 3,8-dihydroxy-6-methoxy-1-methylxanthone from A. 
versicolor reported by Kingston et al247 must be due to a misidentification or contamination 
with a griseofulvin producing Penicillium (J. C. Frisvad, personal communication). 
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2.4.2.2 A. ustus 
Aspergillus ustus (Bainer) Thom & Church, also belongs to the subgenus »Nidulantes« but is 
placed in the section »Usti«, and has no known teleomorphs.  
The most extensive work on A. ustus metabolites have been done in South Africa by the 
group of Steyn and Vleggaar, due to problems with mycotoxicosis in cattle caused by A. us-
tus infections of grains248-250. And as seen in Appendix B, Table 5 the austamides and aust-
diols251,252 are acute toxic and the austocystins both toxic and carcinogenic253. The later 
group is also deca polyketides and closely related to AFB1 and ST both in structure and bio-
logical activity242 also notable is the production of versicolorin C254 which is one of the precur-
sors to ST. 
Aspergillus ustus var. pseudodeflectus is very different from A. ustus sensu strictu and pro-
duces pergillins, the TMC-120's and the ophibolins all showing various biological activities255 
(Appendix 5, Table 5)254,256,257. 
However no studies of airborne A. ustus spores or metabolites have been published, and 
hence the data on airborne AFB1 found in the A. versicolor section is the best when concern-
ing the austocystins. 
2.4.2.3 A. niger complex 
The Aspergillus section Nigri, found in the subgenus Circumdati, is also called the Black As-
pergilli, and contains 8 species: A. heteromorphus, A. ellipticus, A. niger, A. bubingensis, A. 
brasiliensis, A. japonicus, A. carbonarious and A. aculeatus258. 
The literature review on metabolites deals with the first 6 species, as they are very difficult to 
differentiate and seem to produce very similar metabolites (J.C. Frisvad, personal communi-
cation), and can be seen in Appendix B, Table 6. 
When a Niger is found in buildings, there are usually significant quantities of biomass but it is 
not that common that a full overview of its preferred materials has been established. 
Extracts of A. niger generally contains significant quantities of the low toxic259 tetra-cyclic 
compounds and naphtho-γ-pyrones 65, but the distribution of strains producing the highly cy-
totoxic malformins260 not known. This together with the low number of isolates which actually 
produces the highly nephrotoxic component ochratoxin A, makes a this a species which 
could pose a significant indoor problems if these two latter types of metabolites are produced 
in buildings. 
2.4.2.4 Other aspergilli 
A number of other aspergilli are also found in buildings especially the teleomorph Eurotium 
repens de Bary (A. glaucus group in Raper & Fennell236), often isolated from wood containing 
products and in roof construction which are getting very hot during the day. Eurotium is not 
recognised as a mycotoxin-producing genus65, but has however never been tested for their 
inhalation toxicity. Many of them can grow at 37°C and may cause infections in immunosup-
pressed persons.  
A. ochraceus is relatively rare in buildings, but in a household with indoor air problems, 
growth of A. ochraceus was found, and subsequently ochratoxin A was detected in dust us-
ing several highly selective analytical methods261. This means that growth of this species in a 
building should be considered a very serious problem. 
Two studies262 have both shown that A. flavus does not produce aflatoxins when growing on 
different building materials.  The isolates used with both studies were capable of producing 
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theses toxins on laboratory media262,263. However this species produces a number of other 
metabolites which many pose a health risk. 
A. fumigatus, is commonly found in dust and thus isolated frequently on dusty materials, but 
rarely found growing on materials25. When cultivated on wood pieces, it produces tremor-
genic components264, but the responsible components were not detected. Later, Ren et al262 
showed that two isolates capable of producing verruculogen and helvolic acid, failed to pro-
duce these when growing on different materials. This species is the most common infectious 
mould, growing in the lungs of immunosuppressed persons.  
2.4.3 Penicillium  
The genus of Penicillium Link ex Fr. is one of the anamorph genera placed in the family 
Trichocomaceae. It is associated to the holomorph genera, Eupenicillium and Talaromy-
ces265. In the last 10-15 years, the use of secondary metabolite profiles, isoenzyme patterns, 
and genetic approaches has drastically altered the taxonomy of this genus, previously classi-
fied on the basis of morphology. At present 225 accepted species exist in Penicillium. These 
include approx. 3 times as many synonymisized species265, reflecting the difficulties experi-
enced when identifying and classifying Penicillium species. 
Especially the terverticillate penicillia are difficult to identify to species level as they are very 
closely related, and secondary metabolite profiling seems to be most the accurate method266. 
Unfortunately misidentification of production cultures has obscured the connection between 
species and secondary metabolites62,267,268. 
2.4.3.1 P. chrysogenum 
Penicillium chrysogenum Thom, is placed the series Chrysogena Raper & Thom ex Stolk & 
Samson269 in the subgenus Penicillium. 
P. chrysogenum has 16 synonomised species269: 
• P. griseoroseum Dierckx 
• P. brunneorubrum Dierckx 
• P. citreoroseum Dierckx,  
• P. baculatum Westling 
• P. notatum Westling 
• P. meleagrinum Biourge 
• P. flavidomarginatum Biourge 
• P. cyaneofulvum Biourge 
• P. roseocitreum Biourge 
• P. rubens Biourge 
• P. camerunense Heim apud Heim 
• P. chrysogenum var. brevisterigma Romankova 
• P. harmonense Baghdadi 
• P. verrucosum var. cyclopium strain ananas-olens Ramire 
 
P. chrysogenum is found in dry habitats and can grow at temperatures as low as 5°C270. It is 
known to produce a large number of metabolites especially antibacterial as shown in Table 7 
in Appendix B. However, this also reflects the many screening projects including this species 
due to its original production of penicillin. The most toxic metabolites isolated have been the 
neurotoxic roquefortine C but it may also produce secalonic acid D176,271-273 which is pro-
duced by the closely related P. oxalicum, (J.C. Frisvad, personal communication). 
PR-toxin have been reported from this species by Frisvad & Filtenborg274 and by Dai et al275, 
but these findings are still discussed (J.C. Frisvad, personal communication). 
An inflammatory mediator may be present in the spores, as methanol extracted spores were 
non active compared with non-extracted spores146. 
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2.4.3.2 P. brevicompactum 
Penicillium brevicompactum Dierckx265 is now placed in the series Olsonii269 in the subgenus 
Penicillium. It is common on wood, some fruits, tropical soil and can grow at a lower aw than 
other penicillia124,269.     
P. brevicompactum has 9 synonomised species269: 
• P. griseobrunneum Dierckx 
• P. stolenifererum Thom 
• P. tabescens Westling 
• P. szaferi K.M. Zalessky 
• P. hagemiii K.M. Zalessky 
• P. biolowiezense K.M. Zalessky 
• P. patris-meii K.M. Zalessky 
• P. brunneostoloiferum Abe 
• P. brunneostoloiferum Abe ex Ramirez 
 
As seen from Table 8 in Appendix B, this fungus is capable of producing a high number of 
biologically active metabolites, from which mycophenolic acid is the most well known and 
most consistently produced268,276. This component was the first mould metabolite to be puri-
fied and crystallised, as early as in 1893277. It is being used as both an antibacterial and im-
munosuppressant drug. The most toxic component is the mytagenic botryodiploidin278-280, but 
it has not been prooven to be the principle component for a number of mycotoxicosis cases 
where this species has been the primary contaminant (J.C. Frisvad, personal communica-
tion). However most of the biologically active components seem to be able to interact with 
the growth of plants281-283. 
2.4.3.3 P. polonicum 
Penicillium polonicum K.M. Zalessky also found in the subgenus Penicillium, but the series 
Viridicata, some times refereed to as the Penicillium aurantiogriseum complex. The series 
are generally found on cereals and produces a high number of secondary metabolites269. 
P. polonium has 2 synonomised species:  
• P. aurantigriseum var. polonicum (K.M. Zalessky) Frisvad • P. carneolutescens G. Smidth 
 
Some of the most toxic Penicillium species are found in the aurantiogriseum complex, but it 
is extremely difficult to distinguish the individual species by other means than metabolite pro-
filing. Consequently literature has been obscured especially in this complex and the literature 
review will mostly be based on the paper of Frisvad & Lund284,285, and can be seen in Table 
9, Appendix B. 
P. polonicum produces at least the groups of highly toxic components, the verrucosidins286 
who are tremorgenic, the cytotoxic penicillic acid, which is extremely active against rodent 
lung macrophages (in vitro)287, and nephrotoxic glycopeptides which may be involved in the 
Balkan nephropathy endemic 288.  
2.4.3.4 P. expansum 
P. expansum is occasionally isolated in buildings, where it is often isolated from wood63. On 
this substrate, Land and Hult289 showed that some P. expansum could produce patulin. This 
mycotoxin is one of the most toxic Penicillium metabolites, being very highly cytotoxic and 
has a high inhibitory effect on the activity of mouse peritoneal macrophages290, as well as 
increases the susceptibility of fungal and bacterial infections213. 
However on agar substrates this species produces patulin, citrinin, chaetoglobosin C, roque-
fortine C, and the communisins A and B, one of the most toxic mixtures in this genus65.  
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2.4.4 Trichoderma  
Trichoderma Pers. ex Fr. is common on water-damaged wood containing materials, and from 
Danish buildings six different species have been isolated: T. longibrachiatum, T. harzianum, 
T. citrinoviride, T. atroviride, T. viride and T. harmatum71. 
Trichoderma was originally known for producing trichodermin and trichodermol which was 
originally isolated from a T. viride strain, and crystallised for the X-ray structure determination 
as the first TR by Godtfredsen & Vangedal291,292. Later another ester, Harzianum A, of tricho-
dermol has been isolated293. As trichodermol and esters of it are not commercially available, 
very few surveys for these metabolites have been performed, probably also due to its very 
low toxicity.  
Cvetnic & Pepelnjak294 have reported the production of DAS from T. viride using TLC, but it 
has not been possible to obtain any of the strains, for verification of this very unlikely finding. 
As seen in Appendix B, Table 10, the majority of the non-peptabol metabolites seems to be 
antibiotic and especially antifungal, and a large number of these seem to be small pyrones 
and lactones (<300 g/mol) often being volatile. Production of gliotoxin and viridin have also 
been reported from several Trichoderma species, but these have always been shown to be 
T. virens295 which has not been found in mouldy buildings65. 
The major group of biologically active metabolites are the peptabols, and cyclic peptides, 
Appendix B, Table 11, who often works by making pores in the cell membranes of the target 
organisms giving free passage of ions over the cell membrane. These metabolites have both 
antibacterial, and antifungal properties, but few reports exists of their effect on mammalian 
cells as most of the work on Trichoderma has been done to identify new antibacterial, and 
antifungal components. A number of proteins with severe biological properties ribosome in-
activation296 and high toxicity297,298 have also been described. 
No studies on the inhalation toxicity of these species or their peptabols exist, but they may be 
significantly more potent when inhaled. 
2.4.5 Memnoniella 
Only one species from the genus Memnoniella Höhnel has been identified in buildings and 
that is M. echinata Galloway, which is closely related to Stachybotrys179,299. As seen in Ap-
pendix B, Table 12, a number of biosynthetic groups are produced by this species. The 
griseofulvins which is a known type of antibiotics44 and are commercially used as such, can 
inhibit the polymerisation of turbulin in mammalian cells176. 
Two mycophenolic acid analogues; memnoconol and memnoconone300 have also been iso-
lated along with a number of spiriocyclic drimanes very similar to the ones produced by S. 
chartarum223,300-303 also the production of the simple trichothecenes; trichodermol and tricho-
dermin are common with Stachybotrys304.  
2.4.6 Alternaria 
The genus of Alternaria Nees ex Fr. comprises more than 40 species270 and is very common 
in soil and the phylloplane species A. alternata and A. tenuissima are found in very high 
numbers in the outdoors air during the summer25.  The toxicology of the Alternaria toxins 
have been reviewed thoroughly by Woody & Chu305. The acute toxicity (LD50) in rodents of 
alternariols seems to be in the range of 400 mg/kg, which is quite low even though they are 
reported teratogenic at 10 lower levels. They are mutagenic in the Ames test, but only few 
data in higher animals exists. Tenuazonic acid (LD50 10-200 mg/kg in rodents) is more toxic 
 Page   23 
and the altertoxins are about 1000 more toxic (LD50, 200 µg/kg in rodents). In Appendix B, 
Table 13 the biologically active metabolites of this groups have been compiled. It should be 
noted that A. alternata in grains may to be associated to esophageal-canser in China. 
The most potent mycotoxins produced by this genus, are the AAL toxins which are related to 
the fumonisins306,307 Alternaria alternata f.sp. lycopersici infecting tomato plants, but these 
strains have not been linked to buildings. 
Ren et al308 showed that only alternariols were produced on various building materials, 
whereas the altertoxins were not produced in detectable quantities. 
However if species of this genus should be the cause of the health problems observed in 
mouldy buildings, very different metabolites should be produced selectively in buildings,  
2.4.7 Chaetomium 
The teleomorph genus of Chaetomium Kunze ex Fr. comprises about 160-180 species270 
and has the genus of Acremonium Link ex Fr. as anamorph genus.  
The genus one of the most important deteriorators of cotton and cellulose containing materi-
als270 and in buildings C. globosum Kunze ex Steud. is the most common species16. 
C. globosum is  known from the cytohalasin mycotoxins, which are also produced by several 
Penicillium species, and who inhibit cytoplasmatic cleavage, and inhibit glucose transport in 
the tissue176. However the knowledge of toxicity of these components during inhalation is not 
known. 
The major work done on the metabolites has been performed in Japan309, but as seen in Ta-
bel 14 from Appendix B, many other metabolites are produced by species of the genus, es-
pecially the highly cytotoxic chaetomin which inhibits protein synthesis, the cytotoxic chaeto-
cins, the mutagenic mollicellins and the chaetochromins who are cytotoxic, teratogenic and 
induces liver injuries310. 
Interestingly some species also produce sterigmatocystins311 but these species have not 
been found in buildings. 
2.4.8 Cladosporium 
Cladosporium Link ex Fr. is a phylloplane genus and during the summer there can be as 
many as 10 000 spores per. m3 air of C. cladosporioides and C. herbarum25, and both con-
tains many of the same allergenic proteins312. 
On indoor surfaces C. sphaerospermum Penz. and some times also C. herbarum (Pers.) 
Link ex Gray is frequently isolated from bathrooms and silicone caulkings11,25. 
As seen in Appendix B, Table 15 no papers on real mycotoxins have been found from this 
genus, but a number of antifungal metabolites have been isolated along with a few plant 
growth inhibitors.  
2.4.9 Ulocladium 
The genus of Ulocladium (Thüm.) Simmons is often isolated from water-damaged materials 
together with Stachybotrys, and generally it is Ulocladium chartarum and U. atrum which are 
two commonly species of this genus in buildings16,63.  
Although this genus is morphologically similar to Alternaria and share the same major-
allergen, almost no secondary metabolites have been isolated as seen in Table 16 in Appen-
dix B. 
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2.4.10 Paecilomyces 
From the genus Paecilomyces Bain. two species are found in water damaged buildings, P. 
variotii Bain. and P. lilacinus (Thom) Samson, with the first being the most abundant.  
P. variotii is capable of growing on very low nutrient substrates as optical lenses, whereas P. 
lilacinus seems to prefer protein rich media270. 
P. variotii can produce the strongly cytotoxic mycotoxins patulin and viriditoxin65 as well the 
metabolites: ferrirubin, variotin, fusigen and indole-3-acetic acid25. 
2.5 Biomarkers of mould growth 
As earlier mentioned, not all spores are viable and hence a number of methods for measur-
ing chemical and molecular biological markers are needed. These methods can also provide 
much faster measurements for mould determination and significantly better quantification. 
For determination of moulds, four different principles can be used for material samples or air 
filters: 
• Determination of the activity of fungal enzymes. Here two methods have been used: 
i) Fluorescein diacetate hydrolytic activity (by determining fluorescein) will both detect the 
presence of bacteria and/or moulds in wooden samples125,313; ii) Determination of the ac-
tivity of β-N-acetylglucosaminidase314 (a enzyme in the chitinase partway) which is now 
commercially available as the Mycometer TestTM. Both methods have the advantage that 
the samples can be incubated for as long time as wanted, and hence a very high sensitiv-
ity can be obtained as many molecules of reactant can be obtained from each enzyme 
molecule. However these methods only detect functional enzymes.  
• Chemical markers, which can be genus, species, or isolate specific. These include: 
i) extracellular polysaccharides from Penicillium and Aspergillus30,315;ii) 18:2ω-
phosphorlipid fatty acids314;iii) β-glucan from the cell wall, also being an important in-
flammatory marker37,39; iv) mycotoxins or secondary metabolites who are species spe-
cific47; v) MVOC's in the air41,316; vi) chitin from the cell wall 317; and finally the cell mem-
brane material ergosterol 318,319. All these metabolites can principally be detected using 
various analytical methods as described for metabolites in section 2.6.  
• PCR-based methods, detecting specific parts of the fungal DNA, enabling even iso-
late recondition if needed, and also recently quantitation229. These methods will undoubt-
edly be very important in the future especially when the DNA-chip technology comes 
down in price.  
• Bioassay detection, either by detection cytotoxicity320,321 or more specific mode of ac-
tion, as the protein translation inhibition which is highly selective against trichothe-
cenes322. Such methods give health relevant data but do not give any information on the 
producing mould. 
All these methods are significantly faster than cultivation techniques and can also detect 
dead spores and mycelia, and will be the predominant methods in the future. 
2.5.1 Ergosterol 
Ergosterol (Erg) is the predominant compound in the fungal cell membrane, making it a suit-
able indicator for fungal growth, although it should be noted that also some amoebae and 
green algae are capable of producing Erg323.  
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Erg is partially bound as different esters324, and thus three different extractions can be per-
formed: Free Erg, extracted without saponification; Total free Erg by saponification of the 
esters after extraction; and Total Erg by saponification of the sample during extraction325-
327,327-330. In plant tissue extraction has shown some matrix dependency due to instability of 
Erg under various conditions, as exposure to sunlight or low pH327,328,331. 
Extraction has included reflux in methanol-water with or without NaOH/KOH for 30-90 min, 
generally being labour intensive compared with the microwave-assisted extraction for total 
Erg developed by Young330 and the extraction method of Larsson and co-workers318,332,333. 
These methods have been able to detect quantities down to 500 pg, corresponding to 200 
spores81,88. 
Erg is an excellent marker for quantification of fungal biomass on building materials318,334 and 
can also be used as exposure marker in air or dust, where especially Larsson et al332,335 and 
Miller et al22,81,88,336 have used it. However here it was found not to correlate with question-
naire data on mould in the home and not with as self-reported symptoms81. 
2.6 Detection of fungal metabolites 
Although perhaps more than half the time of the present work has been spent on developing 
analytical methods and trouble shooting on instruments, this subchapter will only give an 
overview of the analytical methods, as a more detailed literature review can be found in the 
papers 1-13. 
2.6.1 Chromatographic methods for detection of mycotoxins 
Fungal metabolites can be detected by various methods, often combined with chroma-
tographic methods337,338. 
2.6.1.1 Thin layer chromatography 
Thin layer chromatography (TLC) is the oldest of the chromatographic method, and requires 
less expensive and advanced equipment than the other chromatographic methods274 and a 
considerable sample speed can be achieved compared with other methods, unless 2-D TLC 
is used337,339. 
Target components can after separation be detected visually or instrumentally under light or 
under UV-light, the latter being very sensitive to fluorescent components. Usually the target 
components can be more or less selectively coloured by spraying with various reagents274,337. 
Antimicrobially components can be found by spraying the plate with a suspension of micro-
organisms in a growth substrate and after incubation for some days spots with no growth can 
be detected.  
Mass spectrometric methods such as MALDI-TOF and FAB-MS can also be used as detec-
tion methods of TLC339 although it seems more troublesome and slower than LC-MS and will 
probably only be used for very special applications. 
TLC is not specific enough for detection of TR340 although a number of "selective" colouring 
methods have been published341,342. 
For sterigmatocystins, spraying with AlCl3 is considered quite specific when combined with 
sample preparation methods removing quinones and related components343. 
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2.6.1.2 Gas chromatography 
As previously mentioned, mycotoxins are generally not volatile and hence gas chroma-
tographic detection of them will always have to face instability problems during injection and 
chromatography344. On the other hand capillary GC gives 10-100 times higher separation 
power345 than LC (packed column) and runs very stable with flame ionisation, electron cap-
ture detection (ECD), and MS, which are significantly more sensitive than UV and refraction 
index detectors used in LC. 
Almost all GC methods for mycotoxins start with derivatisation of free OH and N-H groups346 
to decrease the thermal lability. Acid groups are usually methylated, and alcohol groups are 
reacted to their TMS ether or esterficied to their acetyl or pentafluoropropionyl esters340,344. 
GC methods on most mycotoxins have been published, inter alia AFB1 and ST346, Alternaria 
mycotoxins347, penicillic acid348, patulin349, the backbone of the AAL toxins and the fumonis-
ins350, and especially the TR340. The latter, is the only group where GC-MS or GC-ECD has 
been the primary analytical method.351-365. 
2.6.1.2.1 GC-MS for trichothecenes 
The use of MS detection of the pentafluoropropionyl- (PFP) or heptafluorobuturyl (HPB) es-
ters will give the highest sensitivity if the MS has a mass range > m/z 800340. These deriva-
tives can be formed by the imidazoles PFPI and HFBI respectively or acid anhydrides PFPA 
and HFBA respectively, although the latter needs a nucleophilic catalyst such as triethyl-
amine, dimethylaminopyridin or imidazole340. Unfortunately the TB react slowly with both 
types of reagents and can undergo isomerisation giving more than one peak352.  The fluori-
nated derivatives can be detected selectively to very low levels using negative ion chemical 
ionisation (NICI)-MS or ECD, but also positive electron impact ionisation (EI+)-MS or positive 
chemical ionisation (PCI)-MS can been used360,366,367. 
TR lacking free OH groups cannot be detected using NICI and ECD unless they are hydro-
lysed to their parent alcohols prior to derivatisation353,360. 
2.6.1.2.2 GC-MS for sterols 
GC-MS has also been used, usually based on an internal standard, such as cholesterol or 
dehydrocholesterol335,368, as a isotope substituted standard is not commercially available. Erg 
has usually been derivatised to its tertiary-butyldimethylsilyl or trimethylsilyl (TMS) ether to 
reduce decomposition during injection and chromatography. On-column injection can also be 
used to further reduce decomposition330, but this method requires cleaner samples and is not 
as robust as splitless injection368. 
2.6.1.3 High performance liquid chromatography  
Since the late 1980s and the start of the 1990s HPLC have been the most important analyti-
cal method for mycotoxins337,369,370. 
The success of HPLC compared with the other methods have several reasons. Firstly the 
instruments have decreased in price as well as getting easier to maintain. They are easily 
automated and PCs can sample and do automated detection of target compounds. Many 
column materials are available from many different manufactures, and significantly larger 
samples can be injected than in a GC. More over samples do generally not demand derivati-
sation as GC does. 
From the mid 1990s the use of HPLC with MS detection employing atmospheric pressure 
ionisation techniques (API)371 such as electrospray372 and atmospheric pressure chemical 
 Page   27 
ionisation (APCI) have greatly expanded the use of HPLC for mycotoxins372,373. As toxins 
previously transparent to UV detectors can now be detected, e.g. the fumonisins which pre-
viously needed OPA derivatisation374,375, small peptides376,377,  and especially the TR378. 
2.6.1.4 Capillary electrophoresis 
Capillary electrophoresis (CE) has been used for detection of mycotoxins and low molecular-
mass compounds since the late 1990s, due to the extreme separation power exceeding cap-
illary GC by several magnitudes, as well as providing very fast separation379-381. 
The method has, however, a number of limitations as uncharged components cannot be 
separated unless micellar CE is being used which greatly lowers its separation power382. The 
very small sample volume (<<1 µl) which can be loaded on to the column gives detection-
limit problems even though several pre-concentration methods exists380,383. This means that 
CE is still generally used with very sensitive detectors such as Laser-Induced Fluorescence 
detection384,385. CE-MS methods have been used for low molecular-mass compounds but it 
has not yet been possible to use it in combination with micellar CE371,371,381.  
2.6.1.5 Immunochemical methods 
For routine analysis, enzyme linked immunoassay (ELISA) is used for detection of AFB1, the 
TB DON, ochratoxin A and zearalenone in cereals386,387.  
An increasingly important and very specific technique is to combine chromatographic detec-
tion methods with immunoaffinity clean-up388. 
Monoclonal antibodies have also been prepared for the TB 3- and 15-acetyl-DON389,390, 
sporidesmin A391, the MTR roridin A392, the TA DAS393,394 and presumable a number of other 
mycotoxins.  
A roridin A ELISA has been used to detect SG and SH in building material samples320, as the 
assay cross-reacts with SG (4-7%) and SH (15-19%)392,394. Also the MTR hydrolysis product 
verrucarol, was detected in serum using DAS-ELISA samples after it was derivatised to di-
acetyl-verrucarol which is structurally similar to DAS. 
2.6.1.6 Bioassay for detection of mycotoxins 
The first assays for measuring Stachybotrys toxins, were rabbit skin test which later have 
been shown to be highly sensitive for TR66,188,395. However due to ethical reasons this method 
is not used any more, as in vitro cultivated cell lines of human or animal origin can provide 
the same sensitivity and specificity321. Cell cultures are the most common assay for cytotoxic-
ity testing, and have been very successful for detection of the cytotoxic trichothecenes20,321,396 
and cytotoxic indoor air organisms148,149. It should be noted that great differences in sensitiv-
ity and specificity of different cell types exist321. Most of the methods are used in combination 
with the MTT test, which measures if the mitochondria are functioning using a simple color-
metric detection321,397. The cell assays can also be used for measuring other reactions than 
cytotoxicity, e.g. induction of inflammatory mediators such as NO and different inter-
leukins152,398. 
The major problem with mammalian cell cultures is the need for cultivation in highly sterile 
environments and frequent sub-cultivation which is very time and material-consuming. Hence 
a more simple solution can be used, e.g. sperm cells50,399-401 who are available from local 
insemination centres, blood cells which can assayed for haemolysis229 and/or rings from 
chicken trachea where the movement of the cilia can be monitored402. A very simples assays 
is the brine shrimp Arthemia salina184,403 which has been extensively used for TR and other 
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mycotoxins as the aflatoxins403. Engler et al404 used the yeast Kluyveromyces marxianus 
grown in microtitre plates for detection of TR by monitoring its expression of β-galactosidase. 
An assay measuring protein translation inhibition have has reported by Yike et al322. This 
assay has detection limits 20-400 times lower than cell cultures. 
2.6.2 Sample preparation 
The most time-consuming part of analysing for mycotoxins and other fungal metabolites, is 
extraction and especially the sample clean-up. 
2.6.2.1 Trichothecenes 
TR range from polar compounds like nivalenol (NIV) extracted with methanol-water or ace-
tonitril-water mixtures to apolar compounds such as diacetoxyscirpentriol (DAS) and T-2 
toxin (T-2) extracted with mixtures of chloroform, dichloromethane and ethyl acetate. Thus no 
method can provide full extraction (≈ > 80%) of all TR unless multiple extractions are per-
formed 340. 
The MTR can be extracted using water-methanol to dichloromethane-methanol mixtures, but 
the first mixture should extract fewer interfering components405. 
At least one solid phase extraction (SPE) step has to be included before the TR can be de-
tected. Most successful are normal phases, such as silica gel, florisil, charcoal-alumina or 
MycoSep columns340,359. Reversed phase has also been published351,406 but due to the large 
difference in polarity of the TR and the time-consuming evaporation of water these methods 
have not been as popular as the normal phase ones. For the MTR the PEI silica has proven 
to be superior, as it selectively removes the spiriocyclic drimanes, phenolic compounds and 
the brownish gum always present in extracts from Stachybotrys405,407. 
For the polar TB immunoaffinity clean-up is also widely used, as they are soluble in the wa-
ter-acetonitrile mixtures used for loading immunoaffinity columns340,390, and can be detected 
using HPLC with UV detection. 
2.6.3 Detection of mycotoxins in air and settled dust 
To estimate the human exposure to mycotoxins, these have to be measured and quantified 
directly in air samples or in settled dust. But as spores and airborne dust contain interfering 
components and the spore concentration is very low 408(usually << 5000 m-3), detection of 
airborne mycotoxins will be very difficult due to the very low quantities. Until now, airborne 
mycotoxins have only been detected in environments with high concentrations of airborne 
spores, such as the agricultural industry and the feed-handling industry. Here several studies 
have demonstrated airborne AFB1 when handling materials infested with A. flavus32,409. 
Richard et al261 detected ochratoxin A in dust from a dwelling with growth of A. ochraceus, 
using LC-MS and HPLC-FLD from samples cleaned up using immunoaffinity clean-up. 
Sorenson46 showed that spores released from a S. chartarum isolates growing on rice, con-
tained ≈ 4×10-14 g MTR per spore, meaning that about 1500 spores (450 spores using the 
data of Nikulin et al45) should be collected, if assuming 80% extraction efficiency and 50 pg 
detection limit in sample, however as there are different MTR present (unless they are hydro-
lysed to verrucarol) and rice and MEA are good substrate for MTR production significant 
more spores may be needed. 
Smoragiewicz et al410 reported that dust from a ventilation system contained the TR roridin A, 
T-2 tetraol, T-2 toxin, and DAS. They also reported TR from cultures of the non-TR producing 
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genera Penicillium, Aspergillus, Alternaria, and Ulocladium, which demonstrates that all their 
results must be false positives.  
Yike et al229,322 demonstrated that dust and air samples from houses infested with S. charta-
rum inhibited their protein translation assay, which strongly suggested the presence of tricho-
thecenes in the air. 
To conclude it should be possible to detect mycotoxins in air samples, but no validated sam-
pling and clean-up procedures exist, meaning that this major problem has to be addressed 
first.  
 Page   30 
 
3 OVERVIEW OF EXPERIMENTAL WORK  
The details of the experiments performed during this study can be found in the papers 1-13. 
However results of a number of small experiments not included in the papers can be found in 
the discussion part and identification of components initially reported as unknown. 
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Figure 4. Overview of experimental work. 
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4 RESULTS AND DISCUSSION 
The reason for the more detailed comments and results included in the thesis, is that a num-
ber of them would not fit into any scientific papers, but that I feel they should be documented 
somewhere.  
4.1 The building associated funga 
As mentioned in paragraph 2.1.1 the associated funga reported from different countries var-
ies considerably. Unfortunately this study has not analysed field samples enough to make 
definite conclusions on this issue. However a number of observations are still interesting: 
• It was not possible to get any material samples with Alternaria infestation, all were in-
stead infested with Ulocladium. Although > 15 field samples which should contain Alter-
naria were received). 
• Almost all (>50%) of the material samples received were at least partly infested with P. 
chrysogenum and A. versicolor, although the presence of the latter could only be re-
vealed by chemical detection of sterigmatocystin (ST), see section 4.3.2.1, page 44. 
• When Trichoderma spp. or Chaetomium spp. were present on a material they grew in 
almost pure culture and with significant biomass. 
4.1.1 Penicillium and Aspergillus cultures received from Finland 
A number of Aspergillus and Penicillium isolates collected from both material and air samples 
were received from National Public Health Institute, Kuopio, Finland (KTL). They were culti-
vated on YES, CYA, CREA and MEA and identified by colony diameter and morphology. 
Isolates that could not be unquestionably identified were metabolite-profiled by HPLC-DAD 
(YEA and CYA). 
 
Table 6 
Aspergillus and Penicillium isolates (n=131) received from KTL1 
Species Frequency 
(%) 
Species Frequency 
(%) 
Species Frequency 
(%) 
Aspergillus versicolor 23 P. citreonigrum 3 Penicillium charlesii 1 
Penicillium brevicompactum 11 Aspergillus ustus2 2 Penicillium commune 1 
Aspergillus fumigatus 10 Penicillium crustosum 2 Penicillium echnilatum 1 
Penicillium corylophilum 5 Penicillium solitum 2 Penicillium janczewskii 1 
Aspergillus sydowii 5 Aspergillus niger3 2 Penicillium manginii 1 
Eurotium repens 5 Penicillium decumbens 2 Penicillium purpugenum 1 
Penicillium chrysogenum 5 Penicillium expansum 2 Penicillium rosepurureum 1 
Penicillium palitans 5 Penicillium rugulosum 2 Penicillium variabel 1 
Penicillium glabrum 4 Aspergillus flavus 1 Penicillium vinaceum 1 
Penicillium italicum 4 Penicillium albocoremium 1  
1From Anne Hyvärinen, National Public Health Institute, Kuopio, Finland. 2Not a classic A. ustus but Aspergillus ustus var. pseu-
dodeflectus. 3Did not produce detectable quantities (HPLC-FLD) ochratoxin A on CYA or YES agar. 
 
As seen in Table 6, A. versicolor was the most predominant mould almost contributing with 
25% of the isolates and more than 50% of all aspergilli. Surprisingly A. fumigatus was very 
frequently isolated (10%) which might be due to sampling on dusty surfaces, as A. fumigatus 
is frequently recorded in Danish house dust (S. Gravesen, personal communication). 
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P. brevicompactum was the most frequently isolated Penicillium, confirming results from the 
on-going Danish School study, where P. brevicompactum, P. corylophilum and P. chry-
sogenum were the most common penicillia. 
 
These results contradict results from North America, reporting P. aurantiogriseum and P. 
viridicatum as the most abundant Penicillium species. This might be due to misidentification 
with P. palitans and other species from the aurantiogriseum-complex (J.C. Frisvad, personal 
communication), but unfortunately it has not been possible to obtain any of these Penicillium 
isolates to verify the identification.  
4.2 Fungal growth on materials 
In papers 2 and 3, material samples were water-damaged (aw ≈ 1) and significantly higher 
number of spores were applied to the materials than naturally found in buildings. The moulds 
were usually able to cover the materials where they occur "naturally" within 4-10 days, clearly 
demonstrating that when water damages occur, action should be taken the same day if ma-
terials should be saved. This also complies with observations by several consultant engi-
neers (M. Ø. Hansen, personal communication), who report complains from the inhabitants 
within 10-30 days after a single water damage, and complaints within 2-4 days in buildings 
with a known water damage history. 
When using lower aw (papers 10 and 13) the growth rate decreased dramatically and with 
very few exceptions only the primary and secondary colonisers were observed growing on 
the materials. At stationary conditions (paper 10), only Penicillium and Aspergillus species 
grew, with P. chrysogenum and A. versicolor being the most common species. However on 
wooden materials A. flavus and Eurotium spp. were observed quite frequently and always 
with significant biomass. At 5°C only P. chrysogenum and A. versicolor grew, with the latter 
producing conidiophores with very few conidia. 
Wooden and wallpapered materials supported growth down to 78% RH (paper 10), which 
was lower than the other materials. It was seen that the planned pinewood  was usually not 
infested on as much of the surface as the rough materials, but on the areas where growth 
occurred there was not significant difference in the 
produced biomass. At 5°C this limit was about 90% 
RH, whereas the results only indicates a limit be-
tween 80 and 90% RH. These results comply per-
fectly with the results of Hukka & Viitanen141 and 
Grant et al55, when the uncertainties of the RH 
measurements of both studies (±2%) are taken into 
account. 
Interestingly, the gypsum boards did not support 
growth <90% RH, but did support production of 
significant quantities of biomass at 95% RH, it is 
also clear that the fibre-gypsum was less suscepti-
ble than the cardboard-gypsum, which is the most 
common type in Denmark. Paper insulation mate-
rial did not support fungal growth at all due to the 
high contents of borates, although it should be 
noted that this material when damaged supports 
growth of several moulds including Stachybotrys (unpublished results). The almost totally 
1
5 cm
2
2
 
Figure 6. Concrete after 4 months at 95% RH 
and 10°C, at #1 can A. versicolor conidiophores 
be seen and at #2 sterile mycelia. 
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inorganic concrete materials partly supported germination of especially A. versicolor and 
sterilia mycelia at RH >90% and growth at 95%, as seen in Figure 6. This must be due to 
trace quantities of organic components in the concrete. As the concrete materials were 
cleaner than the ones used in buildings concrete based materials will probably support more 
growth under field conditions (paper 10). 
When comparing Tables 2 and 3, it is clear that the temperature drop from 10 to 5°C had a 
dramatic effect on the fungal growth, showing no growth at 90% RH and 5°C, and that also 
here was wooden and the wallpapered materials the most susceptible (paper 10). 
4.2.1 Methods for testing the susceptibility of materials 
As mentioned in the literature part, testing materials for their susceptibility is difficult, even 
just controlling the humidity is difficult. As this was the first time such a test was performed at 
the Danish Building Re-
search Institute, it was tried 
to keep the set-up as simple 
as possible (paper 10), and 
regard the study as a pilot 
project which should ex-
plore difficulties such as 
humidity range, inoculation, 
and especially assessment 
of the materials. This set-up 
is shown in Figure 7, and 
was primarily built by Gun-
nar Holm. Initial conditions may play an important role for the surface aw of the materials, and 
as it was desired to use steel chamber and take the materials out for assesment, it was nec-
essary to use the sample boxes for reasons occupational health. 
This meant that the surface aw would be controlled by the RH of 
the incoming air to the sample box and primarily by the absorb-
ance of water by the material until equilibrium, which small ex-
periments had showed would take months. This meant that we 
had to add the quantity of liquid water to the materials, assuming 
that it would be equally distributed within a few days. Although 
this should tested in future experiments. 
I paper 13, the set-up at TNO Bouw was used, and the initial 
humidity was controlled by a high continuous airflow over the 
materials (see Figure 8). This means that the absorption of water 
from the airflow was so little that the change in humidity over the 
10 materials in each channel could be neglected. However this 
approach created another problem as the air speed itself can 
inhibits growth if the speed is too high. This is illustrated in Fig-
ure 9, where the air speed was higher in one side of the channel 
than in the other. 
The TNO approach (paper 13) had another advantage, as it is 
possible to work with transient humidity conditions, and here it 
1 mm
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Dry air 0.1 m3/hr air
Dry air
 
Figure 7. The fungal growth assesment set-up used in Paper 10. 
 
Figure 8. The TNO set-up, 10 
material in each row. In this 
case infested with P. chry-
sogenum. 
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was seen that the stress of using periods of high and low humidity during a day, trying to 
mimic a bathroom. This had a strong selectivity stress towards the phylloplane, Cladospo-
rium, which under transient conditions was able to outgrow P. chrysogenum.  
The instationary conditions, with and without surface conden-
sation (paper 13), can cope with conditions which keeps the 
storage moulds away and still be too dry for the phylloplane. It 
can also cope with water accumulation in the surface of mate-
rials, especially when working with two to three layer systems, 
like a painted piece of cardboard gypsum (3-layer system)11. 
Hence, the total growth behaviour of materials is extremely 
complicated, and to characterise a material well, the perform-
ance and associated funga under at least three different envi-
ronmental conditions is needed: 
• The lowest RH which supports growth. 
• The performance under transient conditions. 
• The performance under water damage. 
4.2.2 Growth assessment 
In paper 10, the materials had to be taken out of the set-up for assesment. This was very 
time consuming and obscured the environmental conditions for the samples. Using the ap-
proach of Adan11 as in Paper 13 (see Figure 8), the materials can be assessed several times 
a day if required. The time resolution of this process describes the susceptibility - as how fast 
growth started - better than endpoint determinations of biomass. The latter parameter seems 
to describes how much of the substrate could be utilised (papers 10 and 13). 
Visual inspection (paper 13) has a major problem, especially using the 5 point scale de-
scribed by British Standard411, as the assessed coverage area is the output parameter. This 
does not take the concentration of fungal biomass into account. Thus a material with very 
light coverage over all of the material will be assessed to have a higher value than a material 
with heavy growth over only a part of the material. 
The use of image analysis was partly explored at the stay at TNO Bouw (unpublished), and 
this technique will undoubtedly help in future studies, as images for assessing the materials 
can be taken automatically several times a day. It can also cope with the high growth rate 
observed on some paints (where 
the materials had to be assessed 2-
3 times per day, paper 13). Also a 
more standardized assessment in-
cluding the fungal "concentration" 
can be made. However this will re-
quire that the image-analysis is cali-
brated carefully against very well-
described samples. Here chemical 
markers could help to compare the 
appearance of different moulds.  
The use of dissection microscopy 
showed that the moulds often grew 
in mixtures (see Figure 10). Looking at materials with scarce growth and a fibrous surface 
was very difficult, and only sporulation could be detected. However it was possible to distin-
 
Figure 9. The influence of too 
high air velocity on A. versicolor 
growth in one side of the set-up. 
 
 
Figure 10. Mixture of A. flavus, A. versicolor and P. chrysogenum, 
growing on pinewood. 
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guish A. versicolor, often seen as white to olive conidiophores with very few spores and P. 
chrysogenum, often as light bluish or white conidiophores with very long chains of spores 
attached. 
When no sporulation occurred on fibrous materials such as the pinewood or gypsum boards 
it was only the chemical markers which could detect growth, but in no case significant bio-
mass overlooked. 
4.2.2.1 Biological markers 
One or both the biological markers ergosterol (Erg) and the Mycometer TestTM were used in 
papers 5, 10, 12 and 13. 
Qualitative determination or Erg was easily performed by the standard HPLC and TLC meth-
ods already used at the department, but quantitative determination proved to be painstaking 
process. External standard quantitation using HPLC or GC-MS proved unreliable, especially 
using GC-MS where both splitless injection, various ion-trap phenomena, and the breakdown 
of the GCQ followed by it being rebuilt in USA, complicates things further (paper 5).   
All the sterol standards obtained were almost transparent to the HPLC-DAD, leaving GC-MS 
with internal standard as the only possibility. LC-MS was not available at that time, and will 
probably not be an alternative, as the low-polar solvents used to elute it will give problems 
with the ionization process. Several sterols were tried as internal standard for GC-MS, but 
the high dynamics of the external ionisation ion-trap system did not give better standard de-
viations (SD) than 25% when working on standards. When using 4-D2-ergosterol as internal 
standard, synthesised by Dr. J.Ø. Madsen, Erg could be determined with a SD of < 5%, as 
variation in the ionization and the dynamics of the gate lens is no longer interfering with the 
analysis. 
In paper 5 it was shown that no SPE clean-up step was needed when using GC-MS/MS and 
that the sample did not need to be neutralised after the saponification when splitless injec-
tions was used. Microwave assisted extraction was proven to be a very powerful and fast 
technique but very dangerous, as the vials occasionally exploded and ripped open the mi-
crowave oven door. 
As many samples could be hydrolysed in standard laboratory vials at the same time - this 
method was preferred. It was possible to reach 120 samples per day, although the GC-
MS/MS can only analyse 60-65 samples per day. The SD ranged from 1-4% in spiked sam-
ples and in real samples SD ranged from 4-12%, with detection limits in the sample of 2-10 
ng, which is fully sufficient as the variation of fungal growth on surfaces is much higher. 
However during analyses of samples described in papers 10 and 13, this detection limits was 
difficult to reach and the general limit was 10-30 ng, which is significantly higher than re-
ported in paper 5, which was already higher than reported elsewhere 318,330. One of the major 
problems was the daughter ion-yield (number of daughter ions / number of the parent ion in 
the full scan chromatogram), decreased to 4-8% for unknown reasons, compared with a yield 
of > 50% of the PFP or HFB-trichothecene derivatives. The water and oxygen levels in the 
system ware extremely low, and various q-values, ion-source temperatures and CID voltages 
were explored as well as alternative tuning of the lenses, but with no increased sensitivity.  
Sample decomposition during injection was a particular problem while running the sample 
described in paper 13, where the painted materials had a dramatic impact on the sensitivity 
due to deposits in the liner (not visible). In the future such samples should probably, after 
hydrolysis, be loaded (cold) onto a C18 cartridge which can be cleaned with water-methanol 
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mixtures, before the sterols can be eluted with methanol/dichloromethane, but would com-
promise sample preparation speed.  
In paper 12, the m/ 363 and 365 were used as parent ions and m/z 157 and 159 as daughter 
ions for Erg and 4-D2-Erg respectively, this combined with newly cleaned ion source assem-
ble and new liners in the GC every 60 injections lowered the detection limit to 1 ng (20 pg 
injected).  
In paper 10, both Erg and the Mycometer Test™ showed growth or no growth, but the corre-
lation was obscured by the high variability of the fungal growth. This problem was overcome 
in paper 12, where the same sub-sample of material or agar were analysed for enzyme activ-
ity with the Mycometer Test™ and for ergosterol (Erg) using GC-MS/MS. Here it was noticed 
that the enzyme activity would usually be highest during the initial growth phase and usually 
decreased to about 50-80% whereas Erg would only decrease to 90-70% of it peak value, as 
illustrated in Figure 11. When comparing enzyme activity, Erg and dry weight of agar cultures 
it was noticed that these parameter did not always peak at the same time, probably due to 
different induction of the en-
zyme.  
Compared with visual inspec-
tion, paper 10, the chemical 
markers generally showed the 
same, but were a nice alterna-
tive on very fibrous surfaces 
where even the use of a ste-
reomicroscope gave problems 
with distinguishing fungal 
growth from fibres. Erg has the 
advance of being an absolute 
method, which can be good for 
comparing different ratings of 
mould growth.  
The secondary metabolites 
were very useful species-
specific biomarkers, and in papers 3 and 10, significant growth of A. versicolor (see section 
4.3.2.1, page 44) was hidden by P. chrysogenum.  
Metabolites may also indicate how wet the materials have been, e.g. does the presence of 
the A. versicolor metabolites PE1, XOO and ROQ but not ST, indicates 0.95 > aw > 0.90, 
whereas ST indicates aw > 0.95 (see section 4.3.2.1, page 44). 
4.3 Growth and metabolite production 
In this chapter the most important results of the different moulds and their growth and me-
tabolites production will be discussed. 
4.3.1 Stachybotrys 
Experimental growth of S. chartarum IBT 7711 could be recognised after 5 days of incuba-
tion (paper 2) on new water-damaged (aw ≈ 1) gypsum boards, which is partly due to the high 
dose of spores (4×103 spores/cm2), but still surprisingly fast. Growth of the other 4 isolates 
was not as fast, but the gypsum boards were still totally covered with the fungus after 14 
days. None of the 5 isolates could grow on chipboard, acoustic ceiling tiles or pinewood 
pieces. 
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Figure 11. Comparison of Mycometer test and ergosterol determinations 
on gypsum board inoculated with Stachybotrys chartarum (IBT 9694). 
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These findings are in accordance with field observations14 and paper 4 where consistently 
wet gypsum boards seem to be the main substrate of Stachybotrys in buildings25.  
In paper 10 where mixtures of common 
moulds were inoculated under regulated 
humidities and temperatures (95-70% RH) 
Stachybotrys was only found on the three 
types of gypsum boards when RH ≥95, and 
here only with very limited production of 
biomass had occurred, as shown in Figure 
12. This demonstrates that this species 
generally require water-damaged materials 
to produce significant quantities of biomass 
and compete with the penicillia and asper-
gilli. This is in accordance with the litera-
ture (see Table , p.5) where Stachybotrys 
is seen to require aw 0.95 or more for 
growth, although Pasanen et al107,108 have 
reported growth as low as aw 0.78-0.81 
which is highly unlikely. This is presumable due to the 1 ml spore suspension added to very 
small samples (down to 0.25 g), meaning that aw of the samples would be higher than the RH 
in the air controlled by the saturated salt solutions for an unknown period. 
4.3.1.1 Analysis for trichothecenes 
In papers 1 and 2, GC-MS negative ion chemical ionisation (NICI) was used successfully for 
detection of the trichothecenes (TR) as it gave excellent matrix suppression compared with 
EI+ ionization, as illustrated i Figure 2 in paper 2. However, the matrix suppression could also 
be obtained with more polar extraction mixtures (methanol-water) and more effective removal 
of acid residues from the derivatised samples. Combined with a number of problems with 
NICI compared with EI+ (paper 1, 2 and 8) the latter became the preferred as NICI gave the 
following problems: 
• A decrease in sensitivity after 10-15 samples was observed. This could be avoided by 
changing the ion volume. 
• After changing to the turbo pump, it took 1-2 hr to stabilise the ionisation gas. 
• The MS got very dirty much quicker and needed to be cleaned every 2-3 months, which 
is very time consuming. 
• Very short lifetime of the filament (1-2 months)  
• The high pressure of methane, which was necessary to obtain a high sensitivity and high 
m/z ions, gave a poor mass resolution of approx. m/z 0.5-1 (10% valley), making auto-
matic data processing very difficult. 
• If the method should be used on the type A trichothecenes (TA) from Fusarium, the ion 
volume temperature should be raised to 120°C to avoid condensation. However this gave 
almost no high-mass ions (<m/z 300) especially not for the type B trichothecenes (TB).  
• The number of ionised molecules is about 10 times as low in NICI as in EI+, meaning 
than when MS/MS (which looses 10-90% of the ions) was used a significant drop in sen-
sitivity was observed. 
 
 
Figure 12. Scarce growth of S. chartarum on a gypsum 
board at 95% RH and 10°C after 4 months. 
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In EI+ the daughter ion spectra were significantly more reproducible than the full scan spec-
tra. Thus EI+ ionisation combined with MS/MS (paper 8) was used in all other studies except 
papers 1 and 2. 
In the study of TR produced by Fusa-
rium (paper 8) it was observed that the 
methods used in papers 1 and 2, could 
not fully derivatise the type B trichothe-
cenes (TB) and that a number of arte-
facts were produced. A number of 
methods using imidazole or acid anhy-
dride based reagents and mixtures of 
these were tried but none were suc-
cessful, until the method of Langseth et 
al396 was applied. This method worked 
both with PFP and HFB esters, but the 
PFP was chosen as the HFB gives MW 
exceeding the upper mass range of the 
GCQ (m/z 1000). 
However this derivatisation method did 
not work for trichodermol and verrucarol 
as partly facilitated apotrichothecene 
rearrangements (ring breakage of the epoxy group)412, so the original method (papers 1 and 
2) using HFBI was not changed for these trichothecenes (Figure 13). 
To speed up the hydrolysis step it was tried to pass the hydrolysed sample through a strong 
cat-ion exchanger for neutralisation of the NaOH405, which worked fine on standards. How-
ever with fungal extracts huge quantities of interfering peaks and irreproducible derivatisation 
were observed, hence the liquid-liquid extraction seems to be a powerful clean-up step. 
Parallel to changing the GC-MS method to EI+, a clean-up method for HPLC detection was 
developed to detect the unhydrolysed macrocyclic trichothecenes (MTR). It was clear that 
reversed phase clean-up was not effective due to the polarity difference between the MTR a 
problem well known from the simple trichothecenes where normal phase clean-up is the 
most effective340. Silica and PEI silica (provided by B.B. Jarvis407) were tested, but it was 
clear that the latter was significantly better to remove the spiriocyclic drimanes. By dry-
packing the PEI in syringes between two pieces of filter-support material stamped out by a 
sharp steel cylinder a SPE-PEI module could be manufactured on less than 30 sec. The di-
chloromethane sufficient to elute the macrocyclic trichothecenes could then be placed in the 
RVC (takes 24 vial) and evaporated in 2 hr giving a much higher sample throughput com-
pared with the method of Hinkley & Jarvis405. The effect of cleaning up the extract on the PEI 
columns is illustrated in Figure 14, where the HPLC profiles of crude extract is compared with 
the cleaned up extracts on a MTR and an non-MTR producing S. chartarum on PSA agar. 
It was noted that the sample should be totally dry before redissolving it in dichloromethane, 
as water or methanol traces facilitated the breakthrough of the spiriocyclic drimanes in the 
dichloromethane fraction. When trying to fractionate Stachybotrys extracts it was also noted 
that the dry solvent blanks from the PEI-columns were toxic to the boar sperm used by Pel-
tola et al231 and the human bronchoalveolar cells used by Norn et al413. 
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To study the ratio between trichodermol and trichodermin in the crude extracts, unhydrolysed 
crude and PEI cleaned extracts were HFB derivatised and analysed using GC-MS/MS. The 
PEI clean-up step was necessary to avoid huge quantities of interfering peaks and unrepro-
ducible derivatisation. It was also shown that the trichodermol TR are predominantly present 
as trichodermin (paper 6-8). 
4.3.1.2 Metabolites produced by Stachybotrys 
During the first part of study (papers 1 and 2) it was believed that most isolates would pro-
duce MTR208. This was, however later shown not to be true, papers 6-9 and Jarvis et al44, as 
only 30-40% of the isolates produces MTR.  
The samples collected in a school and a dwelling (paper 1) both yielded verrucarol upon hy-
drolysis (up to 15 ng/cm2 SH equivalents) as well as trichodermol (not quantified). When in-
cubating different strains on water-damaged new and old gypsum boards (paper 2), only 2 of 
5 isolates yielded high quantities of verrucarol upon hydrolysis (up to 120 ng/cm2 SH equiva-
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Figure 14. HPLC-DAD chromatograms (260 nm) of Stachybotrys chartarum extracts from PSA agar: a) crude 
extract (IBT 7711); b) PEI cleaned up extract from a satratoxin producing strain (IBT 7711); c) PEI cleaned 
up extract from an atranone producer (IBT 9466). 
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lents), one isolate produced significantly less MTR. In extracts from the last two isolates ver-
rucarol was perhaps present, but detection could only be performed on the non-specific m/z 
213 ion, [HFB-O]-, which was observed from many peaks of the chromatogram. 
The satratoxin levels detected (15-120 ng/cm2) are the same as reported by Johanning et 
al23 who found 33 ng cm-2 satratoxin H in biomass scraped off from a infested building mate-
rial, but lower than found by Nikulin et al107 who detected 2-3.5 µg/cm2 satratoxins from a 
highly toxic strain of S. chartarum (isolate #72 = IBT 9460). 
Temperature and humidity did not seem to influence the production of the spiriocyclic dri-
manes (paper 10) when growing on gypsum boards, as these were detected in substantial 
quantities at 10°C and 95% RH at gypsum boards. 
In papers 6, only S. chartarum produced satratoxins G, H and iso-F whereas S. dichroa 
stopped the trichothecene biosynthesis at roridin E (see Figure 2, p. 14). S. oenanthes pro-
duced trichodermol type TR. S. bisbyi, S. albipes, S. microspora S. nilagrica S. parvispora, S. 
theobromae, and S. cylindrospora did not produce any detectable quantities of TR. The latter 
species has been reported to produce trichodermol and trichodermin414 and El-Maghraby et 
al415 have reported that S. albipes, S. kampalensis and S. microspora produced MTR. Unfor-
tunately these strains are not available in any culture collection. However as only 1-3 strains 
of each species were tested, the study is not big enough for major conclusions on these rare 
species, as it should also be noted that only ALK and PSA were used for these species.  
In papers 6 and 8 it was observed that the strains capable of producing MTR did this on all 
solid substrates tested (CMA, V8, YES, PSA, OAT, PSA, DRYES, ALK, CYA and rice ex-
tracts agar), with PSA and ALK agar yielding the highest quantities. On the latter agar, en-
hanced production of stachybotrylactones and lactams was observed, often more than 20 
different components with the UV spectra illustrated in Figure 14A. As these components are 
the main interfering components (removed by the PEI silica SPE clean-up), PSA agar was 
chosen as the standard substrate for chemotaxonomic studies of S. chartarum.  
The rich substrates CYA and YES, where high quantities of biomass was produced, yielded 
surprisingly low quantities of MTR together with CMA, V8, OAT and rice extract agar. The 
low quantities of MTR produced on the latter substrate is surprising since whole rice is a very 
good substrate used extensively by Jarvis and co-workers44,204,304. The construction card-
board used in study 12 gave approx. as much of the MTR per area as PSA agar. 
Three taxa was found among the isolates from buildings (paper 6): i) the MTR producing S. 
chartarum isolates; ii) the non MTR producing S. chartarum isolates; iii) a new undescribed 
species, referred to as Stachybotrys sp. type A.  
The latter taxon did not show PCR amplification of the TR5 gene (paper 7) and did not pro-
duce detectable quantities of trichodermol. However this was not the same in paper 6, where 
25% of the Type A isolates produced trichodermol or esters of it, which was also confirmed in 
paper 8, where trichodermol and trichodiene was detected from the type A isolate. 
Study paper 6, 7 and 9 showed that and the non-MTR producing S. chartarum taxon and the 
Type A taxon consistently produced 6β-hydroxy-dolabella-3E,8E,12-trien-14-one and often 
also epoxydolabellane A (see Figure 14C), both precursors to the atranones227. Due to the 
lack of pure reference standards the identity of these had to be confirmed using LC-MS. This 
was kindly performed by Hanne Jakobsen, on the new Micromass LCT system using elec-
trospray ionization (ESI) with the same or similar eluents as the general LC method370. In 
Figure 15) the ESI spectra of these two dolabellanes can be seen.  
When growing on PSA agar, S. chartarum rarely produced the atranones themselves, which 
is different to growth on rice227. However, some of the isolates tested in the spring of 2001 
also produced the atranones, indicating small changes in the PSA, may induce this.  
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Two extracts of atranone producing isolates on rice (Jarvis, B.B., Hinkley, S.F., Nielsen, K.F. 
et al, to be published) contained trace levels of verrucarol upon hydrolysis (GC-MS) and also 
were significant more toxic that the other atranone producing isolates although still being 
magnitudes less cytotoxic than the MTR pro-
ducers. Trace level of verrucarol was also de-
tected in the material sample from the Belgium 
IPH case home from which none of 6 isolates 
were MTR producers. When IBT 14915 (an 
atranone producer) in paper 2 was inoculated 
on gypsum boards trace level of verrucarol 
was also detected. Altogether these observa-
tions indicate that the atranone producers may 
be able to synthesise the verrucarol type TR. 
Hopefully a more sensitive LC-MS method can 
reveal if MTR are produced by these strains. 
The very clear distinction of atranone produc-
ers and MTR-producers on agar substrates 
(papers 6-9) suggests that the genes from the 
atranone biosynthesis perhaps in inserted in, 
or near the genes coding for the enzymes used for synthesising trichodermin into verrucarol-
type TR or epi-genetic changes (rearrangements in the 3D structure of the genes), so that 
only of these pathways is expressed. 
The isolates studied by Ruotsalainen et al148 were retrieved from Public Health Institute, Ku-
opio Finland (KTL). Originally two large groups of isolates were observed, one which was 
highly cytotoxic and one which induced inflammatory responses in the murine macrophages. 
When analysing (paper 9) the chemical profiles of the 20 isolates, it was shown that all the 
11 isolates being cytotoxic, except one which was probably contaminated or confused by 
another isolate, belonged to the MTR producing taxon. All the isolates inducing inflammatory 
responses belonged to the atranone producing S. chartarum taxon. In the original study148 it 
was also observed that as the only isolate HT16, did not induce the strong inflammatory re-
sponse as well as not being cytotoxic at 105 spores/ml. This isolate was the only Stachybot-
rys sp. type A, suggesting that this taxon is not producing the inflammatory inducing sub-
stance(s) and that the effects is not due to the particle effects, as the spores are almost iden-
tical in size and shape (paper 6). The pure atranones B and D were did not induce any in-
flammatory response in the macrophages. Thus, the specific agent triggering the inflamma-
tory response in the macrophages is still unidentified. The inflammatory agent(s) may be 
present in the MTR-producing isolates, but due to the extremely potent cytotoxins the 
macrophages are killed before they can respond or that the spores contains components 
inhibiting the induction of TNFα221.  
Identification of the component inducing the inflammatory response is of special interest 
since high induction of TNFα is known to be a significant factor of the induction for lung dam-
age153. Nikulin et al45,216 suggested that the MTR were the main reason of the lung tissue 
inflammation they observed when installing mice with S. chartarum spores from a MTR pro-
ducer (#72) and a non-MTR producer (#29, later shown to produce atranones, paper 6). 
However #29 also produced significantly smaller quantities of the spiriocyclic drimanes, mak-
ing these components an alternative agent. 
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Figure 15. Positive ESI spectra of Epoxydolabellane 
A and 6β-hydroxydolabella-3E,8E,12-trien-14-one. 
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When looking at the number of papers dealing with possible causative agents to the IPH, it is 
surprising how little effort has been put into the spiriocyclic drimanes, which are produced at 
considerably higher levels than the atranones and trichothecenes, presumable 10-500 times 
more, based on their extension coefficient. Especially the spiriocyclic drimanes isolated from 
S. microspora226,416 which enhances the plasminogen-mediated fibrinolysis should be taken 
into consideration as they might be produced by the S. chartarum isolates in buildings. The 
neurotoxic symptoms reported by 
Johanning et al21,23 could be due 
to the neurotoxic as well as the 
nerve activator compounds417,418. 
It the present work attempts were 
not made to differentiate between 
the different spiriocyclic drimanes 
as their UV spectra are very simi-
lar. Furthermore there was only 
very limited time to run LC-MS 
analyses. A single subclass, in-
cluding 5-7 analogues of the 
spiriocyclic drimanes was, how-
ever, tentatively identified (paper 
6), by their distinct UV-spectra seen in Figure 16, as the Mer-NF5003221 components. LC-MS 
analyses pointed at molecular masses (MW) of 470 Da of three analogues, two analogues of 
412 Da, one with 368 Da. All with slightly higher MW than the reported B and E analogue221, 
however one minor analogue also fitted MW, 386 Da, with the F analogue221. The attention 
was drawn to these components, as B.B. Jarvis had never seen these in Stachybotrys ex-
tracts from rice. These components are produced on most agar substrates, especially 
DRYES and PSA, as well as on hay (unpublished) and in crude extracts from the building 
materials (paper 1, 2, 10 and 11). In paper 10, it was shown that the spiriocyclic drimanes 
and atranones were produced at 10°C and 95% RH on several types of gypsum boards indi-
cating that these metabolites are produced under most environmental conditions. 
 
Airborne Stachybotrys metabolites 
Late in the study a number of air samples (24 hr, 60 m3/min) and material samples were re-
ceived from E. Johanning. The filters and materials had already been shown to be highly 
cytotoxic in the pig kidney cell line used by Gareis et al321, which indicated the presence of 
MTR. Analysis of these samples revealed that two air samples contained several spiriocyclic 
drimanes including Mer-NF5003 analogues as seen on Figure 17, and probably also satra-
toxins G and H (the UV spectra were very weak), which were confirmed by the presence of 
verrucarol in the two hydrolysed samples, detected by GC-MS and GC-MS/MS (Figure 18). 
Based on HPLC-DAD detection of satratoxins G and H, the total MTR contents were esti-
mated to 75 and 100 ng (± 50%), whereas GC-MS showed 130 and 150 ng (± 50%) respec-
tively. 
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Figure 16. UV and ESI spectra of two MER-NF500 analogues. 
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These quantities correspond to about 100 and 116 pg/m3, as about 1.5% of the filter area 
was extracted, using the MTR contents of Sorenson et al46 of 40 ppm in the spores from rice 
cultures which corresponds to about 0.04 pg/spore (assuming a density of 1 g/cm3, and ellip-
soidal shape of 11 x 4 µm) which correspond to about 2700 spores/m3. Based on data of 
Nikulin et al45 who found 0.14 pg/spore from MEA culture, this corresponds to 770 spores/m3, 
which are high but realistic concentrations. Several of the material samples (vacuum cleaned 
onto the ALK filters) from the same building contained significantly higher quantities of the 
same drimanes as well as satratoxins G and H. 
When working with these filters as well as samples from non problem buildings it was clear a 
significant quantities of black sticky material was also collected on the filters, and more 
method development is needed to clean-up these samples more efficiently. 
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Figure 17. HPLC chromatogram (260nm) of air sample from a stachybotrys infested house. With the UV spec-
tra of peaks corresponding to metabolites. 
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Figure 18. Chromatograms of HBF-derivatised hydrolysed air sample, from above: Total ion chromatogram; 
extracted ion (m/z 444) from the full scan event; extracted ion (m/z 231) from the MS/MS scan event on m/z 
444. In the right side is the full-scan and MS/MS spectra inserted. 
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When comparing exposure data to animal studies, it seems for the non-toxicologist to be 
very high quantities that have been instilled in rats and mice. Often 105 to 106 spores in sin-
gle doses45,217-219,419 and down to 103 spores in several doses216, and with the concentrations 
of Stachybotrys spores even in highly infested buildings generally <<1000 spores/m3. 
As seen in the literature part, many data on the toxicity of trichothecenes exist, however only 
af few studies take lung toxicity, particle effects, and other metabolites into account.  
Using the data of Nikulin et al45 who used 106 spores (containing 140 ng MTR) as a single 
dose, the death of 2 of 4 animals, resembles the LD50 value (not taking the statistical uncer-
tainty into account). Directly transferred to a human (70 kg) assuming the same susceptibility 
per weight, corresponds to about 750 µg MTR or 3×109 spores. 
As concentrations of Stachybotrys spores even in highly infested buildings, is generally be-
low 1000 per m3 (Hunter et al10 have reported 20 times higher values) and with a human res-
piratory rate of 1.5 m3/hr, about 36 000 spores can inhaled per day.  This is so much lower 
than the LD50 value, that there is no reason to suspect lethal mycotoxicoses even if a 1000x 
lower LD50 is used, to cope with individual and species susceptibility as well as more toxic 
strains into account. 
Workers handling infested materials, and not using the prescribed respiratory filters may be 
exposed to very high levels. Assuming up to 0.1-1 µg/cm2 MTR and a LD50 of 750 µg MTR 
this corresponds to dust from 0.15-1.5 m2, and it is not likely that any persons will inhale so 
much biomass even if working in a small unventilated room. But significant inflammation in 
the lungs and decrease in platelet concentration, as well as changes in the lymphocyte sub-
populations may be possible. Such effects were observed in mice when instilling 6 dose over 
3 weeks using 103 spores each time216. This corresponds to the dust from 2-15 cm2 infested 
material per day. However these does not take the higher metabolism and shorter life span 
of the mice into account. 
To asses the risk of people living in mouldy homes repetitive exposures of small doses is 
needed to estimate the No observed adverse effect level (NOAEL)420. This is especially im-
portant for the MTR, as they have immunosuppressing effects at far lower levels than the 
acute ones and should be combined with the other metabolites. 
To conclude on this species, which is the far most investigated indoor contaminants, and still 
not been established any causal relationship to IPH, although is seems that the MTR are not 
the principle components. The general immunosuppression of people exposed to stachybot-
rys may also be explained by the spirocyclic drimanes, although exposure to MTR producing 
strains must be considered to be worse.  
Significant is needed to characterise the health effects of spiriocyclic drimanes as they are 
the primary metabolites of S. chartarum when growing on building materials. More over they 
are also produced in its natural habitat, hay, and have been proven pharmacologically active 
in many assays (Appendix B, Table 2). 
4.3.2 Aspergillus  
4.3.2.1 A. versicolor 
In paper 2, it was shown that this species was capable of growing on almost all the water-
damaged materials, and that chipboard and wallpaper supported production of the most visi-
ble biomass. Furthermore (paper 13), it was observed that A. versicolor grew especially fast 
on paints, and transient humidity conditions greatly slowed its growth.  
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Two different growth patterns were seen: either low biomass production and heavy sporula-
tion or high biomass production (white-red mycelia) with very low sporulation (papers 2, 3 
and 10).  
In paper 10, A. versicolor was one of 
the most frequently observed mould 
growing on the materials, even capa-
ble of growing at 5°C. This is contra-
dictory to Smith & Hill94, who ob-
served that A. versicolor requires 9°C 
for growth on a high nutrient substrate 
such as MEA. 
It was capable to grow on the three 
types of concrete at RH > 0.90 (paper 
10), although the produced quantities 
of biomass were very low, except for 
a few hotspots (illustrated in Figure 
19). It was notable, that it always was 
A. versicolor that grew on the concretes and never P. chrysogenum, which indicates that A. 
versicolor may require less nutrients or is better grow at high pH. This is confirmed by private 
consultants who often see A. versicolor growing in plaster (M. Ø. Hansen, personal commu-
nication).  
In paper 2, it was shown that all the 5 isolates of A. versicolor from buildings produced, very 
high quantities of sterigmatocystins (ST) and 5-methoxysterigmatocystin (5ST), up to 30 
µg/cm2 on the material samples. In addition other ST analogues, versicolorins and other 
components from this biosynthetic pathway were 
usually also present in lower quantities esti-
mated on the peak areas and the molar absorp-
tivities. The amounts of biomass scraped from 
the materials were estimated to less than 100 
mg, which means that the total contents of 
sterigmatocystins may have been more than 1% 
of the biomass. All the materials, especially wall-
paper supported production of ST, which was 
positively correlated to the amount of visible 
biomass and negative correlated with sporula-
tion. This is quite obvious, as substantial energy 
is put into sporulation.  
In the study on naturally infested materials (pa-
per 3) it was observed that red coloured areas infested with non- or poorly sporulating iso-
lates contained the largest quantities of ST, whereas areas with many conidia contained very 
small quantities of ST. This is important for exposure assesment, as the spores are consid-
ered the source of exposure to ST, although new studies have shown than smaller fragments 
than the spores are liberated from its mycelium84. 
 
 
Figure 19. A "hotspot" of A. versicolor conidiophores on low 
density concrete (bar is 1 mm). 
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Figure 20. UV spectrum and positive ESI spec-
trum of 5-methoxysterigmatocystin. 
 Page   46 
In both paper 2 and 3, the investigated materials were 
soakingley wet (aw > 0.99) and compared with paper 10 
and 13 where different humidities were applied, it was 
apparent that ST production was correlated with RH, 
and that ST production was not detectable at aw < 0.90. 
This complies with findings on cereals245, where sterig-
matocystin production started at aw 0.89 with a maxi-
mum production and biomass at aw 0.93. 
In paper 2 and 3, 5ST was tentative detected based on 
its UV spectrum, especially the shoulder at 270-280 nm 
(Figure 20) not seen in the UC-spectra of other sterigmatocystins. Later it was shown by 
positive electrospray LC-MS, that the molecular weight was 354 Da. This is seen as the 
[M+H]+ ion in Figure 20. The M+64 adduct could not be accounted for but it was also ob-
served for ST.  
A number of A. versicolor isolates produced one to five components resembling the known 
component versicolin421-423 (J.C. Frisvad, personal communication). Two of the UV spectra 
are shown in Figure 21. Al least one of these was produced in substantial quantities on wall-
papered gypsum boards (paper 2).  
It was tried to clean up 5 of these components by growing a 
particular good producer on YES agar, where they often 
are produced in very high quantities. But as the compo-
nents seem to be unstable when cleaned-up, and as time 
was short the project (2 weeks) it was abandoned. Later it 
was tried to tentative identify the analogues by LC-MS as a 
literature review showed that it might be 2,3,6-
trihydroxytoluene423 and esters hereof. However this ana-
logues was not commercially available, but the two ana-
logues to isomers 3,4,5-trihydroxytoluene, and 2,4,6-
trihydroxy toluene of were purchased. Especially the 3,5,6 
analogue, had a similar UV-spectrum (Figure 22) and a 
retention time similar to several of the "versicolins".  
LC-MS of extracts containing the "versicolins" indicated MW of 260 and 262 Da, and several 
with 242 Da. However other, less abounded, unexplained ions were also present, meaning 
that these MW may not be correct. This was further complicated, as LC-MS of the two com-
mercial analogues indicated the 2,4,6-analogue was not ionised at all, and that the 3,4,5 ana-
logue showed 6 major ions at m/z 253, 294, 311 and 481, with no apparent ionization 
mechanism. Thus the ionisation conditions, including ion-polarity, have to be optimized for 
this type of components before any definite MW could be assigned.  
In paper 10 and 13, where the sterigmatocystins and their analogues were almost never de-
tected, and number of other metabolites were detected. These have previously been de-
tected in extracts of A. ochraceus (J.C. Frisvad, personal communication), and are named 
ROQ, PE1 and XXO until their structure is known, their UV spectra can be seen in Fig. 11. 
Especially the latter component was often detected in material extracts. Occasional was the 
known component penigequinolone detected. Looking at some of the very small peaks in the 
chromatograms from both agar and material extracts (paper 2 and 3) revealed that these 
metabolites were present in many A. versicolor extracts. 
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Figure 21. UV spectra of two peaks re-
sembling versicolin. 
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Figure 22. UV spectra 3,4,5-
trihydroxytoluene and 2,4,6-trihydroxy 
toluene. 
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LC-MS analysis indicated that XXO had a MW of 431 Da, and 
an analogue eluting at 1-2 min. before a MW of 447 Da. 
Three analogues of ROQ were detected, however the MW as 
only determined for on of them as 393 Da. It is interesting 
that these presumable nitrogen-containing metabolites (nitro-
gen rule) are still biosynthesised at RH < 90% while the poly-
ketide pathway that produced ST, is shut down. However at 
86% RH they were not biosynthesised by the still growing A. 
versicolor. 
Four other types of metabolites, eluting between 3 and 10 
min, seemed to be strongly associated with growth of this 
species under low RH, and their UV spectra can be seen in 
Figure 23, all has several analogues often also seen. A few of 
the metabolites have been seen in agar culture extracts.  
The HPLC-DAD analyses of the samples of paper 10 and 13, 
also revealed a ERG analogue eluting approx. 2 min after 
having identical UV spectra, it was only detected in samples 
infested with A. versicolor. Inspection of the full scan seg-
ments of the GC-MS analyses indicated no other sterols, 
which together with the retention time and same UV spectrum 
strongly indicates that it was an ester of ergosterol. 
It is obvious that the metabolism of this species is very diverse, and needs much more atten-
tion, as most of the metabolites produced at aw < 0.95 are unknown. These metabolites may 
be important for the adverse health effects associated to growth of A. versicolor, especially 
because they were liberated 
from the materials by a light vac-
uum, and hence have the capa-
bility of becoming airborne.  
Animal tests have also shown 
that A. versicolor induces in-
flammatory responses in rats 
and mice145,151. These things 
combined with the small liber-
ated fragments from the spores 
or hyphae84, means that the 
growth of A. versicolor poses a 
health risk even if air measure-
ments does not show elevated 
concentrations of spores. 
4.3.2.2 A. ustus 
In paper 3, A. ustus were incubated on a number of materials, they grew very slowly on pure 
gypsum boards and chipboard whereas growth was much faster on the wallpapered ones, 
which it covered the surface after 2 weeks. On the gypsum boards solid structures, 1-2 mm 
in diameter, containing up to 100 Hülle cells were observed. The A. ustus isolates studied in 
paper 3, were all isolated from mouldy buildings, and produced no detectable quantities of 
any known mycotoxins from this species. The highly toxic austamides, austdiols, and the 
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Figure 23. From above, UV spec-
tra of the structurally unknown 
ROQ, XXO, and PE1. 
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Figure 24. UV spectra of four unknown metabolites presumable pro-
duced by A. versicolor 
 Page   48 
austocystins (Appendix B, Table 5) who are consistently 
found in cereal isolates (J.C. Frisvad, personal communi-
cation) were not produced in detectable quantities on the 
materials or in agar cultures. Instead a number of metabo-
lites with UV spectra resembling the ones seen in Figure 
25, with varying UV-max, all eluting between from 14 min 
to 35 min, were observed. The low toxic kotanines, also 
seen from isolates of A. niger was the only known me-
tabolites produced on the materials. 
The indoor isolates appears to be Aspergillus ustus var. 
pseudodeflectus, which should be described as a new 
species, as varieties are not accepted any more169. 
In agar culture extracts of the indoor air type, components 
resembling the drimane sesquiterpenes, the TMC's, per-
gillins and ophibolins seem to be present (Appendix B, 
Table 5). These metabolites are not described as toxic, 
and have been isolated from Aspergillus ustus var. pseudodeflectus, but a definitive identifi-
cation of these metabolites was not possible due to the lack of reference standards and LC-
MS analyses. 
The general conclusion on the indoor air A. ustus isolates, is that studies on their in vitro and 
in vitro pulmonary toxicity and inflammatory potential is needed (grown on relevant materi-
als), as well as knowledge on what is actually liberated from materials infested by these iso-
lates. 
4.3.2.3 A. niger complex 
Growth of especially A. niger was extremely fast on all artificially infested materials except on 
gypsum board and the wallpapered gypsum boards where almost no biomass were pro-
duced (paper 3). The other materials were covered by black Aspergillus heads in one to two 
weeks, and substantial quantities of biomass could be scraped off the material. This indi-
cates that the gypsum 
boards contains com-
ponents inhibiting the 
growth of this species. 
All isolates (paper 3) 
produced high quanti-
ties (>20 different) 
naphtho-γ-pyrones and 
tetracyclic compounds eluting from 6 to 35 min (UV spectra, see Figure 26) and the known 
compounds orlandin and nigragillin (Appendix B, Table 6). The quantities of these compo-
nents made detection of the malformins and other end-absorption components impossible, 
and if the spores are later shown to be highly cytotoxic a more selective method against 
these small cyclic peptides should be developed. After the study the samples were reana-
lysed using HPLC-FLD for the presence of ochratoxins, but these analyses were also nega-
tive. 
When observing the spores on the media it is clear that they contains a high number of other 
metabolites, but as for A. ustus, studies on their in vitro and in vitro pulmonary toxicity and 
inflammatory potential is needed. 
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Figure 25. Common UV-spectra from 
Aspergillus ustus var. pseudodeflectus. 
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Figure 26. UV spectra of a tetracyclic compound (left) and naphtho-γ-pyrones. 
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4.3.2.4 A. flavus 
In paper 10, A. flavus contaminated a number of the wooden materials, presumable due to 
ineffective X- ray sterilisation (25 kGy), as A. flavus growth was seen on a piece of pinewood  
returned from the sterilisation plant. It should be noted that all boxes were marked with small 
X-ray indicators to assure that they were x-rayed. 
However as A. flavus usually produces aflatoxins, extracts from materials where it grew were 
analysed with HPLC-FLD, where the samples had been derivatised using trifluoroacetic acid 
to produce the stronger fluorescent hemiacetals424, which had a 52 times lower detection limit 
(≈100 pg) for the B1 analogue than the underivatised. No aflatoxin was detected in of these 
samples, which complies with the results of Ren et al262 and by Rao et al263. Surprisingly, the 
isolate recovered from one of the materials did not produce aflatoxins on CYA or YES agar.  
However the in vitro and in vivo toxic and inflammatory potential of material cultures should 
still be investigated as this species produces many other metabolites when growing on mate-
rials, and hence may still be a problem. 
4.3.3 Penicillium  
In papers 3 and 10, it was observed that the penicillia produced significant less biomass than 
the aspergilli, based on visual observations, what could be scraped off the materials and the 
size ergosterol peak in the HPLC chromatograms. 
It has been a problem to obtain materials with other penicillia than P. chrysogenum, as identi-
fication to the species level is not done by the consultant engineers we collaborates with, and 
who have a good source of naturally infested materials. 
4.3.3.1 P. chrysogenum 
In paper 3 it was observed 
that this species grew very 
fast on the wallpapered gyp-
sum boards and chipboard, 
seen as grey to light green 
discolouring patches. The 
materials were overgrown in 
two to three weeks.  
On the naturally infested 
materials investigated it was 
present in almost all sam-
ples, with more substantial 
amount of biomass than on 
the artificially infested mate-
rials. Isolation often also 
revealed an additional but 
limited number of A. versi-
color colonies, indicating 
that it often grows in mixed 
cultures, which was also observed in paper 10. The mixed cultures may be due to a lower 
quantities of antifungal metabolites, or perhaps that the metabolites does not diffuse in these 
solid materials. 
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Figure 27. A MDF plate (20×14 cm) from paper 10, after 4 months at 
95%RH and 10°C. # 1 and 2 are P. chrysogenum growth (2 mm high) and 
#3 is a Eurotium Sp., #4 is Ulocladium sp., and the rest of the material is 
partly covered with a mixture of A. versicolor and P. chrysogenum. 
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In paper 13, P. chrysogenum (CBS 401.92) was surprisingly fast on the painted samples, 
where it grew faster than A. versicolor, and was visible after 2 weeks, here it appeared light 
blue, but changed colour to grey over time. 
P. chrysogenum produced (paper 3, 10 and 13) very low quantities of secondary metabolites 
compared with Aspergillus species, e.g. were no P. chrysogenum metabolites detected in 
any of the large areas seen on Figure 27, except for occasional detection of chrysogine, and  
2-pyrovoylaminobenzamide no metabolites could be associated to growth of this species 
under non water damage conditions. A considerable number of the P. chrysogenum infested 
samples in paper 13 were contaminated with an unknown Aspergillus, producing totally un-
known metabolites perhaps related to A. ustus and/or A. versicolor. 
On water-damaged wallpapered gypsum boards it produced chrysogine (paper 3) whereas 
this metabolite was not detected on chipboard. The natural samples, meleagrin was detected 
as the only metabolite, which is interesting as it is a predecessor of the neurotoxic roque-
fortine C (paper 3). TLC analyses274 showed that all isolates produced an unknown metabo-
lite appearing as dark blue spots after spraying with anis aldehyde. This metabolite was only 
detected from P. chrysogenum and had approximately 10% higher Rf-value than griseofulvin.  
Recently it was shown that double blinded placebo controlled exposure of 8 "sensitive" hu-
mans to 6×105 spores/m3 for 6 min of P. chrysogenum, grown on wallpapered gypsum 
boards, did not induce any significant changes in self reported symptoms, clinical measure-
ments or blood analyses (Meyer, H.W., Kildesø, J., Nielsen, K.F. et al, to be published).  
As for most of the other moulds, no data no the long term toxic potential of this species ex-
ists, and hence it may produce toxic metabolites, not detectable with HPLC-DAD. However 
on the other hand, it may be one of the moulds that obscure detection of more toxic species. 
4.3.3.2 P. brevicompactum 
All isolates grew well on water-damaged wallpapered chipboard and chipboard (paper 3) 
whereas the growth was slower on the wallpapered gypsum-boards, and no growth was ob-
served on gypsumboards. This observation suggest that growth it is stimulated by compo-
nents present in wood, which corresponds well to field observations where it is frequently 
isolated from wooden materials124. 
On chipboard (paper 3), 1/3 of the isolates produced mycophenolic acid, and 1/2 of the 
stains also produces asperphenamate, a tanzawaid acid analogue425(UV in Figure 28), and 
the structurally unknown metabolite O.  
In paper 10, this species was not isolated from any of 
the materials, indicating that it has difficulties with 
competing with P. chrysogenum and A. versicolor. 
However the dust from one MDF plate (10°C, 95% RH) 
contained another tanzawaid acid analogue indication 
the presence of P. brevicompactum on the material, 
and other possible analogue was detected from a 
beech wood piece (90% RH, 20°C), also indicating the 
presence of P. brevicompactum. 
Especially the presence of the immunosuppressing mycophenolic acid, a number of metabo-
lites with unknown biologically activities, and the anecdotal mycotoxicoses after ingestion of 
infected food, suggests that may have strong in vitro and in vivo toxic and inflammatory po-
tential, which of needs further investigation, as it is on of the most common penicillia in 
mouldy buildings. 
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Figure 28. UV spectra of unknown tan-
zawaid acid analogue. 
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4.3.3.3 P. polonicum 
Only two indoor strains were available, and they grew on all the materials, although usually 
with not very much biomass (paper 3). They both produced 3-methoxy-viridicatin, verruco-
fortine, and the tremorgenic verrucosidin. 
However as it is not clear how common this species is in the indoor environment, there are 
other species which need to have their in vitro and in vivo toxic and inflammatory potential 
determined before this species. 
4.3.3.4 Penicillium expansum 
Only one isolate of indoor origin was available (paper 3) and it grew very poor on all the four 
materials, and no metabolites were detected in any of these samples. This is contradictory to 
Land and Hult289 who saw production of the patulin, when their strains were inoculated on 
wood and wood chips. 
As this species can produce some of the most toxic components found in this genus, it is 
necessary to know if its presence in buildings is due to growth on materials or introduced 
from mouldy fruits.  
4.3.4 Trichoderma  
In paper 2, where the materials were inoculated at aw ≈ 1, growth of Trichoderma could be 
detected after 3-4 days on wooden materials whereas it was much more slow on other mate-
rials and did not occur on the new gypsum boards. These observations are fully in accor-
dance with field observations (paper 4) where Trichoderma is generally found on wood prod-
ucts25,71. 
In paper 10, where the humidity was lower, Trichoderma was only growing on a very small 
fraction at the wooden materials and here not even as the dominating mould. This further 
demonstrates that this genus requires water-damaged materials to grow. 
None of the T. atroviride, T. harzianum, T. longibrachiatum and T. viride infested materials 
from, paper 2, revealed trichodermol upon hydrolysis, which was also the case for the YES 
extracts from the 36 isolated investigated by Lübeck et al71. 
In a later paper 8, 150 additional agar extract from U. Thrane's collection were screened for 
trichodermol, however only one isolate (IBT 9471 = ATCC 90237) was able to produce 
trichodermol as also found by Corley et al293. It was not been possible to obtain other known 
trichodermol producing isolates, as the isolate used produce the first trichodermin by 
Godtfredsen & Vangedal291 at LEO pharmaceuticals, Denmark, is not available.  
The literature review on Trichoderma showed that the peptides are some of the dominating 
biologically active metabolites (Appendix B, Table 11), but they were not targeted in this work 
due to lack of LC-MS facilities. 
Recently it was shown that double blinded exposure of 8 "sensitive" humans to 6×105 
spores/m3 of T. harzianum, grown on wallpapered gypsum boards, during 6 min, did not in-
duce any significant changes in self reported symptoms, clinical measurements or blood 
analyses (Meyer, H.W., Kildesø, J., Nielsen, K.F. et al, to be published). The set-up was (for 
economic reasons) partly buildt in plastic, and during characterization of the set-up it was 
shown that particles smaller than the spores were absorbed to the walls of the set-up.  
As T. harzianum as A. versicolor, also produces smaller particles (Kildesø, J.K., Würtz, H., 
Nielsen, K.F. et al, to be published) than the spores the people were not exposed to these 
fine particles. 
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To conclude on this genus, it is important that their in vitro and in vitro pulmonary toxicity and 
inflammatory potential is investigated (grown on relevant materials), as well as knowledge on 
what is actually liberated from materials infested. 
4.3.5 Memnoniella echinata 
No growth tests were performed with this species on materials, but an infested piece of 
Memnoniella infested gypsum board received from Dr. E. Johanning. Dust, sampled by the 
ALK mouthpiece, from this sample contained griseofulvin and its two dechlorinated deriva-
tives. 
Chemical analysis (unpublished) were performed on 11 isolates, grown on ALK, PSA, SYES, 
CYA and V8 agar: Results showed that the three griseofulvins where consistently produced 
on all media and in significant in quantities compared to other metabolites, and combined 
with data from rice cultures44, it must concluded that these components seems to be pro-
duced on all solid substrates. Spiriocyclic drimanes, similar to the ones produced by S. char-
tarum, were also consistent produced, however in significant (ca. 10×) lower quantities than 
the griseofulvins, based on the UV molecular absorptivities.  
The production of trichodermol or esters of it, varied considerable even in the same isolates 
on the same media (papers 8 and 11). 
 
To conclude on this species, it seems to be isolated the same places as S. chartarum al-
though less frequently, which may be due to difficulties of distinguishing it from S. chartarum. 
However studies on its in vitro and in vitro pulmonary toxicity and inflammatory potential is 
needed (grown on relevant materials), as well as knowledge on what is actually liberated 
from infested materials. 
4.3.6 Alternaria 
All the isolates, except of the A. infectoria group isolate, inoculated on different materials 
(paper 3) grew well and produces alternariol, it's mono methyl ether and three to five un-
known analogues with identical UV-spectra. However these metabolites very low toxic and 
should not be considered mycotoxins (see section 2.4.6, p. 22). No altertoxins, tentoxin or 
tenuazonic acid was detected in any of the extracts, confirming results of Ren et al308.  
 
It was tried to find naturally infested material with growth of Alternaria, but all samples (>15) 
brought to the department was infested with Ulocladium sp. and not Alternaria. This may in-
dicate that actual Alternaria growth on materials may not be that common, and that the many 
findings of Alternaria in the indoor air environment may originate from out door sources. 
However it has still not been shown if the AAL toxins are produced by Alternaria in buildings, 
although this is very unlikely, as this type of strains are only known as endophytes in 
plants350,426. These metabolites are the only really mycotoxins known from this species, but 
need LC-MS detection or the unspecific OPA derivatisation also used for fumonisins. Thus, 
the presence of this fungus in buildings only seems to pose a very limited risk, especially as 
the main source of exposure comes from outdoors, where the air concentrations are magni-
tudes higher than indoors. 
 Page   53 
4.3.7 Chaetomium globosum 
Being an ascomycete this genus has a very characteristic appearance (paper 3) due to its 
distinct black or dark green, hairy perithecia visible to the naked eye. Field samples were all 
very wet wallpaper, gypsum board and wood products (paper 3 and 4). On the artificially in-
fested water-damaged material growth was very fast covering the surface with substantial 
amounts of biomass after two weeks (paper 3). 
In paper 10 where mixtures of common moulds were inoculated under controlled humidities 
Chaetomium was only found growing at one material clearly showing that this genus gener-
ally requires water-damaged materials to grow. 
When growing on building materials (paper 3) C. 
globosum consistently produced high quantities of 
biomass (up to 10 mg/cm2). Very high quantities of 
secondary metabolites, especially chaetoglobosins 
A, C and analogues were produced in very similar 
quantities, 28-50 and 5-7 µg/cm2 respectively, by 
six isolates incubated on wallpapered gypsum. An 
unknown metabolite, was detected in all Chae-
tomium extracts except in IBT 7029, which had 
visible smaller peritricia than the other isolates. Hence this component may be a species-
specific marker. Its UV data (see Figure 29) did not seem to match any of the components 
found in Table 15 in Appendix B. 
The metabolite profile of naturally infested materials were very similar to the artificially in-
fested materials, chaetoglobosin A and C production in quantities up to 3 µg/cm2. Besides 
these, three other chaetoglobosins and approximately 10 unknown metabolites were also 
detected. Analyses of two old (2-3 years) heavily black-stained materials did not reveal chae-
toglobosins A or C, but a number more polar analogues, which are probably hydrolysis or 
oxidation products of the original metabolites, however these extracts have not yet been sub-
jected to LC-MS analyses. 
C. globosum grew very well together with gram negative bacteria on various building materi-
als without it was possible to se this in the stereo microscope. However when determining 
the inflammatory potential of this mixture in mice macrophages huge quantities of TNFα and 
NO was liberated due to endotoxin from the bacteria. This observation may point against 
more studies on the interaction between bacteria and moulds as the bacteria may need the 
moulds powerful enzyme-systems. However spores from the pure cultures did not induce 
any inflammatory response in macrophages, but was cytotoxic to the cells (unpublished). 
 
When concerning risk assessment of this fungus in buildings, it is clear the cytotoxic and cy-
toplasmatic cleavage inhibiting chaetoglobosins is the main concern. However as no data on 
inhalation of the spores have been found in the literature. As the spores of this fungus is 
packed in the Peritrecia the exposure to airborne spores may be rather limited and smaller 
particles released from dry mycelia, as it has been shown for A. versicolor, must be studied 
before any attempt on risk assesment is tried. 
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Figure 29. Unknown metabolite from C. globo-
sum. 
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4.3.8 Cladosporium 
C. sphaerospermum seems to be the most predominant species growing in buildings, and 
was able to out grow P. chrysogenum even in a ratio of 1 to 100 (paper 13). This is a result 
of their ability to re-attain growth from the hyphal tip much faster than penicillia119, which is 
presumable why this and other phylloplanes are so common in bathrooms and on silicon 
caulkings in the window frame, environments which often have very different humidities dur-
ing the day. 
No secondary metabolites were detected in any of the samples in paper 13, and this genus is 
known for the very few metabolites it produces, and it ability to grow under these special 
conditions may account for this. 
The high number of spores of C. cladosporioides (up to 15000m-3) found out doors during the 
summer and the apparent lack of metabolite production on materials, and no inflammatory 
response when in instilled mice lungs217, suggests that this genus should generally not be 
considered more than a humidity indicator. 
 
4.3.9 Ulocladium 
All four isolates inoculated on materials (paper 3) grew well, but did not produce any detect-
able quantities of secondary metabolites, which is in accordance with the literature where 
extremely few metabolites from this genus have been described. Analyses of natural sam-
ples with excessive growth have not either revealed any metabolites in the polarity range we 
look at using present HPLC-DAD method.  
In Study 10, it was only isolates at RH ≈ 0.95, indication that is also requires very high RH, 
and not metabolite seemed to be associated to it. 
To conclude on this genus, it seems to be isolated the same places as S. chartarum although 
more frequently, as it is presumable able to grow under the same humidities as Alternaria, 
but the low production of metabolites no known knowledge of mycotoxicoses indicates that it 
is not a major problem. However this should be confirmed by testing its in vitro and in vitro 
pulmonary toxicity and inflammatory potential. 
It is a good indicator for wet environments and hence water-damage, but requires significant 
microscopic training if it should be differentiated from Alternaria. 
 
4.3.10 Paecilomyces 
P. lilacinus was found to grow poorly on all the artificially infested materials except on gyp-
sum boards, where the characteristic pink cotton-like mycelium was produced, but only in 
modest amounts, and no metabolites were detected in the extract (paper 3). 
P. variotii grew well on the artificially infested chipboards and wallpapered chipboard, but the 
quantities of biomass were very limited, however at the chipboard did support production of 
seven components with totally unknown UV-spectra. 
These two species, both needs to have their in vitro and in vitro pulmonary toxicity and in-
flammatory potential determined (grown on relevant materials) besides determining the size 
of particles liberated from materials infested with them. 
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4.3.11 Eurotium 
In study 10, Eurotium sp. was isolated from several of the wooden materials inoculated at 25, 
20 and 10°C (materials were not sterilised prior to inoculation at 10°C).  
The HPLC analyses revealed the 
presence of very high quantities of 
metabolites compared with A. versi-
color and P. chrysogenum. These me-
tabolites were probably present in the 
ascoma (see Figure 30) as these 
structures were very predominant. 
Echinulin and several derivatives were 
detected along with a high number of 
antraquinones, including questin and 
questinol, several benzoquinones, 
including flavoglausin, produced by 
many Eurotium species427. Also two 
isochromane toxin analogues425,428 
were detected. 
The high quantities of metabolites sampled on the filters indicates that this genus may be 
important, and the in vitro and in vitro pulmonary toxicity and inflammatory potential of dust 
from infested materials is needed. 
 
4.4 Overall discussion 
4.4.1 Growth on materials 
It has been demonstrated that the tertiary colonisers in practise require almost liquid water to 
grow on the materials. Hence the name water-damage moulds is very appropriate. To avoid 
growth of these is theoretically very simple, as it just requires dry constructions. However due 
to insufficient quality assurance in the building industry and partly also insufficient mainte-
nance, these five problems are observed: 
• The climate screen, especially the roof, should be watertight, which should not pose any 
problem. However this is actually a major problem in Denmark, as seen in paper 4, espe-
cially due to leaking flat roofs. 
• Leaking pipes, especially when they are hidden in the constructions, constitutes a sub-
stantial part of the severe water damages (papers 3 and 4). 
• Rising damp from the ground, due to lack of drainage or capillary breaking layer. 
• Water build into the construction either from hardening concrete, which had not had the 
time to dry out. Also materials which have been placed on the ground or out in the rain is 
becoming an increasing problem and a number of these cases have been reported in the 
press. 
• When parts of the building is exposed to rain during the building process, this an engi-
neering or planning problem which demand that the partly finish construction is shielded 
during the building process.  
 
Figure 30. The ascomata from Eurotium sp. on a piece of pine-
wood after 4 months at 10°C and 95% RH. 
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Solving these problems is a not a matter of choosing or developing other materials, as al-
most all materials was able to support fungal growth (paper 4 and 10). Instead it is a matter 
of creating new quality assurance systems, which can be practically implemented during the 
building process.  
4.4.2 Metabolites 
The water-damage moulds produced very high quantities of secondary metabolites, and as 
secondary metabolites are signal components169, these metabolites must be very important 
for the fungi, as they must use significant energy and internal resources on producing them.  
Trichoderma spp. produced very low quantities of detected metabolites, which is probably 
due to the poor extraction and UV-absorption of the peptabols which this genus is so known 
for. 
When comparing the quantities and number of metabolites produced the aspergilli and peni-
cillia on agar substrates with the metabolites produced on building materials, it was clear that 
the rich agar substrates short circuits the metabolism of these genera. It appeared that the 
aspergilli produced significant higher quantities on moisture saturated materials, whereas the 
penicillia seemed to need the many nutrients found in the rich agar media. 
When comparing the metabolism of aspergilli and penicillia with Stachybotrys, it is seems like 
this short circuiting is correlated to the extensively mycelia production, which seemed to be 
negatively correlated the sporulation. Thus, when trying to predict the production of metabo-
lites on various matrixes such as building materials, by using agar substrates, media enhanc-
ing sporulation and decreasing pure mycelia growth should be used.  
Especially when working with A. versicolor, it was frustrating to see the numbers of unknown 
metabolites in the extracts. Hopefully accurate-mass LC-MS, will make identification of some 
metabolites which is probably known in literature possible.  
It is essential to investigate the toxicity and inflammatory responses of all appropriate moulds 
as function of the humidity, as it may only under certain humidities that they are toxic or in-
flammagenious. Perhaps it is also isolate depended or perhaps loses some of the strains the 
ability of producing important metabolites when held in the lab, as it observed when working 
on the membrane-toxin (paper 7).  
The total microbial flora still needs to be established, at bacteria presumable means a lot 
under certain conditions and there may be several types of bacteria present at the materials 
which have not been determined. The bacteria may need the moulds to degrade the materi-
als, and especially genera as Stachybotrys, Chaetomium and Trichoderma that are very well 
known producers of cellulases and as they requires almost saturated conditions they will 
have to compete with bacteria which can also grow at these aw. 
4.4.2.1 Analytical methods 
Extraction of the metabolites was the most important step, and it was clear that extracting 
whole materials in organic solvents is not a suitable technique as: i) very huge quantities of 
interfering material was also extracted from the material (paper 1-3) which may obscure de-
tection or even react with the target components; ii) mycotoxins as ST and TR, could only be 
extracted from the material-matrix in very limited quantities, <1% of spiked quantities (paper 
2); iii) the detected metabolites may not become airborne, especially if they are excreted into 
the material. It is important to evade interfering components, as it will require a number of 
different solid phase extracting (SPE) techniques for each or a group of components. This 
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makes screening impossible, as it perhaps needed to make 2-6 different SPE clean-up steps 
per analysis, which is very time and resource consuming. 
Scraping off the material using a blade worked better (paper 3) but material is easily lost if it 
is dry and if the material is very wet then significant quantities of interfering material may still 
be present from the material. Hence the vacuum sampling technique used in paper 10 and 
13, is much better as it only samples metabolites that may become airborne and samples a 
minimum of matrix. 
The used detection methods have unfortunately only worked on medium to apolar sub-
stances, which could be detected using HPLC-UV, except for the trichothecenes, which were 
targeted by GC-MS. However important substances as the nephrotoxic glycopeptides, AAL 
toxins, malformins, cyclosporin analogues, and many peptides would have evaded detection, 
this also includes unknown toxins and of course metabolites present below the detection 
limits.  
Appropriate bioassays would cope with these problems as these, but it would still need a lot 
of assays for the different activities, so it would have been perfect to combine this study with 
a lot of assay tests, unfortunately this was not possible.  
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5 CONCLUSION 
Moulds growing on water-damaged materials produce a high number of very toxic metabo-
lites. The production of these metabolites is very dependent on the humidity of and for some 
moulds also the substrate.  
Three taxa of Stachybotrys are found in buildings of these only one taxon, approx. 35% of 
the isolates, actually produced satratoxins whereas most other strains stop the trichothecene 
biosynthesis at trichodermin. All three taxa produced high quantities of the pharmacologically 
active spiriocyclic drimanes and their precursors. These two groups of metabolites and the 
atranones, which are produced by the two non-satratoxin producing taxa, are produced on 
building materials under field conditions. Idiopathic pulmonary hemasiderosis in infants did 
not seem to be associated with satratoxin production. Stachybotrys biomass collected on 
filters from naturally infested materials samples, contained significant higher quantities of 
metabolites than any other fungal species investigated during the study.  
This study has shown that spiriocyclic drimanes and satratoxins were present on filters from 
air-samplings in a building with severe health problems due to growth of S. chartarum. 
Aspergillus versicolor, which is perhaps the most common species found in mouldy buildings, 
had a very diverse metabolism, where many of its biosynthetic pathways were only occa-
sionally expressed. When growing on materials under high water activity (>0.95%) most iso-
lates produced high quantities of the carcinogenic mycotoxin, sterigmatocystin, whereas 
aw<0.90 a number of structurally unknown metabolites, presumably alkaloids, also known 
from A. ochraceus were produced. A. versicolor grew often in mixed cultures with other 
moulds where it sporulated poorly, meaning that it may evade detection by cultivation based 
methods. 
Penicillium chrysogenum is the most frequently detected species, but it produces surprisingly 
few detectable metabolites and often none. Combined with the lack of observed effects in 
patients experimentally exposed to high quantities of the spores it indicates that it may not be 
important from a heath point of view and is actually obscuring the detection of more toxic 
genera and species. 
On water-damaged materials Chaetomium globosum produces high quantities of chaetoglo-
bosins, whereas P. brevicompactum produces mycophenolic acid and P. polonicum the tre-
morgenic verrucosidin. The A. ustus isolates from buildings are macro-morphologically and 
chemically very different from cereal isolates, and should be described as a new species. 
Trichoderma longibrachiatum, T. harzianum, T. citrinoviride, T. atroviride and T. viride does 
not produce detectable quantities of trichothecenes when growing on materials, and even on 
laboratory media <1% of the isolates produce trichodermol or esters of it. 
When mouldy material are investigated for mycotoxins they should be vacuum sampled onto 
filters, as it dramatically decreases the number of interfering substances from the materials 
and gives a more precise description of peoples exposure. 
Except from Stachybotrys, almost no data on the pulmonary toxicity and inflammatory poten-
tial of the spores and fragments exist from indoor moulds grown on appropriate materials,   
and not on agar media where the secondary metabolism is often short circuited. 
The minimal RH for growth on wood-based materials and material containing starch is just 
below 80% at room temperature, and increases to about 90% at 5°C. On paper-mineral 
composites such as gypsumboard the min RH is approx. 90% RH from room temperature to 
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5°C. Pure mineral based materials with few organic additives seems to be able to support 
growth at RH ≥ 0.90, although 95% RH was needed to generate chemical detectable quanti-
ties of biomass. S. chartarum requires RH ≥ 95% to grow on gypsum boards. 
When applying transient humidities to material samples during a day, the phylloplane Clado-
sporium was able to outgrow P. chrysogenum, even though it can grow under lower RH than 
Cladosporium under constant humidity. This is presumably why phylloplanes like Cladospo-
rium, Ulocladium, Phoma and Aureobasidium are very common i bathrooms and other 
places with instationary humidity conditions. 
Ergosterol content of building materials could be very precisely be quantified and quickly 
analysed (60-100 samples per day) by isotope dilution GC-MS/MS, although not being as 
sensitive as other GC-MS based methods due to interference from the isotope marked stan-
dard and instrumental problems on the ion-trap used. Visual assessment, especially sup-
ported by dissection microscopy, was however just a sensitive and is able to cope with the 
high variation in mould biomass on materials, but should occasionally be supplemented with 
chemical markers for comparison with other studies. 
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6 PERSPECTIVES AND FUTURE RESEARCH 
Although excellent research is being done in this field especially in Scandinavia, The Nether-
lands and North America, we are far away from a major breakthrough, and hence much more 
research is needed. 
 
Smaller projects 
Studies on the inhalative toxicity of the spiriocyclic drimanes found in the spores of Stachy-
botrys are needed. This should be followed by development of specialised methods for de-
tecting these metabolites as they are present in substantial quantity and have shown to be 
good biomarkers in this study.  
Studies on the three different Stachybotrys taxa are needed, to se if atranone and satratoxin 
producing isolates coexists, and/or also to see if the atranone producing taxa over long time 
also can produce low quantities of satratoxins. 
An immunochemical assay for detection of sterigmatocystin-guanine and other adducts of 
this toxin could be used to determine if people are exposed to the toxin through the air or 
only through the food.  
The unknown A. versicolor metabolites needs to be structure elucidated and produced in 
sufficient quantities for a toxicological evaluation. 
As exposure to mycotoxins may originate from particles significant smaller than the spores it 
should be determined if filters or adsorption materials, like activated carbon, should be used 
for sampling of the mycotoxins. These studies should also face clean-up problems due to 
interfering substances collected from the air. 
 
Major projects 
General microbiological work is needed so the total indoor funga can be established pre-
cisely and to the species level, as a lot of confusion exists, especially in Penicillium.  
A lot of work is needed on the ecology of the moulds on the materials and the performance of 
different materials, especially under dynamic conditions. It is also very important to know the 
response of the moulds to both short and long periods of increased humidity still close to 
their critical RH.  
Co-ordinated and comparable tests of the inflammatory potential and the toxicity of particles 
released from infested materials, including materials from problem buildings and materials 
incubated at realistic conditions, should be performed. These tests should be performed from 
a representative number of isolates from all relevant species. Such results can be used to 
rate the health impact of the moulds in epidemiological studies and for risk handling in 
mouldy buildings. 
Inhalation experiments where the cognitive performance on mice or rats and their off-spring 
are measured should also be tried. This was very successful for low concentration exposure 
to xylene429, and if combined with exposures to known areas of naturally infested and artifi-
cially infested materials kept under well characterised ventilation conditions, this may be the 
way to a major breakthrough. 
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APPENDIX B 
Here are listed chemical and biological data from the components the different mould genera 
and species covered in section 2.4. When the mono isotopic mass was not listed in the paper 
it was calculated1. This appendix has its own reference list. 
 
Table 1 
Trichothecenes from Stachybotrys species from Stachybotrys species 
Component Producing species Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
1 
Satratoxin H 2 S. chartarum Highly cytotoxic C29H36O9  225(14700), 255(10400) 528.24
Iso-Satratoxin H 3 S. chartarum Highly cytotoxic C29H36O9   528.24
Satratoxin G4 S. chartarum Highly cytotoxic C29H36O10 256(6500) 544.23
Iso- satratoxin G 3 S. chartarum Highly cytotoxic C29H36O10 260 544.23
Satratoxin F 4 S. chartarum Highly cytotoxic C29H34O10 250 (5900) 542.33
Iso- satratoxin F 3 S. chartarum Highly cytotoxic C29H34O10 251(17700) 542.33
Roridin E 5 S. chartarum Highly cytotoxic C29H38O8 195(15800), 223(25100), 263(19900) 514.26
Iso-roridin E6 S. chartarum Highly cytotoxic C29H38O8 223(24000), 262(16000) 514.26
Epi-roridin E6 S. chartarum Highly cytotoxic C29H38O8 223(24000), 262(16000) 514.26
Verrucarin J7,8 S. chartarum Highly cytotoxic C27H32O8 196(15500), 219(19900), 262(14500) 484.21
Verrucarin B7,8 S. chartarum Highly cytotoxic C27H32O9 258.5(23400) 500.20
Roridin L-23,9 S. chartarum Highly cytotoxic C29H38O9 259(24650) 530.25
Trichoverrol A7,8 S. chartarum Highly cytotoxic C23H32O7 260(36300) 420.21
Trichoverrol B7,8 S. chartarum Highly cytotoxic C23H32O7 260(33900) 420.21
Trichoverrin A 7,8 S. chartarum Highly cytotoxic C29H40O9 260(39800) 532.27
Trichoverrin B7,8 S. chartarum Highly cytotoxic C29H40O9 260(33800) 532.27
Trichodermin10 S. chartarum,  
S. cylindrospora 
 C17H24O4 End abs. 292.38
Trichodermol10 S. chartarum,  
S. cylindrospora 
 C15H22O3 End abs. 250.34
1Molecular ion according to  
 
Table 2 
Non-trichothecene secondary metabolites and mycotoxins from Stachybotrys species  
Component Producing 
species 
Biologically effect Elementary 
composition 
λ(log ε) M (Da)
Atranone A11 S. chartarum  C24H32O6 224(10500) 416.22
Atranone B11 S. chartarum  C25H34O7 231(10800) 446.23
Atranone C11 S. chartarum  C24H32O6 End abs 416.22
Atranone D11 S. chartarum  C24H34O4 231(14800) 386.25
Atranone E11 S. chartarum  C24H34O4 226(12500) 386.2457
Atranone F12 S. chartarum  C24H32O7 237(4169) 432.2148
Atranone G12 S. chartarum  C25H34O8  462.2254
Epoxydolabellane A6,12 S. chartarum  C20H30O3 235(8870) 318.2206
6β-hydroxydolabella-
3E,8E,12-trien-14-one 13 
S. chartarum  C20H30O2 236(8710) 302.2246
Mellin5 S. chartarum  C10H10O3 246, 314 178.063
K-76 COOH 14-16  Anti diabetics, necrosis factor-
liberation inhibitors 
C23H30O7  418.1992
6,8-dihydroxy-3,5,7-
trimethylisochroman10 
S. cylindrospora  C11H13O3 202(38000), 25(8000), 
275(41007), 281(1400) 
208.1091
Bisbynin17 S. bisbyi Enhances fibrinolytical activity C15H22O5 End abs. 282.1467
Epi-cochlioquinone18,19 S. bisbyi Inhibitor of cholesterol acetyltrans-
ferece 
C30H44O8 270(10200), 386(1100) 523.3004
F1839-A20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C23H31NO5 218(37424), 262(6553), 
301(3182) 
401.2202
F1839-B20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C24H33NO6 218(41271), 271(6230), 
308(2910) 
431.2308
F1839-C20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C24H33NO6 217(33069), 267(5293), 
302(2525) 
431.2308
F1839-D20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C23H31NO5 225(31615), 255(10385), 
298(4924) 
401.2202
F1839-E20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C25H35NO6 217(31462), 262(6408), 
302(2314) 
445.2464
F1839-F20,21  Inhibitor of Pancreatic cholesterol C28H39NO7 217(33069), 267(5293), 501.2727
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esterase 300(2525) 
F1839-I20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C23H32NO4 229(11384), 282(9412), 
325(3683) 
386.2331
F1839-J20,21  Inhibitor of Pancreatic cholesterol 
esterase 
C29H41NO6 218(32041), 261(7357), 
301(2323) 
499.2934
FR90145922 23 S. chartarum Immunosuppressant, cyclosporin 
analogue 
C62H111N11O13 End abs 1217.8363
K-7624,25 S. complementi Complement inhibitor 
Inhibitor of Pancreatic cholesterol 
esterase 
C23H30O6 246(16500), 307(6700), 
359(5400) 
402.2043
Kampanol A26 S. kampalensis RAS farnasyl-potein transferase 
inhibitor 
C25H32O6 223(13330), 262(5118), 
308(2408) 
428.2199
Kampanol B 26 S. kampalensis RAS farnasyl-potein transferase 
inhibitor 
C27H38O7  474.2617
Kampanol C 26 S. kampalensis  C25H25O6 208(23369), 230(sh), 282(7480), 
314(3360) 
428.2199
L-671 77627-29 S. chartarum,  
S. cylindrospora 
Complement inhibitor, antimanic 
depressive drug 
C23H32O5 230 (230%), 286(187%), 
330(118%) 
388.2250
Mer-NF5003 B28,30  Cytotoxic, antiviral C23H32O6 229(12200),  281(9410), 
328(4700), PP* 
404.2199
Mer-NF5003 E28,30  Cytotoxic, antiviral C23H32O5 225(15100), 286(10800), 
328(5430), PP 
388.2250
Mer-NF5003 F, 28,30,31  Cytotoxic, antiviral, cholesterol 
lowering 
C23H30O5 245(14900), 301(5610), 
352(4090), PP 
386.2093
NG-24232,33 S. parvispora Activator of nerve growth C27H37NO6 214(41800), 258(9600), 
306(3300) 
471.2622
NG-24332,33 S. parvispora Activator of nerve growth C25H35NO5 214(40800), 257(8900), 
302(3300) 
429.2515
NG-24534 S. parvispora Activator of nerve growth C31H39NO5 222(27800), 261(10500), 
285(4900), 296(4700) 
505.2828
Parvisporin35 S. parvispora Neurotoxic C23H34O5 206(16700), 295(5800) 390.2406
SMTP-1 36 S. microspora Enhances plasminogen activity C25H35NO5 214(39700), 254(7200), 
299(2800) 
429.2515
SMTP-2 36 S. microspora Enhances plasminogen activity C25H37NO7 212(34000), 252(8000), 
294(3000) 
463.2570
SMTP-337 S. microspora Enhances plasminogen activity C26H35NO7 214(43000), 256(9500), 
298(3400) 
473.2414
SMTP-437 S. microspora Enhances plasminogen activity C32H39NO6 214(40700), 259(8400), 
302(2500) 
533.2777
SMTP-537 S. microspora Enhances plasminogen activity C29H41NO6 215(36700), 259(7600), 
300(2300) 
499.2934
SMTP-637 S. microspora Enhances plasminogen activity C34H40N2O6 216(50300), 260(10100), 
282(6200), 290(5400), 
308(2500) 
572.2886
SMTP-738 S. microspora Enhances plasminogen activity C51H68N2O10 213(82500), 257(18800), 
302(5820) 
868.4876
SMTP-838 S. microspora Enhances plasminogen activity C52H70N2O10 213(79500), 257(18200), 
302(5600) 
882.5033
Spirodihydrobenzofu-
ranlactam 1 39,40 
S. chartarum HIV protease inhibitor 
Anti-manic depression drug 
C23H31NO4  385.2253
Spirodihydrobenzofu-
ranlactam 2 39,40 
S. chartarum HIV protease inhibitor C25H35NO5  429.2515
Spirodihydrobenzofu-
ranlactam 3 39,40 
S. chartarum HIV protease inhibitor C28H39NO6  485.2777
Spirodihydrobenzofu-
ranlactam 4 39,40 
S. chartarum HIV protease inhibitor C28H37NO8  515.2519
Spirodihydrobenzofu-
ranlactam 5 39 
S. chartarum HIV protease inhibitor C23H29NO5  399.2046
Spirodihydrobenzofu-
ranlactam 6 39,40 
S. chartarum HIV protease inhibitor C52H70N2O10  882.5030
Stachybocin A41-43 S. chartarum Endothelium receptor antagonister C52H70N2O10 218(70500), 266(15400), 300-
310(5300) PP 
882.5030
Stachybocin B41-43 S. chartarum Endothelium receptor antagonister C52H70N2O11 218(70500), 265(15700), 300-
310(5400) PP 
898.4980
Stachybocin C41-43 S. chartarum Endothelium receptor antagonister C52H70N2O11 218(69100), 265(15300), 300-
310(5400) PP 
898.4980
Stachybocin D44 S. chartarum  C52H70O12N2 218(77100), 265(17100), 295-
315(5800) 
914.4929
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Stachybotramide6,10 S. chartarum,  
S. cylindrospora 
 C25H37O5N  431.2672
Stachybotrin 45 S. alternans  C25H35NO5  429.2383
Stachybotrin A46 S. alternans  C26H37NO5  443.2673
Stachybotral46 S. alternans  C23H32O4  372.2302
RF-4667A47 S. elegans ACAT inhibitor C29H44O10 End abs. 552.66
RF-4667D47 S. elegans ACAT inhibitor C25H40O8  468.2723
RF-4667F47 S. elegans ACAT inhibitor C25H40O8  468.2723
RF-4667G47 S. elegans ACAT inhibitor C23H38O7  426.2618
RF-4667H47 S. elegans ACAT inhibitor C23H38O7  426.2618
RF-4667I47 S. elegans ACAT inhibitor C23H38O7  426.2618
RF-4667J47 S. elegans ACAT inhibitor C21H36O6  384.2512
Q-11270 A48 S. chartarum  C28H39NO6 PP 485.2777
Q-11270 B48 S. chartarum  C28H39NO7 PP 501.2726
BR-01149  Bone resorption suppressant C23H32O4 230(120000), 240(73000), 
300(84000), 340(3000) 
372.2302
Stachybotrin A50  Antibacterial, antifungal C23H31NO5 220(17000), 254(6400), 
302(2900) 
401.2202
Stachybotrin B50  Antibacterial, antifungal C23H31NO4  385.2254
Stachybotrin C35 S. parvispora  C31H39NO5  216(52800), 258(12600), 
301(4000) 
505.2828
Stachybotrydial6,10 S. chartarum Complement inhibitor, Inhibitor of 
Pancreatic cholesterol esterase 
C23H30O5 248, 307, 359,PP 386.21
Stachybotrylactone6,10  
(Stachybotrolide46) 
S. chartarum Complement inhibitor C23H30O5 218(28000), 268(5300), 
309(2600) 
386.21
Stachyflin51  Antiviral C23H31NO4  385.229
152 S. cylindrospora  C25H26O5 260(10600), 320(3700) 406.1780
252 S. cylindrospora  C25H26O5 265(8500), 278(6900) 406.1780
352 S. cylindrospora  C25H26O5 330(7700) 406.1780
153  HIV protease inhibitor C28H37NO9 218, 265, 300 531.2468
154, several tautomer S. parvispora Chymase inhibitor, antifungal C26H30O5 222(31700), 255(13400), 
315(5100) 
422.2093
Stachylysin55 S. chartarum Haemolytic Pentamer  11920, 
monomer
Staplabin36,56,57 S. microspora Enhances plasminogen activity C28H39NO6 216(33500), 258(7300), 
300(500) 
485.2777
* Printed in paper 
 
Table 3 
Secondary metabolites and mycotoxins from Aspergillus versicolor  
related to sterigmatocystin and its biosynthesis 
Component Biologically effect Elementary 
composition
λ(log ε) M (Da) 
5-Methoxysterigmatocystin 58,59  Cytotoxic C19H14O7 232(24100), 248(26800), 279(11200), 331(12100) 354.0739
Aversin59  C20H16O7 224(36700), 251(13400), 285(33600), 313(8900), 363(4960), 
440(7830) 
368.0896
Averufin 59-61  C20H16O7 223(33000), 256(16500), 265(18500), 286(24800), 
294(30800), 319(12500), 454(10500) 
368.0895
Deoxyaverufinon 62  C20H16O7 210(21900), 222.7(30150), 254.5(13400), 266(14500), 
292.4(23900), 320.5(7050), 454.5(6900) 
368.0895
Deoxyaverufin62  C20H14O7  366.0739
Demethylsterigmatocystin63  C17H10O6  310.0477
Dihydrodemethylsterigmatocystin 
59,64 
 C17H12O6 233(26800), 250(33100), 259(30300), 335(19400) 312.0633
Dihydrosterigmatocystin 59,64 Cytotoxic C18H14O6 208(20400), 232(26300), 247(30900), 325(16300) 326.0790
Norsolorinic acid 59  C20H18O7 234(23667), 265(16650), 283(17352), 297(19872), 
313(23763), 465(7336) 
370.1052
Demethyl solorinic acid65  C20H18O7 223(30903), 280(33884), 335(4786), 400(4571) 370.1052
O-methylaversin  C21H18O7 222(33800), 285(39200), 348(4700), 407(4200) 382.1052
O-Methylsterigmatocystin 59  C19H14O6 236(40700), 310(16500) 338.0790
Sterigmatin66  C17H10O6  310.0477
Sterigmatocystin 59 LD50 30-120 mg/kg in 
animals, carcinogenic 
C18H12O6 208(19000), 235(24500), 249(27500), 329(13100) 324.0633
Averufanin63,67  C20H18O7  370.1952
Averufin67,68  C20H16O7 223(33000), 256(16500), 265(18500), 286(24800), 368.0896
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294(30800), 319(12500), 454(10500) 
Versiconol 59,63  C18H16O8 224(30100), 266(14100), 294(23900), 315(12300), 455(7499) 360.0845
Versicolorin A 59,69  C18H10O7 222(28100), 255(13500), 267(18200), 290(25100), 326(6700), 
450(7000) 
338.0426
Versicolorin B 59,69  C18H12O7 223(23900), 255(13500), 266(19500), 291(24000), 
324(12800), 450(8700) 
340.0582
Versicolorin C 59,69-71 Toxic to ducklings C18H12O7 223(23800), 255(15800), 267(20400), 292(28800), 
326(10000), 450(10700) 
340.0582
6-Deoxyversicolorin A72  C18H10O6  322.0477
5,6-Dimethoxydihydrosterig-
matocystin 73 
 C20H18O8 233(25100), 248(33500), 276(7600), 330(18000) 386.1001
5,6-Dimethoxysterigmatocystin 73 Cytotoxic C20H16O8 233(27200), 248(34000), 275(7700), 330(19200) 384.0845
6,8-dimethylnidurufin 59,74  C22H20O8 224(48200), 251(19000), 288(30900), 314(8540), 444(8790) 412.1157
6,8-O-Dimethylversicolorin A75  C20H14O7 223(47900), 250(18200), 282(46800), 312(10700), 435(11200) 366.0739
Versicolo<rone 76  C20H16O7 224(23988), 254(11749), 263(13800), 291(25500), 320(8320), 
454(10715) 
368.0896
 
 
Table 4 
Secondary metabolites not related to the sterigmatocystin biosynthesis from A. versicolor  
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
A 77 Cholesterol lowering C31H40O8 240, 340 540.2724
B 77 Cholesterol lowering C31H40O8  554.2881
SIPI-1-278 Cholesterol lowering C21H22O7 223, 263, 292, 451 386.1366
SIPI-1-378 Cholesterol lowering C22H24O7 223, 263, 292, 449 400.1522
SIPI-1-478 Cholesterol lowering C24H28O7 223, 263, 293 428.1835
Aspercolorin71 Toxic to ducklings C25H28N4O5 210(28080), 226(18920), 260(13620), 
315(4170) 
464.206 
Versiol 79  C16H22O3  262.157 
Ferricrocin 80 Iron III binding peptide C29H44FeN9O13  782.2408
Ferrirhodin 81 Iron III binding peptide C41H64FeN9O17  1010.377
MM 4084 82     
Versimide (MM4086)83-85 Insecticide C9H11NO4 204.5(10260) 197.0688
Nidulotoxin86,87     
Nitrobenzoyl ester 288  C22H25NO8 257(21100) 431.1581
Nitrobenzoyl ester 388  C22H25NO7 256(8200) 415.1631
Nitrobenzoyl ester 488  C22H25NO8 258(7600) 431.1581
FK17-P2a89  C13H16O5  252.0998
FK17-P2b189  C13H16O4  236.1049
FK17-P2b289  C13H16O4  236.1049
FK17-P389  C13H15ClO4  270.066 
Insulicolide A88,90 Cytotoxic to cancer cells 
in NCI assay (0.3-1µg/ml)
C22H25NO8 255(16900) 431.1581
Lactone 191  C16H12O6  300.0643
Lactone 291  C16H12O7  316.0583
Versicolin = 2,3,6-trihydroxy toluene 92-95 Antifungal C7H803 222(25120), 256(7943), 390(400), 520(150) 140.0473
Versilin96 Antifungal C7H6O4 212, 257, 387 154.0266
Mycoversilin 97-99 Antifungal C18H16O8 End, 269(1290), PP 360.0845
 
 
 
Table 5 
Secondary metabolites and mycotoxins from Aspergillus ustus  
Component Biologically 
effect 
Elementary 
composition
λ(log ε) M (Da) 
10,20-dehydro[12,13-dehydroproly]-
2-(1',1'-dimethylallyltrytophyl) dike-
topiperazine100 
 C21H21O2N3 224(27540), 272(8510), 284(6920), 292(5130) 347.1635
12,13-dehydroproprolyl-2-(1',1'-
dimethylallyltrytophyl) dike-
topiperazine100 
 C21H23N3O2 223(34674), 268(10715), 283(10000), 292(7760) 349.1792
12,13-dihydro-12-  C21H23N3O4 231(30200), 255(10965), 390(2950) 381.169
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hydroxyaustamide101 
12,13-dihydro-austamide 100  C21H23O3N3 238(30900), 256(13490), 390(3310) 365.1741
4,6-bisdemethylautocystin A67  C17H9ClO6 231(31623), 241(32359), 254(37154), 261(35481), 
270(32359), 325(25119), 360(12300) 
224.0088
4-O-demethylautocystin A67  C18H11ClO6 225(26300), 249(26915), 257(25120), 269(15488), 
314(12023), 361(4075) 
344.0088
6-demethylautocystin A67  C18H11ClO6 239(35480), 254(32359), 261(31625), 270(24547), 
312(16980), 362(5888) 
358.0244
6-epi-Ophiobolin K102 Antibiotic C25H36O3 239(21395) 384.2631
7-chloro-2-(3-furyl)-1,3,8-
trimethoxyxanhone67 
 C20H15ClO6  386.0558
8-deoxy-6-O-methylversicolorin A67  C19H12O6 221(22387), 240(14125), 274(20893), 412(7080), 436(2344) 336.0634
Austalide A102,103  C28H36O9 222(35400), 267(17140) 516.236
Austalide B102,103  C26H34O9 223(28700), 269(16800) 490.2203
Austalide C102,103  C30H38O11 221(26900), 265(13800) 574.242
Austalide D102,103  C28H36O10 222(32700), 268(17700) 532.2308
Austalide E102,103  C28H36O10 222(34600), 266(19600) 532.2308
Austalide F102  C26H34O9 220(30900), 264(16800) 490.2203
Austalide G104  C28H38O9 221(26500), 267(14100) 518.251
Austalide H104  C26H36O8 221, 267 476.240
Austalide I104,105  C27H34O8 221(35600), 266(17000) 486.225
Austalide J105  C25H32O7 221(31900), 267(16200) 444.214
Austalide K104,105  C25H32O5 222(18900), 267(11000) 412.224
Austalide L104,105  C25H32O6 223(31200), 269(16600) 428.219
Austamide100 Acute toxic to 
ducklings 
C21H21O3N3 234(26300), 256(117), 256(1100), 282(8709), 392(2691) 363.1584
Austdiol106,107 Acute toxic to 
ducklings 
C12H12O5 256(15100), 376(24000) 236.0685
Austin108  C27H32O9 243(11900) 500.2047
Austinol107  C25H30O8 246(8080) 458.1941
Austocystin A68 Mutagenic, 
cytotoxic 
C19H13ClO6 229( 25120), 239(33110), 247(34675), 258(10715), 
303(12300), 335(5623) 
372.0401
Austocystin B68 Mutagenic, 
cytotoxic 
C22H20O7 227(24550), 240(25120), 254(33113), 263(21878), 
274(23442), 328(16218), 372(7244) 
396.1209
Austocystin C68 Mutagenic, 
cytotoxic 
C23H22O7 229(20417), 238(24000), 255(20895), 277(18200), 
304(12590), 368(4570) 
398.1366
Austocystin D68 Mutagenic, 
cytotoxic 
C22H20O8 227(19500), 254(31625), 263(22910), 273(23440), 
329(12883), 370(4365) 
412.1158
Austocystin E68 Mutagenic, 
cytotoxic 
C22H22O8 228(19500), 236(23442), 257(22910), 262(22390), 
273(21380), 304(10233), 368(4365) 
414.1315
Austocystin F68 Mutagenic, 
cytotoxic 
C17H10O7 224(27542), 252(34675), 259(30200), 268(25120), 
325(14791), 368(4266) 
326.0426
Austocystin G109 Mutagenic, 
cytotoxic 
C18H11ClO7 225(18620), 249(23442), 309(9772), 340(3236) 374.0193
Austocystin H109 Mutagenic, 
cytotoxic 
C22H18O7 226(11482), 253(14791), 272(10233), 328(6166), 360(2455) 394.1053
Austocystin I109 Mutagenic, 
cytotoxic 
C18H12O7 229(21878), 238(27542), 252(29302), 264(19953), 
300(13800), 355(5129) 
340.0583
Aversin 59  C20H16O7 224(36700), 251(13400), 285(33600), 313(8900), 363(4960), 
440(7830) 
368.0896
Averufanin63,67  C20H18O7  370.1952
Averufin67,68  C20H16O7 223(33000), 256(16500), 265(18500), 286(24800), 
294(30800), 319(12500), 454(10500) 
368.0896
Dehydroaustin107  C27H30O9 End, 239(3800) 498.189
Deoxybrevianamide E    
Dihydropergilin110  C15H18O4 218(21400), 260(12000) 262.1204
Dihydroxy-8-epi-austdiol106  C12H14O4 231(6920), 352(20000) 222.0892
Drimane sesquitepene 1111 Binds to endo-
thelium receptor 
C23H30O5 304(36600) 386.2094
Drimane sesquitepene 2111 Binds to endo-
thelium receptor 
C23H32O4 303(37000) 372.2302
Drimane sesquitepene 3111 Binds to endo-
thelium receptor 
C23H32O5 205(6000), 303(32000) 388.2251
Drimane sesquitepene 4111 Binds to endo-
thelium receptor 
C23H32O4 202(8400), 294(34500) 372.2302
Drimane sesquitepene 5111 Binds to endo- C21H28O5 255(24100) 360.1937
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thelium receptor 
Drimane sesquitepene 6111 Binds to endo-
thelium receptor 
C23H30O5 300(36200) 386.2094
Drimane sesquitepene 7111 Binds to endo-
thelium receptor 
C15H24O3 232(1800 252.1726
Iso-austin107  C27H32O9 240(7300) 500.2047
Mer-NF8054X112  C38H42O5 242(20400) 458.3032
Ophibolin G113 Inhibiting wheat 
and bacteria 
C25H34O2 235(36300) 366.2559
Ophibolin H113 Antibiotic C25H38O3 243(19500) 386.2821
Ophiobolin K102 Antibiotic C25H36O3 240(23470) 384.2631
Pergillin114 Plant growth 
inhibitor 
C15H16O4 225(9550), 287(10700) 260.105
Phenylahistin115,116 Mammalian cell 
cycle inhibitor, 
anti-tumor 
activity 
C20H22N4O2 202(24000), 233(11220), 320(26900) 350.1743
Prolyl-2-(1',1'-dimethylallyl) trypto-
phyldiketopiperazine100 
 C21H25N3O2 225(32359), 275(7079), 283(8128), 291(7079) 351.1949
TMC-120A117,118 Inhibitor of IL-5 
mediated pro-
longed eosiophil 
survival 
C15H14NO2 210(31520), 250(33880), 323(7080), 340(11220), 354(12880) 241.1103
TMC-120B117,118 Inhibitor of IL-5 
mediated pro-
longed eosiophil 
survival 
C15H12NO2 212(34670), 233(12880), 239(12880), 271(23440), 
295(21380), 302(21380), 365(7760) 
239.0946
TMC-120C117,118 Inhibitor of IL-5 
mediated pro-
longed eosiophil 
survival 
C15H14NO3 211(32360), 253(31620), 354(10230), 413(1120) 257.1052
Ustic acid119,120  C21H18O6Cl2  436.0481
Nornidulin (Ustin) 119  C19H15O5Cl3  427.9987
Versicolorin C 59,102  C18H12O7 223(23800), 255(15800), 267(20400), 292(28800), 
326(10000), 450(10700) 
340.0582
PR-163686    
 
 
Table 6 
Secondary metabolites and mycotoxins from Aspergillus niger  
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da)
10, 23-Dihydro-24,25,dehydro-21-oxo-
aflavinine121 
Antiinsectan C28H37NO2 224(18200), 267(4200), 273(1400), 283(2100), 
291(1750) 
419.2824
10, 23-Dihydro-24,25,dehydro-
aflavinine121 
 C28H39NO 226(31600), 284(4400), 291(4100) 405.3032
14-Epi-14-hydroxy-10, 23,dihydro-
24,25,dehydro-aflavinine121 
 C28H39NO2 226(16400), 284(2290), 292(2100) 421.2980
16-Keto-aspergillimide 122 Anthelmintic C20H27N3O4  373.2003
1-Hydroxyyanuthone A123 Antifungal, antibacterial C24H32O5 234(8510), 290(220) 400.2251
1-Hydroxyyanuthone C123 Antibacterial C24H32O5 232(4680), 282(468) 400.2251
22-Deacetylyanuthone A123 Antibacterial C22H32O4 238(16220), 302(480) 360.2302
2-Methylene-3-(6-hydroxyhexyl)-
butanedioic acid 124,125 
Plant growth regulator C11H18O4  214.1225
2-Methylene-3-hexyl-bubutanedioic acid 
124 
 C11H18O5  230.1154
2-Methylene-3-hexyl-maleic acid anhy-
dride 124,126 
Plant growth regulator C12H16O5 253 240.0998
4-hyroxymandelic acid*  C8H8O4  168.0423
Orbole*    
Antifumicin A*    
Antifumicin B*    
Aspereyellone*    
6'-O-demethylnigerone127  C31H24O10 226(39810), 278(63095), 408(10000) 556.139
Aflavinine121  C28H39NO 225(18700), 283(3010), 291(2710) 405.3032
Antafumicin A128 Antifungal C13H14O6 217(21000), 279(15500), 317(8720) 266.0786
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Antafumicin B128 Antifungal C13H14O6 217(21000), 279(15500), 317(8720) 266.0786
Asnipyrone A129  C21H22O3 240(18600), 290(19055), 378(31625) 322.1570
Asnipyrone B129  C20H20O3 235(16600), 265(15490), 376(33885)  308.1413
Asperazine130,131 Cytotoxic, anti leukemic C40H36N6O4 225, 275, 300 
Asperenone132  C22H24O3 242(13800), 300(9200), 414-416(94200) 312.1726
Asperic acid130  C16H28O4 225, 280 
Asperparaline A (Aspergillimide) 
122,133,134 
Paralyses silkworms, 
Anthelmintic 
C20H29N3O3 206 359.2209
Asperparaline B133 Paralyses silkworms C19H27N3O3  345.2053
Asperparaline C133 Antiins Paralyses 
silkworms ectan 
C19H27N3O3  345.2053
Asperrubrol132,135  C20H22O 242(9800), 293(11200), 400(63200) 278.1672
Aurasperone A 136-138 Acute toxic C32H26O10 225(51300), 258(53700), 280(100000), 
325(8710), 406(12880) , PP 
570.1526
Aurasperone B 136,138 Acute toxic C32H30O12 235(51000), 282(87700), 321(20100), 
334(20000), 410(13600) , PP 
606.1737
Aurasperone C 136,138 Acute toxic C31H28O12 236, 283.5, 323, 336, 412 , PP 592.1581
Aurasperone D 137,138 Depress central nerv-
ous system 
C31H24O10 235-240(50119), 280(51286), 320-325(15136), 
380(7080) 
556.139
Aurasperone E137 Depress central nerv-
ous system 
C32H28O11 230(72444), 282(147910), 322(22387), 
330(20418), 400(19500) 
588.1631
BMS-192548139    
BMS-192548140 Neuropeptide Y recep-
tor inhibitor 
C21H18O9 280(4440), 320(35548), 414(38822) , PP 414.0950
Dianhydro-aurasperone C141 Acute toxic, Anti-cancer 
cell drug 
C31H24O10 225(22908), 255(26915), 280(85113), 325(3715), 
405(5754) 
556.1369
Flavasperone 136-138  C16H14O5 225(28184), 254(47863), 406(5495) , PP 286.0841
Fonsecin monomethylether138,142  C16H16O6 232(28500), 277(40500), 317(9100), 330(10000), 
395(8400)  
304.0947
Fonsecinone A143  C32H26O10 228(45700), 256(44670), 278(67600), 
325(11480), 398(7080) 
570.1526
Fonsecinone B143  C32H28O11 229(38900), 255(41700), 280(70800), 
320(14125), 328(14125), 403(9120) 
588.1631
Fonsecinone C143  C32H28O11 234(51285), 254(38000), 279(60255), 
315(19500), 327(14800), 398(7080) 
588.1631
Fonsecinone D143  C32H26O10 227(26900), 279(48975), 316(8128), 328(6920), 
403(6310) 
570.1526
Heminigerone 127  C16H14O5 225(25119), 242(32360), 247(31623), 
277(33884), 378(4467) 
286.0841
Hexylitaconic acid125,130 Plant growth inhibitor   
Hydroxyhexyl-butanedioic acid 125    
Iso-aurasperone A137,138 Depress central nerv-
ous system 
C32H26O10 255(33884), 275(38905), 385-390(3467) 570.1626
Iso-nigerone 127  C32H26O10 228(50119), 248(56234), 279(66069), 390(9550) 570.1626
Kotanin86,144  C23H20O8 203(92%), 208(100), 237(35), 259(15%), 
296(36%), 306(41%), 317(35%) 
424.1158
Malformin A159,145 Cytotoxic C23H39O5N5S2 End abs. 529.2396
Malformin A259,145 Cytotoxic C22H37O5N5S2 End abs. 515.2239
Malformin B1a, B1b, B3, B559,145,146 Cytotoxic C23H39O5N5S2 End abs. 529.2396
Malformin B2, B559,145,146 Cytotoxic C22H37O5N5S2 End abs. 515.2239
Malformin C59,147 Cytotoxic C23H39O5N5S2 End abs. 529.2396
Nigerazine A148 Plant growth inhibitor   
Nigerazine B148 Plant growth inhibitor C16H22N2O 280(22400) 258.1732
Nigerone 127  C32H26O10 226(51286), 278(83186), 407(14125) 570.1626
Nigragillin59 Toxic to silkworms C13H22ON2 262(26200) 222.1739
Ochratoxin A86,149 Cytotoxic, nephrotoxic C20H18ClNO6 205(94%), 215(98%), 218(21%), 283(2%), 
332(17%) 
403.0823
Orlandin144 Plant growth inhibitor C22H18O8 311(29500), 321(25120) 410.1002
Oxalic acid 86,150 Toxic   
Pyrophen130,151  C16H17NO4  287.1158
Rubrofusarin B137,141 Anti-cancer cell drug  C16H14O5 225(39810), 250(37153), 375(79433), 320(5248), 
395(9120) 
286.0841
Rubrofusarin127    
SB200437122,122,152 Anthelmintic   
SB203105122,122,152 Anthelmintic   
Tubingensin A153 Antiviral   
Tubingensin B153 Cytotoxic C28H35NO 218(17200), 237(25500), 260(10100), 401.2720
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299(10100), 325(2200), 338(6700) 
VM54159122 122,152 Anthelmintic   
Yanuthone A123 Antibacterial C24H34O5 232(7950), 310(500) 402.2407
Yanuthone B123 Antifungal, antibacterial C24H32O5 244(4470), 290(1950), 338(830) 400.2251
Yanuthone C123 Antibacterial C24H34O5 232(13180), 280(2040), 322(1070) 402.2407
Yanuthone D123 Antifungal, antibacterial C28H38O8 226(7940), 254(3715), 298(1150) 502.2567
Yanuthone E123 Antibacterial C29H42O8 234(9120), 280(1000), 340(450) 518.2881
* J.C. Frisvad, personal communication. 
 
Table 7 
Secondary metabolites and mycotoxins from Penicillium chrysogenum  
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
ω-hydroxyemodine 154  C15H10O6  286.0477
2-Acetyl-4(3H)-quinazolinone 155,156  C10H8N2O2  188.0586
2-pyrovoylaminobenzamide 154,157,158  C10H10N2O3 211(16500), 242(9700), 305(6930) 206.0690
2-[(2-hydroxypropionyl)amino] benzamide 
159,160 
 C10H12O3N2 249(23440), 293(5838) 208.0849
Chrysogine 154,155,161  C10H10N2O2 226(21877), 230(20892), 238(12882), 265(7244), 
273(6606), 292(2884), 305(3890), 316(3235) 
190.0743
Emodic acid 154  C15H8O6  284.032
Meleagrin 154   218(60%), 229(67%), 259(20%), 283(25%), 
329(66%) 
N-acetyl-amino-3H-phenoxazine-3-one 154    
N-formyl-O-aminophenol 154    
Questiomycin A 154,162,163  C12H8N2O2 425(23200) 212.0586
Questiomycin B 154    
Roquefortine C 59,154  C22H23O2N5 209(29500), 240(16200), 328(27000) 389.1854
Roquefortine D 59,154   203(67%), 218(100%), 283(43%), 288(45%), 
294(44%), 302(45%) 
Sorbicillin 164-167 Antioxidant C14H16O3 320(22900), 380(8000) 232.1100
Xanthocillin X (Brevicid) 154,168,169 Antibiotic C18H12O2N2 221(18%), 239(21%), 265(5%), 294(12%), 
362(100%) 
288.0900
Xanthocillin X monomethylether 170 Antibiotic C19H14O2N2 243, 303, 368, 385170 
236(14200), 295(17200), 360(30000)171 
302.1056
Xanthocillin X dimethylether 170 Antibiotic C20H16O2N2 230, 296, 363, 380 316.1212
Methoxy xanthocillin X dimethylether 170 Antibiotic  243, 303, 368, 385 346
α-Penitrin172  C14H17NO3 PP 247.1208
β-Penitrin164,172  C14H17NO3 PP 247.1208
Penitrinic acid164,172  C15H17NO5 PP 291.1107
Tiglic acid164  C5H8O2  100.0524
d-α-methylbutyric acid164    
Furoic acid164    
β-Indoleacetic acid164    
Phenylacetic acid164    
2-Decenedioic acid164  C10H10O4  194.0579
Xanthocillin Y1 (Brevicid) 168,173  C18H12N2O3  304.0849
Xanthocillin Y2 (Brevicid) 168,173  C18H12N2O4  320.0798
1,4-Di-4-hydroxyphenyl-2,3-diformamid-
(1,3)-butandien168 
   
2-Aminophenol163,168  C6H7NO  109.0528
N-formyl-2-amino-phenol168  C12H8N2O2 237(27990), 422(21827) 212.0586
2-Amino-3H-phemoxazon-(3) 168    
N-Acetyl-2-amino-3H-phenoxazon-(3)168    
A168  C12H18N2O2 237(28184), 422(21827), 434(22029) 222.1368
e168  C14H10N2O3 243(20417), 406(15136) 254.0691
B168   218(10233), 245(12023), 286(6310) 
d168  C18H16N2O4  324.1111
C168    
Penicillin G174 154   208(100%), 244(4%), 259(4%) 
Penicillin F154  C14H20N2O4S  312.1145
Chrysogenin175  C18H22O6  334.1417
Sorrentanone167  C14H14O4 194(5300), 272(8700) 246.0892
Secalonic acid D176-179** Toxic, teratogenic, 
toxic to mitochon-
C32H30O14 239(18200), 267(16200), 338(33885) 638.1635
 Page   90 
Table 7 
Secondary metabolites and mycotoxins from Penicillium chrysogenum  
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
dria 
Bisvertinolone167,180 Antibacterial   512
Lumdidin = met Ø    
Produced by the closely related P. oxalicum, making it very likely that it is also produced by P. chrysogenum (J. C. Frisvad, 
personal communication). 
 
Table 8 
Secondary metabolites and mycotoxins from Penicillium brevicompactum 
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
1,4-Dimethyl-hydroxy-3-[4'-methoxyphenylmethyl]-
2-5piperazinedione 5 181 
 C14H18N2O4 213(6600), 228(8700), 276(1200) 278.1267
11-(5'-epoxy-4'-hydroxy-3'-hydroxymethylcyclo-2'-
hexenone)-∆-drimene 181 
Antifungal C22H32O4 221(4650), 239(8250) 360.2301
1-Deoxypebrolide 182  C24H30O6  414.2042
2,4-Dihydroxy-6-(1,2-dioxopropyl)benzoic acid 
120,183-187** 
 C10H8O6 214(100%), 239(18%), 261(46%), 
279(15%), 296 (23%) 
224.0320
2,4-Dihydroxy-6-(1-hydroxy-oxopropyl)benzoic acid 
120,183-186**187 
 C10H10O6 212(100%), 240(22%), 261(33%), 
287(18%), 3098(20%) 
226.0477
2,4-Dihydroxy-6-(2-oxopropyl)benzoic acid 
183,184,188** 
 C10H10O5 214(100%), 239(18%), 263(37%), 
287(18%), 298(21%) 
210.0528
2,4-Dihydroxy-6-propylbenzoic acid 154    
2-Carboxy-3,5-dihydoxybenzylmethylketone 154    
2-Carboxy-3,5-dihydoxyphenylethyl carbinol 154    
3,5-Dihydroxyphthalic acid 154,184,188  C8H6O6  198.0164
3-Thiomethyl-3-[4'-(3''-methyl-2''-
butenoyl)phenylmethyl]-2-5-piperazinedione 181 
 C17H22O3S 207(14125), 229(15136), 277(4000) 334.1352
6-Hydroxy-3-methylthio-3-[4'-(3''-methyl-2''-
butenoyl)phenylmethyl]-2-5-piperazinedione 4 181 
 C17H22N2O4S  350.1301
Adenophostin A 189-191 Ca2+ release in mus-
cle189 
C14H26N5O18P3 256 645.0486
Adenophostin B 189-191 Ca2+ release in mus-
cle189 
C18H28N5O19P3 256 711.0591
Asperphenamate 192,193  C30H26N2O4  478.1894
Botryodiploidin 154,194-196 Genotoxic C7H12O3 278 144.0787
Brevianamide A154,197-199  C21H23N3O3 235(28600), 256(7100), 404(3260) 365.1739
Brevianamide B154,197,200  C21H23N3O3 As Brevianamide A 365.1745
Brevianamide C*197,200  C21H23N3O3 234, 259, 450 365.1741
Brevianamide D*197,200  C21H23N3O3 235, 264, 306, 479 365.1741
Brevianamide E 198,199  C21H15N3O3 239(7500), 296(2050) 357.1113
Brevianamide F197,200  C16H17N3O2 223, 275, 280, 288 283.1321
Brevicompanine A 201 Inhibit plant growth C22H29N3O2 210, 245, 303 367.2236
Brevicompanine B 201 Inhibit plant growth C22H29N3O2 208, 245, 300 367.2246
Brevigellide 154    
Brevigellin A 202  C31H41N5O7 230(10000) 595.3019
Brevione A 203 Inhibit plant growth C27H34O4  422.2457
Brevioxime204,205 Plant hormone activity C15H22N2O3  278.1630
Cis-bis(methylthio)silvatins181,206 207   
Cis-bis(methylthio)silvatins181,206 
parent alcohol 
207   
Compactin 208  C23H34O5 230(19050), 237(19950), 246(12882) 390.2403
Deoxybrevianamide E 197  C21H25N3O2 227, 279, 291.5 351.1947
Desacetylpebrolide182  C22H28O6 230(11900) 388.1886
Erthryo mycophenolic acid  209  C17H20O7  336.1209
Ethyl mycophenolat 209   C19H24O6 303(4700) 348.1573
Iso Brevianamide A 154     
Metabolites O    
Mycochromenic acid 154,209  C17H18O6 246(20500), 280(3200), 321.5(3500), 
332.5(300) 
318.1103
Mycophenolic acid 154,184,210 Anti-cancer211 C17H20O6 214(100%), 235(14%), 249(22%), 
273(2%), 303(11%) 
320.1260
Mycophenolic acid diol lactone 154,209    
N-(2-methyl-3-oxodec-8-enoyl)-pyrrole212 Plant hormone activity C15H21NO2  247.1572
N-(2-methyl-3-oxodecanoyl)-2-pyrroline213 Plant hormone activity C15H25NO2  251.1885
N-(2-methyl-3-oxodecanoyl)-pyrrole212 Plant hormone activity C15H23NO2  249.1729
N-Benzoylphenylalanine193,214,215  C17H17NO3  283.1209
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Table 8 
Secondary metabolites and mycotoxins from Penicillium brevicompactum 
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
N-benzoylphenylalaninol193,214,215  C16H17NO2  255.126
Pebrolide182,216  C24H30O7 230(9700) 430.1992
* Only produced when extract of culture are irradiated with light. **Has a tautomer. 
 
Table 9 
Secondary metabolites and mycotoxins from Penicillium polonicum 
Component Biologically 
effect 
Elementary 
composition 
λ(log ε) M (Da) 
3-methoxyviridicatin217   203(100%), 212(88%), 221(98%), 263(16%), 281(21%), 
300(14%), 315(19%), 323(23%), 335(17%) 
 
Anacine217     
Cyclopenin 154   203(93%), 210(100%), 231(59%), 251(25), 275(5), 
288(7%) 
 
Cyclopenol 154   201(100%), 214(67%), 233(35%), 269(5%), 285(7%)  
Cyclopetin217     
Dehydrocyclopeptin217     
Leucyltryptophanyldiketopiperazine217     
Met AA4     
Met B217     
Met C217     
Met DO217     
met FO217     
Nephrotoxic glycopeptides, Nephrotoxic    
Normeyhylverrucosidin 154     
Orsellinic acid 154     
Aspterric acid     
Anasine     
Pseurotins     
4-methyl-4-[2-(2R)-hydroxyl-3-butynyloxy]     
Ruglosuvine      
Penicillic acid 154 Cytotoxic    
Met POLX217     
Puberuline217     
Verrucofortine 154     
Verrucosidin 154,218 Tremorgenic C24H32O6 241(21000), 294(13000)  416.22 
Viridicatin 154   205(83%), 219(81%), 223(100%), 239(55%), 265(14%), 
288(21%), 297(20%), 308(24%), 318(29%), 329(22%) 
 
Viridicatol 154     
 
Table 10 
Secondary metabolites and mycotoxins from Trichoderma species 
Component Producing species Biologically 
effect 
Elementary 
composition 
λ(log ε) M (Da) 
(2S,3S,4R)-2-[(2R)-2-
hydroxytetracosanoylamino]-1,3,4-
octadecatriol 219 
T. koningii  C42H85O5N  683.6428
24,25-Dihydro trichotetronine 220   C28H34O8 257(35500), 368(39800) 498.2254
3-(2-hydroxypropenyl)-4-(hexa-
2E,4E-dien-6-yl)furan-2(5H)-one221 
T. harzianum  C13H18O3  222.1256
3-(propenyl)-4-(hexa-2E,4E-dien-6-
yl)furan-2(5H)-one221 
T. harzianum  C13H20O4  240.1362
3-3'-isocyanocyclopent-2-
enylidene)propionic acid222 
    
3-Dimethylamino-5-hydroxy-5-vinyl-
2-cyclopenten-1-one223 
T. koningii Antifungal C9H13NO2 Unstable 167.0952
4-Hydroxyphenetyl alcohol 219 T. koningii  C8H10O2  138.0681
4β-Epi- exahydrobenzopyran-5-one 
221,224 
T. harzianum Antifungal C16H26O5  298.1780
4β-Epi-dihydropyran 221,224 T. harzianum  C16H26O4  282.1831
6-n-pentenyl-2H-pyran-2-one225,226  Antifungal C10H12O2 302 166.0994
6-n-pentyl-2H-pyran-2-one225,226  Antifungal C10H14O2 302 164.0845
Bisorbibutenolide227  Antioxidant C28H32O8 263(14700), 293(16300), 
369(14500) 
496.2097
Bisorbicillinolide227  Antioxidant C28H32O8 293(20900), 374(17900), 496.2097
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Table 10 
Secondary metabolites and mycotoxins from Trichoderma species 
Component Producing species Biologically 
effect 
Elementary 
composition 
λ(log ε) M (Da) 
Bisvertinol180,228 T. longibrachiatum   227(9900), 274(15400), 
300(15000), 313sh, 400(24000) 
Bisvertinolone180,228 T. longibrachiatum   272(23000), 294(23000), 
366(24000) 
Chrysophanol86,229 T. viride  C15H10O4 208(51%), 225(100%), 237(33%), 
259(65%), 275(30%), 279(31%), 
283(30), 287(31%), 308(30%), 
428(30%) 
254.0579
Cyclo-(L-Pro-L-Leu)219,230,231 T. koningii  C11H18O2N2  210.1368
Cyclonerodiol 219,230,231 T. harzianum , T. koningii Plant growth 
regulator 
C18H28O2  276.2089
Cyclonerodiol-keto-diol224 T. harzianum , T. koningii  C16H26O4  282.1831
Demethylsorbicillin232  Antioxidant C13H14O3 206(16300), 325(13800) 218.0946
Diene isocyanide222,233 T. harmatum    
Dihydropyran 221,224 T. harzianum  C16H26O4 260(79400) 282.1831
Diterpenoid diketone 4 234 T. harzianum    
Emodin86,229 T. viride  C15H10O5 207(58%), 223(100%), 237(37%), 
255(51%), 267(56%), 275(52%), 
288(60%), 331(6%), 441(33%) 
270.0528
Ergokonin A235 T. koningii Antifungal C34H53NO10S  667.3390
Ergokonin B235 T. koningii Antifungal C28H42O5  458.3032
Harziandione 224,231 T. harzianum    
Harzianolide236 T. harzianum  C13H18O3  222.125
Harzianum A 237 T. harzianum Antifungal C23H28O6 204(9200), 303(21600) 400.1886
Hexahydrobenzopyran-5-one 221 T. harzianum Antifungal C16H26O5  298.1780
Homothallin II233 T. koningii Antibacterial, 
antifungal 
C8H7NO2 257  149.0527
Iso nitril acid 1238 T. harmatum  C9H7NO3  177.0426
Iso nitril acid 2238 T. harmatum  C9H9NO2  163.0634
4,4-Dihydroxy-2-(1-hydroxyheptyl)-
3,4,5,6,7,8-hexahydro-2H-1-
benzopyran-5-one239 
T. koningii Antifungal C16H26O5 260(7943) 298.1780
Isoharzandione240 T. viride Antifungal C20H28O2 255.5(1760) 300.2089
Isonitrin D233 T. koningii  C8H7NO2 236 149.0527
Koninginin A 241,242 T. koningii Inhibiting wheat 
growth 
C16H28O4 End abs. 284.1988
Koninginin B243,244 T. koningii Inhibiting wheat 
growth 
C16H26O4 262(17400) 282.1831
Koninginin D243 T. koningii  C16H26O5  298.1780
Koninginin E243 T. koningii Inhibiting wheat
growth 
C16H26O4 262 282.1831
Koninginin G245 T. aureoviride Inhibiting wheat 
growth 
C16H30O5 212(8510), 260(7590) 302.2069
Methyl Benzoate219 T. koningii  C8H8O2  136.25
MR-304A 246 T. harzianum Melanin synthe-
sis inhibitor 
C8H11NO4 209(4204), 268(726) 174.9906
MR-93A 247 T. harzianum  C8H11NO3 226(8991) 169.0751
Octaketide-acetat diol 3 221 T. harzianum Antifungal C16H28O4  284.1988
Octaketide-triol 10 224 T. harzianum Antifungal C16H26O5  298.1780
Oxosorbicillinol232  Antioxidant C14H16O5 231(11000), 301(9000), 
377.5(17600) 
264.0996
Pachybasin229 T. viride  C15H10O3 327(3.47), 403(3.78) 238.0630
Sorbicillin165,227,228 T. longibrachiatum Antioxidant C14H16O3 318(27000) 232.1099
Sorbiquinol 248 T. longibrachiatum   292(23000), 359(22500), 
374(19500) 
480.2132
Tricho-acorenol219 T. koningii  C15H26O  222.1984
Trichodermin 249 T.  longibrachiatum, T. 
harzianum, T. viride 
Cytotoxic C17H24O4 End abs. 292.1675
Trichodermol 249 T. longibrachiatum, T. 
harzianum, T. viride 
Cytotoxic C15H22O3 End abs. 250.1569
Trichodermolide 248 T. longibrachiatum  C24H28O5 280(52480), 217(14125) 396.1937
Trichodimerol220,228 T. longibrachiatum  C28H32O8 362(4.48), 307(4.20), 295(4.17), 
240(4.0) 
496.2090
Trichotetronine220   C28H32O8 271(38000), 291(42660), 
384(19500)  
496.2098
Trichoviridin233,250   C8H9NO4 220(2500) 183.0532
U-21963251 T. viride Antibiotic C9H7NO3 223(15115) 177.0426
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Secondary metabolites and mycotoxins from Trichoderma species 
Component Producing species Biologically 
effect 
Elementary 
composition 
λ(log ε) M (Da) 
Harzianic acid252 T. harzianum Antibiotic C19H27NO6 244(10964), 299(10471), 
343(23422), 359(25120), 
376(23422), 398(10471) 
365.1838
 
Table 11 
Peptides and peptabols from Trichoderma species 
Component Producing species Biologically effect Amino acids M (Da) 
Atroviridin A, B, C 253 T. atroviride  20 aa 1863 
Harzianin HB I254  T. harzianum Antibacterial, membrane 
modifying 
11aa 1160 
Harzianin HC: I, III, IX, VI, VIII, X, XI, 
XII, XIII, XIV, XV 255 
T. harzianum Antibacterial, membrane 
modifying 
14aa 1401, 1415, 1413, 1385, 1399, 
1413, 1415, 1429, 1443, 1399, 
1427 
Harzianin HK VI 256 T. psedokoningii Membrane modifying 11aa 1174 
Hypomurocin A-1, A-2, A-3, A-4, A-5 
257 
Hypocrea mur-
oiana  
Antibacterial 11aa 1160, 1174, 1174, 1174, 1188 
Hypomurocin  B-1, B-2, B-3a, B-3b, 
B-5, B-5 257 
Hypocrea mur-
oiana  
Antibacterial 18 aa 1718, 1722, 1702, 1732, 1732, 
1746 
Trichocellin A , A-I, A-II, A-III, A-IV, 
A-V, A-VI, A-VII, A-VIII 258 
T. viride Membrane modifying 20aa 1921, 1935, 1921, 1935, 1949, 
1963, 1949, 1963 
Trichocellin B-I, B-II 258 T. viride Membrane modifying 20aa 1922, 1936 
Trichokindin TK-Ia, Ib, IIa, IIb, IIIa, 
IIIb, IV, Va, Vb, VI, VII 259 
T. harzianum Membrane modifying 18aa 1748, 1748, 1762, , 1762, 1762, 
1762, 1776, 1776 
Tricholin260,261 T. viride Fungicide Protein (14200 Da)  
Trichorozin I, II, III, IV 262 T. harzianum Membrane modifiyng 11aa 1161, 1175, 1175, 1189 
Trichorzianin B, IIa, IIIc, IVb, Vb, 
VIa, VIb, VII 263 
T. harzianum Antifungal 19aa (UV data86)  
Trichorzianin A IIA, IIIA, IIIB, IIIC, 
IVB, VB, VIA, VIB VII 263  
T. harzianum Antifungal 19aa (UV data86)  
Trichorzin HA I ,II, III, V, VII 264,265 T. harzianum Antibacterial, membrane 
modifying 
18aa  
Trichorzin HC VIII, XV 264 T. harzianum Antibacterial, membrane 
modifying 
14aa  
Trichorzin KA V 264 T. harzianum Antibacterial, membrane 
modifying 
19aa  
Trichorzin MA I, II, III 264,265 T. harzianum Antibacterial, membrane 
modifying 
18aa  
Trichorzin PA VI, II, IV, V, VII, VIII, 
IX 266,267 
T. harzianum Membrane modifying 18aa  
Trichorzin SA II 264 T. harzianum Antibacterial, membrane 
modifying 
20aa  
Trichorzin TA IIIc 264 T. harzianum Antibacterial, membrane 
modifying 
19aa  
Trichotoxin A268 T. viride  191 aa  
Trichotoxin A-40269 T. viride Membrane modifiyng 18 aa  
Trichotoxin A-50269 T. viride Membrane modifiyng   
Trikoningin KA V270 T. koningii Antibacterial, membrane 
modifying 
19aa 1889 
Trikoningin KB I, II 270 T. koningii Antibacterial, membrane 
modifying 
11aa 1037, 1051 
Trichokonin TK-IIa, IIb, IIc, V, VI, VII, 
VIII271,272 
T. koningii  20 aa 1907, 1923, 1921, 1865, 1936, 
1950, 1950 
 
 
Table 12 
Secondary metabolites and mycotoxins from Memnoniella species 
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
Dechlorogriseofulvin3  C17H18O6 235(21400), 253(15100), 290(24500), 
322(4100) 
318.1104
Epidechlorogriseofulvin3  C17H18O6 248(21880), 288(28840), 320(7244) 318.1104
Griseofulvin3  C17H17O6Cl 236(21300), 252(12500), 291(21800), 
324(5200) 
352.0714
Memnobotrin A273 Cytotoxic to breast cells in NCI assays C25H33NO5 217(26200), 257.5(5600), 300(2300) 427.2359
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Secondary metabolites and mycotoxins from Memnoniella species 
Component Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
Memnobotrin B273 Cytotoxic to cells in NCI assays C27H37NO6 218.5(37200), 259(10600), 302(3300) 471.2621
Memnoconol273 Cytotoxic to cells in NCI assays. Related to 
mycophenolic acid 
C23H32O6 219(28700), 261.5(11100), 290(3000) 404.2199
Memnoconone273 Cytotoxic to cells in NCI assays Related to 
mycophenolic acid 
C23H30O5 219(38000), 261(14600), 289(2900) 386.2093
Norlicxanthone86,274-276  C14H12O5 205(68%), 218847%), 241(100%), 
267(26%), 281(19%), 313(60%), 
346(29%) 
260.0685
L-671 77627-29,277 Complement inhibitor, antimanic depressive 
drug, inhibitor of myo-inositol monophos-
phatase 
C23H32O5 230 (230%), 286(187%), 330(118%) 388.2250
Trichodermin274 Cytotoxic C17H24O4 End abs 292.1675
Trichodermol274 Cytotoxic C15H22O3 End abs 250.1569
Factor A 277 Inhibitor of myo-inositol monophosphatase C23H30O5 247, 308, 356 386.2093
Factor C 277 inhibitor of myo-inositol monophosphatase C23H30O6 247, 308, 356 402.2042
 
Table 13 
Secondary metabolites and mycotoxins from Alternaria species 
Component Producing species Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
Altenuene 278 A. alternata, sp.(= A. tenuis) Cytotoxic C15H16O6 319(6600), 278(10000), 
240(30000) 
292.0946
Altenusin278 A. alternata, sp.(= A. tenuis)  C15H14O6 217, 247, 290 290.0790
Alterlosin I278 A. alternata  C20H14O7 256(31500), 285(15700), 
366(5100) 
366.0752
Alterlosin II278 A. alternata,  C20H16O7 225(30400), 348(5000) 368.0669
Alternariol 278-280 A. alternata, A. tenuissima Teratogenic, 100 mg/kg in mice C14H10O5 218, 258(38000), 302, 330 258.0528
Alternariol mono 
methyl ether 278,279 
A. alternata, A. tenuissima Cytotoxic C15H12O5 335-342, 301, 290, 257, 230 272.0684
Altenuisol 278 A. alternata, sp.(= A. tenuis)  C14H19O6 216(9000), 256(11000), 
278(3500) 
274.0476
Altertoxin I 280,281 A. alternata, A. tenuissima Mutagenic, LC50 200µg/ml to brine 
shrimp, toxic to fibroblast >5µg/ml 
C20H16O6 215(25500), 256(34600), 
285(16300), 296(13300), 
356(6000) 
352.0946
Altertoxin II 281 A. alternata Mutagenic, LC50 200µg/ml brine 
shrimp, toxic to fibroblast >0.02 
µg/ml 
C20H14O6 215(27000), 258(31700), 
286(17000), 297(13500), 
358(5300) 
350.0790
Altertoxin III 281 A. alternata Mutagenic, , toxic to fibroblast >0.2 
µg/ml 
C20H12O6 210(19500), 265(14500), 
352(5200) 
348.0636
Dehydroaltenusin 
278 
A. alternata, sp.(= A. tenuis)  C15H12O6 217(33800), 249(12600), 
300(7500) 
288.0633
Dihydrotentoxin278 A. alternata Interferes with chlorophyl forma-
tion 
C22H32N4O4 258 416.2392
Helmidiol282 A. alternata  C16H24O6 207(17850) 312.1573
Iso-altenuene278 A. alternata, sp. Phytotoxic. C15H16O6 243(25800), 281.4(8490), 
325.7(4863) 
292.0946
Muculosin 283 A. alternata  C14H16N2O3  260.1161
Stemphyltoxin 278 A. alternata Mutagenic C20H12O6 215(29000), 269(24600), 
287(20000), 300(16500), 
374(4700) 
348.0636
Tentoxin278 A. alternata Interferes with chlorophyl forma-
tion 
C22H30N4O4 285(17500) 414.2270
Tenuazonic acid A. alternata, A. tenuissima Monkey LD50 50mg/kg C10H15NO3 218(5000), 277.5(12500) 197.1051
 
 
Table 14 
Secondary metabolites and mycotoxins from Chaetomium species 
Component Producing species Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
Aureonitol 284 C. cochlioides  C13H18O2  206.1307
Spiroketal 4 284 C. cochlioides  C13H20O4  240.1362
Chaetochromin A285,286 C. gracile Cytotoxic, delayed liver 
injuries, teratogenic 
C30H26O10 235(43680), 270(48230), 292(59150), 
325(15470), 335(10740), 410(10470) 
546.1526
Chaetochromin B287 C. gracile Cytotoxic, delayed liver C30H26O16 230(37200), 270(52100), 292(62900), 546.1526
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injuries, teratogenic 325(10300), 340(6500), 412(9500) 
Chaetochromin C287 C. gracile Cytotoxic, delayed liver 
injuries, teratogenic 
C29H24O10 233(33700), 270(37700), 293(45200), 
325(12000), 338(8100), 414(7900) 
532.1369
Chaetochromin D287 C. gracile Cytotoxic, delayed liver 
injuries, teratogenic 
C30H24O10 234(36300), 270(38800), 293(47500), 
325(13000), 338(8200), 416(8700) 
544.1323
Chaetocin B.288 C. virescens cytotoxic in Hela, IC50
30ng/ml 
C30H28N6O6S5 
Unstabile 
Triacetyl-derivat: 209(50100), 
237(20000), 299(6300) 
760.0575
Chaetocin C288 C. virescens cytotoxic in Hela, IC50
20ng/ml 
C30H28N6O6S6 
Unstabile 
Triacetyl-derivat: 210(31600), 
238(12600), 301(5000) 
760.0575
Chaetocin 59 C. minutum Cytostatic, cytotoxic in Hela, 
IC50 40ng/ml 
C30H28O6N6S4 306(6000) 696.0938
Chaetoglobosin A289 C. globosum LD50 6-18 mg/kg in mice, 
multinucleated cells 
C32H36O5N2 223(40700), 274(6600), 282(6600), 
291(5300) 
528.262
Chaetoglobosin B289 C. globosum ED50 3-10 µg/ml in HeLa 
cells, multinucleated cells, 
multinucleated cells 
C32H36O5N2 222(43600), 274(7900), 281(7900), 
290(6700) 
528.262
Chaetoglobosin C289 C. globosum ED50 10-32 µg/ml in HeLa 
cells, multinucleated cells 
C32H36O5N2 222(36300), 273(6700), 281(6700), 
291(5700) 
528.262
Chaetoglobosin D289 C. globosum ED50 3-10 µg/ml in HeLa 
cells, multinucleated cells 
C32H36O5N2 221(43600), 273(9100), 281(9100), 
290(7500) 
528.262
Chaetoglobosin E289 C. globosum ED50 3-10 µg/ml in HeLa 
cells, multinucleated cells 
C32H38O5N2 221(56200), 275(7100), 281(7000), 
291(6300) 
530.278
Chaetoglobosin F289 C. globosum ED50 10 µg/ml in HeLa cells, 
multinucleated cells 
C32H38O5N2 222(47800), 276(6900), 283(6700), 
292(6000) 
530.278
Chaetoglobosin G289 C. globosum ED50 3 µg/ml in HeLa cells, 
multinucleated cells 
C32H36O5N2 222(32300), 275(6000), 282(6000), 
291(5300) 
530.278
Chaetoglobosin J289 C. globosum ED50 3 µg/ml in HeLa cells C32H36O4N2 224(47800), 270(7000), 280(7000), 
290(6000) 
512.258
20-Dihydrochaetoglobosin 
A290 
C. subaffe  C32H32N2O5 212(51286), 221(63100), 266(8510), 
272(8320), 291(6600) 
530.2728
20-Dihydroprochaeto-
globosin II 290 
C. subaffe  C32H36N2O2 221(21880), 291(2400) 480.2779
20-Dihydroprochaeto-
globosin III290 
C. subaffe  C32H38N2O4 222(42660), 291(5250) 514.2833
Chaetohalasin A291 C. brasiliense Cytotoxic in NCI's human 
cell line 8µg/ml, antibacterial
C27H39NO2 212 (6200) 409.2971
Chaetomin 59,292 C. globosum, C. 
cochliodes 
20ng/ml inhibits protein 
synthesis in HeLA cells 
C31H30O6N6S4 295(8250), 284(9600), 275(9100) 710.1094
Chaetoviridin A293 C. globosum  C23H25ClO6 305(26000), 365(19000), 450(4600) 432.1341
Chaetoviridin B293 C. globosum  C23H29ClO7 290(14000), 385(27000), 405(24000), 
430(11200) 
452.1604
Chaetoviridin C293 C. globosum  C23H27ClO6 294(7600), 386(14000), 406(12600), 
430(5500) 
434.1498
Chaetoviridin D293 C. globosum  C23H28ClO8 290(8900), 395(16000), 410(13800), 
430(6200) 
468.1552
Chetracin A 288 C. abuense cytotoxic in Hela, IC50
70ng/ml 
C30H28N6O8S8  855.9738
11α,11'α-dihydroxychaetocin 
288 
C. retardatum cytotoxic in Hela, IC50
40ng/ml 
C30H28O8N6S4 242(17400), 302(2400) 728.0854
Cochliodinol294295 C. globosum and 
C. cochliodes 
Antibiotic. C32H32N2O4 272(11500), 293(11200), 352(5400), 
470(22400) 
508.2362
Colletodiol 296,297 C. funicola  C14H20O6 210(20500), 215(17500), 220(13400), 
225(9700), 230(6400) 
284.126
Differanisole A298  Induces cell differentiation in 
mouse leukemia cells 
C11H12Cl2O4 318(2700), 257(4060), 220(23000) 278.0114
Chrysophanol86,229 C. elatum  C15H10O4 208(51%), 225(100%), 237(33%), 
259(65%), 275(30%), 279(31%), 
283(30), 287(31%), 308(30%), 
428(30%) 
254.24
Flavipin 289     196.037
Heptelidic acid299,300  Antibiotic C15H20O5 End abs. 280.1311
Isocochliodinol300,301   C32H32N2O4  508.2362
Mollicellin A 302 C. mollicellins  C21H18O7  382.1052
Mollicellin B 302 C. mollicellins  C21H18O7  382.1052
Mollicellin C 302 C. mollicellins Mutagenic, antibacterial C22H20O8  412.1158
Mollicellin D 302 C. mollicellins Antibacterial C21H21ClO6  404.1027
Mollicellin E 302 C. mollicellins Mutagenic, antibacterial C22H19ClO8  446.0769
Mollicellin F 302 C. mollicellins Antibacterial C21H17ClO8  432.0612
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Table 14 
Secondary metabolites and mycotoxins from Chaetomium species 
Component Producing species Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
Mollicellin G301,302 C. amygdalis-
porum,  
C mollicellins 
Mutagenic, antibacterial C21H20O6  368.1285
Mollicellin H 302 C. mollicellins C21H10O6  368.126
Neococochliodinol300,301 C. amygdalis-
porum 
 C32H32N2O4  506.0
O-methylsterigmatocystin301 C. thielavioideum Carcinogenic C19H14O6 236(40700), 310(16500) 338.0790
Oosporein303,304 = Chae-
tomidin305 
C. aureum, C. 
trilaterale 
LD50 6 mg/mg in cockerels C14H10O8 208(33500), 291(23000) 306.0375
Prenisatin295 C. globosum Antifungal C13H13O2N 247(19000), 299(3900), 422(1000) 215.0946
Spiroketal 284 C. cochlioides  C13H20O2  208.1464
Sterigmatocystin301 C. udagawae, C. 
thielavioideum 
Carcinogenic C18H12O6 208(19000), 235(24500), 249(27500), 
329(13100) 
324.0633
Chaetoatrosin A306 C. atrobrunneum Inhibitor of chitin synthase II C14H14O5 225(2400), 272(1625), 408(250) 262.0841
Tomichaedin305   C12H8O5  276.9984
 
 
Table 15 
Secondary metabolites and mycotoxins from Cladosporium species 
Component Producing species Biologically effect Elementary 
composition
λ(log ε) M (Da) 
Cladosporol307 C. cladosporioides β-glucan inhibitor C20H16O6 214(19500), 260(11200), 
338(6000) 
352.0947
     
Cladospolide A308 C. cladosporioides, 
C. tenuissimun 
Plant growth regulator C12H20O4 217(10650) 228.1362
Cladospolide B 308 C. cladosporioides, 
C. tenuissimun 
Plant growth regulator C12H20O4 211(5730) 228.1362
Cladospolide C309 C. tenuissimun Plant growth inhibitor C12H20O 214(3.9) 228.1362
Calphostin A310,311 C. cladosporioides Inhibitor of protein kinase C C44H38O12 225(56199), 269(25300), 
476(20400), 543(10200), 
686(9880) 
758.2363
Calphostin B310,311 C. cladosporioides Inhibitor of protein kinase C C37H34O11 225(49500), 269(26600), 
476(21800), 543(11000), 
585(10900) 
654.2101
Calphostin C310,311 C. cladosporioides Inhibitor of protein kinase C C44H38O14 223(58200), 270(29400), 
476(22900), 543(11600), 
586(11200) 
790.2262
Calphostin D310,311 C. cladosporioides Inhibitor of protein kinase C C30H30O10 226(44800), 269(29500), 
474(23500), 539(11900), 
582(12000) 
550.1839
Calphostin I310,311 C. cladosporioides Inhibitor of protein kinase C C44H38O15 217, 258, 348, 475, 540, 
582 
806.2211
Indoleacetic acid86     
Cladosporide A312  Antifunga C25H40O3 284(162) 388.2977
23,24,25,26,27-Pentanor-
lanost-8ene-3β-22-diol312 
 Antifunga C25H42O2  374.3187
Isocladosporin313 C. cladosporioides Antifungal, inhibiting growth of wheat C16H20O5 218(20900), 231(11950), 
269(13030), 306(5984) 
292.1312
Cladosporin 313,314 C. cladosporioides Antifungal, inhibiting growth of wheat C16H20O5 217(20900), 230(11950), 
270(13030), 303(5984) 
292.1312
 
 
Table 16 
Secondary metabolites and mycotoxins from Ulocladium species 
Component Producing species Biologically effect Elementary 
composition 
λ(log ε) M (Da) 
1-hydroxy-6-methyl-8-
(hydroxymethyl)xanthone 315,316 
U. botrytis Antibacterial C15H14O4  258.0892
Ulocladol 317 U. botrytis Tyrosin kinase inhibitor C16H14O7 251(12880), 
299(3465 
318.074
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